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Abstract
The tools and methods for manipulating biological systems have been advancing at
a great pace for the last few decades. These advances make possible the develop-
ment of ever more sophisticated synthetic biological circuits for varied applications;
from the bio-remediation of polluted environments to the dynamic delivery of tar-
geted therapeutics in the body. However, the burden placed on host cells carrying
these synthetic circuits leads a reduction in fitness compared to the unengineered
host or wildtype environmental strain. This leads to challenges in maintaining a
functioning circuit within a host population and ensuring host population existence
in a competitive environment. In this thesis, I explore - and engineer - stability of
synthetic biological systems at the circuit and population levels.
In the first part of the thesis, I consider the population levels of multi-species
bacterial communities within a chemostat environment. The difficulty with con-
structing such communities is that, in the absence of other interactions, differences
in growth rates lead to competitive exclusion of the slower growing strain(s). I
design and construct a two-species community that circumvents competitive exclu-
sion. In this system, the slower growing strain is able to dynamically relieve that
pressure by producing a bacteriocin when its population drops too low; the first sys-
tem to use bacteriocins in this way. Using a mathematical model and computational
simulation I show the different achievable community dynamics and demonstrate
that they are easily experimentally tunable using an inducer molecule or dilution
rate. The novelty of this design is that it can produce stable multi-species com-
munities while only requiring the engineering of one of the constituents. The full
system is constructed and characterised using flow cytometry and Bayesian param-
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eter inference. Finally, the system is tested in competition in a bioreactor and shown
to extend the presence of the two species.
In the second part of the thesis, two approaches to enhancing the stability of
plasmids in a bacterial host are demonstrated: toxin-antitoxin (TA) systems and
bacteriocins. This is the first characterisation of axe/txe and microcin-V in the com-
mensal bacteria E. coli Nissle 1917; a strain commonly used in the development of
engineered probiotics. I show that both approaches improve the stability of burden-
some plasmids in vitro and in an in vivo mouse tumour model. The bacteriocin is
shown to have the added ability of being able to reconstitute a plasmid-bearing pop-
ulation if it is invaded by competitors. Novel deterministic mathematical models
and Bayesian statistical methods are used to understand and explain the differences
in the performance of these systems.
Systems such as these will enable the deployment of synthetic biological sys-
tems in to ever more varied environments, opening doors to a great number of future
applications.
Impact Statement
The research presented here may prove useful within academia and industry. Two
new systems are explored for tackling plasmid stability; a fundamental problem
in the deployment of synthetic biological systems in non-laboratory environments.
These systems are of particular interest for use in industrial bioreactors due to the
current cost of the removal of antibiotics from any products that are being produced.
Further, these systems were demonstrated in the commonly used probiotic bacterial
strain Escherichia coli Nissle 1917 and their function demonstrated in an in vivo
setting. This shows a clear application with regards to the development of future
live biotherapeutics. I have also demonstrated a new approach to multi-species
population control. This is another challenge that is being faced by industry as
microbial communities rather than single strain populations of engineered microbes
become more relevant.
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Chapter 1
Introduction
Modern DNA manipulation techniques have allowed researchers to design and im-
plement gene regulatory networks for therapeutic, industrial and research purposes
in both prokaryotic and eukaryotic organisms. From the production of valuable
compounds, such as artemisinin, in bioreactors to the targeting of genetic diseases
using phage therapy, engineered biological systems are already being used outside
of the laboratory and their development and deployment will continue apace. In this
Chapter I will give a brief overview of the field of synthetic biology and two current
challenges in the field that this thesis will address.
1.1 Overview
The discovery of DNA and the elucidation of the flow of information in molecu-
lar biology, as shown in Figure 1.1, has allowed researchers to think of biological
organisms as systems that are able to be engineered. The development of meth-
ods for the cutting and splicing of DNA enabled rudimentary changes to organisms
through the removal or addition of genes. More recently, genetic engineering has
advanced from knocking out individual genes in an organism to a point where it
is now tractable to create new systems of multiple interacting genes or synthetic
circuits [2]. Engineering principles, such as abstraction and modularity [3], and
methodologies, such as the design-build-test cycle, have been applied to the de-
sign and implementation of these complex systems to produce the field of synthetic
biology. In fact synthetic biology now extends beyond the piecing together of ex-
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RNA
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Figure 1.1: The flow of information in a biological system, often called the central dogma.
The dashed lines represent uncommon flows.
isting biological parts to the design of entirely new genes, proteins and even DNA
analogues.
1.1.1 Applications of Synthetic Biological Systems
Synthetic circuits in host cells, such as bacteria, can take inputs from the environ-
ment and the host and produce outputs that can report on and alter the current state
of the environment or host. Cell-free systems are now being developed that remove
the host cell from the system and create direct interactions between the environ-
ment and the circuit [4]. A library of modules and components have been developed
over the last 20 years including many analogues of electronic components such as
Boolean logic gates [5], memory [6], and clocks [7]. As our understanding of inter-
actions between circuit components and host cells improves, and technologies for
the building of circuits expand, we are able to integrate these components in to ever
more sophisticated devices.
In an industrial setting ‘biological factories’ are being produced that enable the
production of products ranging from simple hydrocarbons such as bioethanol [8]
through to complex pharmaceuticals [9]. Organisms are being developed for the
bioremediation of environmental pollutants such as arsenic [10]. Synthetic biology
also provides tools for further biological research, with optogenetics enabling the
reporting or triggering of neuron firing [11].
One of the most interesting and challenging sectors in which synthetic biology
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is being used is in the development of live biotherapeutics. Systemically delivered
drugs are untargeted, leading to only a small fraction of the therapeutic reaching
the intended location with significant off-target delivery giving rise to unwanted
side-effects. Temporal control of drug activity is reliant on dosing regimens with
predicted systemic circulation and metabolism. An alternative approach is to lever-
age the tools of synthetic biology to develop microbes that can perform targeted
therapeutic delivery with much greater control of location and timing, ultimately
allowing for higher therapeutic doses with lower systemic effects [12]. Figure 1.2
shows how engineered bacteria can be used in the human gastrointestinal tract to
target potential disease states. Recent examples of engineered bacteria being used
for therapeutics include the detection of liver cancer [13] and the prevention of
Pseudomonas aeruginosa infection [14]. In order to make bacterial therapeutics a
reality for humans there are a number of challenges still to face. Creating circuits
that function predictably in any of the potential environments that they are exposed
to is a primary necessity. Further, concerns of de novo genetic constructs escaping
from their intended host organisms must be tackled.
1.1.2 Synthetic Circuits in Host Organisms
Bacteria provide a tractable host for such synthetic biological circuits for several
reasons but none less than due to our level of understanding of the inner workings
of a set of model bacterial organisms and ongoing developments in expanding this
set. A host bacterium can carry the genes comprising a synthetic circuit in two ways:
on its chromosome(s) or on extra-chromosomal material such as pieces of circular,
double stranded DNA called plasmids. There are arguments for and against each
method and both have been used successfully in a variety of organisms.
By encoding a synthetic circuit on the chromosomal DNA of the desired organ-
ism one ensures the stable inheritance of that circuit. Further, one can be confident
of the copy-number of the circuit within the host, leading to potentially greater pre-
dictability of circuit behaviour. Inserting genetic circuits into the chromosome of
bacterial species is not necessarily simple, though new methods using lambda-Red
[16] and CRISPR-Cas9 [17] are making the process easier. However, bacteria are
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Figure 1.2: The gastrointestinal tract is an example of an environment in which live biother-
apeutics can provide targeted benefit. Engineered strains have been designed
to target (a) pathogenic microbes, (b) molecules that may lead to pathological
condition, and (c) specific disease states. Figure taken from [15].
good at streamlining their chromosomes [18]. Although there are a large number
of nonessential genes in the E. coli genome [19], it has been shown that the spatial
positioning of a gene within a cell affects its rate of transcription [20, 21]. This may
lead to unpredictable behaviour unless the circuit is placed in a well characterised
location. Finally, it is common for the development of circuits to be carried out
using plasmids due to the ease of their manipulation but recent work has shown that
moving from multi-copy plasmids to single copy chromosomal insertions can lead
to unexpected change in circuit function [22].
The use of plasmids as vectors for synthetic circuits is common. Plasmids are
a fundamental biological tool and have been widely used in molecular and cellular
biology research, leading to a number of well developed methods for their manip-
ulation [23, 24]. This ease of manipulation enables a level of modularity which is
one of the key engineering goals of synthetic biology [25, 3]. Plasmid copy number
can be an important parameter in the functioning of circuits, and it is non-trivial
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to convert a dynamical gene circuit from a multi-copy plasmid implementation to a
single copy implementation and maintain identical function [22]. As such, plasmids
remain the main vehicle for genetic circuits in industrial batch processes.
However, there are a number of difficulties with their use. Basic problems with
the use of plasmids exist such as plasmid incompatibility [26, 27] and unwanted
horizontal gene transfer [28], though these can often be overcome in the design.
More fundamental is the problem of stable maintenance of plasmids across multiple
generations. As synthetic plasmids often solely carry non-essential genes, their
loss when a cell divides leads to an advantage for the daughter cell that does not
possess the plasmid [29]. I will outline this problem in detail in this Chapter and
demonstrate two different types of system to solve this problem in Chapter 5.
1.1.3 Synthetic Populations in Competitive Environments
As synthetic biological devices begin to leave the laboratory and are used in more
complex environments the challenge becomes not just maintaining a functioning
circuit within a host cell but maintaining a functioning population of cells within an
environment. To do this we must consider how the systems that we design interact
with competitors in the environment. To be able to design systems that will function
in such environments we must be able to predict, and ideally control, the residency
of the cells that make up the systems. A system that produces a targeted therapeutic
is not useful if its occupation of the target environment is so transient that the thera-
peutic is not produced. Equally, we must take care to minimally disturb the present
inhabitants of such environments, unless that is the goal of the system, as healthy
ecosystems often require the balance of many species [30].
In addition to the challenges of maintaining a single synthetic population in
a complex environment, systems are now being designed which take advantage of
complex heterogeneous synthetic populations. The burden that increasingly more
complex circuits place on host cells is leading some researchers to develop systems
in which there is a division of labour [31]. Instead of having a single cell produce
every protein needed in a complex pathway or perform every computation in a logic
network, processes can be distributed between a heterogeneous population of cells,
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each capable of undertaking different tasks, passing metabolites between them as
necessary and communicating through small molecules. By instituting a division
of labour, one can reduce the burden on individual cells, reducing the fitness cost
and the evolutionary pressure to gain mutations which reduce the burden, and the
function, of the circuit [32].
In Chapter 3 I will describe a system that I have developed for the predictable
control of an engineered population in an environment with competition. In Chapter
4 I will describe the construction and characterisation of such a system. This system
enables the residency of two populations with different growth rates, combating
competitive exclusion, while only necessitating the engineering of a single strain.
This affords its use in competition with wild-type strains or previously engineered
systems.
For the remainder of this Chapter I will detail how the dynamic behaviour
of plasmids, though potentially beneficial to bacteria and plasmids alike in nature,
cause problems for their use as vectors in synthetic biology. In a laboratory set-
ting segregational instability is often disregarded as antibiotic selection, through the
expression of antibiotic resistance genes from the plasmids, is an easy way to en-
sure plasmid-free cells are killed. However, with the expansion of the environments
in which synthetic biological systems are used, other solutions are necessary. The
cost of removing and deactivating antibiotics from industrial fermentors means that
they are not used [33]. For clinical applications, it has been shown that antibiotics
increase horizontal gene transfer of resistance genes [34, 35] and it is likely that
disruption of the native microbiota would be undesired [36]. As such, there have
been efforts to use existing stability mechanisms such as toxin-antitoxin (TA) sys-
tems [37, 13], active-partitioning mechanisms [13, 38] and auxotrophy [39, 40] to
improve plasmid maintenance.
Further, I will discuss how, as the complexity of the system being designed and
built increases, synthetic biologists are beginning to spread the burden of systems
across communities of cells rather than expecting a single strain to do everything.
Constructing these synthetic communities produce their own challenges but also
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open the door to new applications.
Finally, I will discuss some of the methods used to model biological systems
in the field and in this thesis. I will also detail some Bayesian approaches to using
these models to gain insight into experimental systems.
1.2 Plasmids Dynamics
Plasmids are extra-chromosomal pieces of double stranded, usually circular, DNA
ranging in size from 1 kilo-base pair up to more than 1 mega-base pair [41]. They
are most common in bacteria but have been found in other domains of life and are
often used as vectors for the transfection of eukaryotic cells. The chromosomal
DNA of bacteria has been compared to a poorly stocked home bookshelf, whereas
plasmids give bacteria access to a vast library of genes [42, p. 24]. “It may take
longer to obtain a book from the library than from one’s own shelves but the library
offers an enormous supply of titles at very low cost to the individual.” A bacterium
is able to gain possession of extra-chromosomal genes either through inheritance
or through horizontal gene transfer, as shown in Figure 1.3. The ability to pick up
these extra-chromosomal genes from the environment, pass the useful ones on to
“offspring” and dispense with the burdensome ones, enables genetic experimenta-
tion to be separated from essential housekeeping chromosomal genes.
1.2.1 Horizontal Gene Transfer
Horizontal gene transfer enables bacteria to pick up genetic material throughout
their lifetime rather than just through inheritance. The mechanisms through which
this can occur are shown in Figure 1.3. Conjugation can carry both plasmids and
conjugative transposons from one cell to another, with the latter capable of enabling
the transfer of the former [44]. The GC content of mobile genetic elements tends
to be lower than that of their hosts [45] which allows for the detection of recently
inserted elements in the genomes of bacteria [46]. Transfer of plasmids by con-
jugation requires a plasmid-borne origin-of-transfer and a mobilisation mechanism
which may be carried on the plasmid, on another extra-chromosomal genetic ele-
ment or in the bacterial genome [47].
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Figure 1.3: (a) Horizontal gene transfer can occur either through the acquisition of genetic
material from the environment (transformation), the passing of genetic material
from one cell to another (conjugation) or through infection by a virus (trans-
duction). (b) Vertical gene transfer is the inheritance of genetic material by
daughter cells when a cell divides. If the genetic material is not in both parts
of the dividing cell, one of the daughters will be no longer carry those genes.
Panel (b) is adapted from [43].
The spread of antibiotic resistance genes occurs through horizontal gene trans-
fer and as such is a subject of much research. Carrying certain types of antibiotic
resistance genes comes with a cost and, therefore, in environments not requiring
resistance there is selection pressure to lose those genes [48, 49]. The expression of
antibiotic resistance genes can be under transcriptional and translational regulation
[50]. Plasmid-borne antibiotic resistance genes are often found on low copy plas-
mids [51] with the ability to increase copy number [52] and conjugation rate [53] in
response to stress. It has been shown that in an environment in which the resistance
genes are necessary, mutations can arise which counter the fitness costs [54].
Horizontal gene transfer is often considered a problem in synthetic biological
applications as it may enable engineered genetic material to escape from its intended
environment with potentially unknown consequences. This has led to systems being
developed to prevent the replication or function of DNA outside of its intended
setting [28, 55].
1.2.2 Vertical Gene Transfer
Vertical gene transfer is conceptually rather simpler than horizontal gene transfer. It
is the inheritance of intra-cellular genetic material by the daughter cells of a dividing
1.3. Segregational Plasmid Stability 25
Table 1.1: Mechanisms of plasmid stability from [1]
Resistance to environmental selection
Complementation of chromosomal mutation
Post-segregational killing of plasmid free cells
Influences of plasmid size and form
Active plasmid partitioning
High copy number
Lowering the difference in specific growth rates
Influences of cultivation conditions
Separation of plasmid free and plasmid bearing cells
Integration into the chromosome
cell. This passing on of genetic material is dependent on the spatial positioning of
the copies of that genetic material within the dividing cell. As can be seen in Figure
1.3b, if copies of the genetic material are distributed across the entire cell, both
daughter cells will inherit that material. If, however, there is an imbalance and the
genetic material is localised to one side of the dividing cell, a daughter cell without
that genetic material will be produced.
Most genes that one encodes on plasmids are non-essential and therefore po-
tentially burdensome to their host as the plasmid ‘hijacks’ the cell’s machinery for
their own purposes [56], though there are a number of exceptions to this rule [57].
This commonly leads to a lower growth rate in plasmid-bearing cells relative to their
plasmid-free counterparts which in turn leads to the dilution and eventual removal
of plasmid-bearing cells from the environment.
A number of mechanisms for improved plasmid stability have been detailed
[1]. Table 1.1 lists these mechanisms. In Section 1.3 I will discuss the mechanisms
that are available to try and prevent plasmid-free cells arising in this way. In Section
1.4 I will discuss methods for preventing plasmid-free cells from overtaking the
population if they do arise.
1.3 Segregational Plasmid Stability
The faithfulness with which a plasmid is able to guarantee its inheritance by both
daughter cells upon the division of the parent is its segregational stability. Two
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evolved mechanisms for improving segregational stability are active partitioning
mechanisms and high plasmid copy number.
1.3.1 Active Partitioning
There are three forms of active partitioning system found in bacterial plasmids:
the type I parABC-like systems, the type II parMRC-like systems and the type III
tubRZ-like systems [58]. The type I and II systems are more common and both are
three component systems involving two proteins and a binding region on the plas-
mid. As an example of the efficacy of such mechanisms, the type I par mechanism
on the P1 plasmid is effective enough that with a plasmid copy number of 3− 4
there is a loss rate of roughly one in 104 divisions [59].
1.3.1.1 Type I - parABC
In the parABC three component system the parC region on the plasmid can be
bound to by the cis-encoded ParB proteins. This complex can then move within the
cell, dependent on the distribution of ParA proteins. ParA is a cis-encoded ATPase
which, when in a dimer with ATP, binds to the surface of the bacterial nucleoid,
forming filaments with other bound ParA-ATP dimers [60]. The ParB of the ParB-
plasmid complex binds to the ParA-ATP dimer, which promotes the conversion of
ParA-ATP to ParA-ADP. This causes the ParA to unbind from the nucleoid.
It had been thought that ParB was immobilised by ParA and moved randomly
once the ParA had become unbound. The movement of the ParA on and off the
nucleoid is dependent on the position of the ParB-plasmids, leading to oscillations
around regularly spaced equilibrium positions. However, it is possible that the dis-
assembly of the ParA-ATP pulls the ParB along the ParA filament [60]. This allows
the ParB to interact with the next ParA-ATP in the chain rather than randomly dif-
fusing until it is immobilised by the next ParA that it bumps in to. A schematic of
the model is shown in Figure 1.4. Computational modelling shows that this model
produces a regular spacing of plasmids across the nucleoid of the cell, which fits
experimental data from Escherichia coli plasmid pB171 [61]. The regular spacing
of the plasmids ensures that there is equal distribution between two daughter cells
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Figure 1.4: A model of plasmid positioning by parABC. (1) ParA-ATP dimers bind to the
bacterial nucleoid. (2) ParB, bound to the parC region on the plasmid, asso-
ciates with the nucleoid bound ParA-ATP. (3) The ParB promotes the conver-
sion of ParA-ATP to ParA-ADP, leading to the unbinding of the ParA-ADP
from the nucleoid. (4’) In the diffusion-immobilisation model, the ParB is then
released from the unbound ParA-ADP and the plasmid diffuses randomly. (4)
In the model theorised by [60] the ParB is dragged to the next bound ParA-ATP
in the filament. (5) When the ParB reaches the end of a filament it randomly
diffuses until it associates again with a ParA-ATP dimer. (6) The unbound
ParA-ADP diffuses randomly and after a period of time until it reforms ParA-
ATP. Adapted from [60]
at division.
1.3.1.2 Type II - parMRC
The model type II par system is the parMRC mechanism found in the E. coli R1
plasmid [62]. parMRC is a three component system with similar constituents to
parABC [63]. The parC is a DNA sequence on the plasmid on to which the ParR
adapter proteins bind. The ParM proteins bind with ATP and begin to form polar
filaments, though these are disassembled upon hydrolysis of the ATP [64]. The
ParRC complex binds to the ParM filament, stabilising the end [65]. Two ParM
filaments can associate to form bipolar filaments with a ParRC complex at either
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Figure 1.5: A model of plasmid positioning by parMRC. (1) ParR binds to the parC region
of the plasmid. When two plasmids encounter each other they associate for
a period of time. (2) Each ParR-parC complex is able to clamp a ParM-ATP
subunit. (3) The ParM filament polymerises bidirectionally. (4) The filament
continues to grow until the plasmids have been pushed to opposite poles of the
cell. (5) Finally, the filament disassembles, leaving the plasmids at the poles
for a period of time before they begin to diffuse randomly. Adapted from [66]
end. The binding of ParRC to the end of a ParM filament accelerates the filament’s
growth [62]. This leads to the bipolar filaments pushing the plasmids at either end
apart and towards the poles of the host cell [58]. A model of the action of the
parMRC system of the R1 plasmid is shown in Figure 1.5. Thus, whereas the type
I systems used filaments to “pull” plasmids around a cell, the type II system uses
filaments to “push” plasmids away from each other.
1.3.2 Plasmid Copy Number
If no active partitioning mechanisms are present, plasmids are assumed to be free to
diffuse randomly throughout the cell. If it is assumed that cells divide perfectly in
half, there is a 50% chance of each plasmid being passed on to a specific daughter
cell. Then the distribution of plasmids in each daughter cell after division follows a
Binomial distribution with probability of 0.5 and the number of trials equal to the
number of plasmids, n. The probability that no plasmid will end up in a specific
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Figure 1.6: (a) The probability of producing a plasmid-free daughter cell based on the as-
sumption of a random distribution of monomeric plasmids within the cell. The
dashed lines show the copy number needed to replicate the stability of the parti-
tioning mechanism found on the P1 plasmid. (b) With no copy number control
the binomial distribution of plasmids between daughter cells at division leads
to an increasing plasmid copy number variance as generations progress. In
this model plasmids are binomially distributed between daughter cells and then
replicate once before the daughter cells divide. The dashed line shows the ini-
tial plasmid copy number. (c) This variance in plasmid copy number leads to
increases in the plasmid loss probability as the subset of the population with
lower plasmid copy number increases.
daughter cell reduces to 0.5n and since there are two daughter cells, the probability
of producing a plasmid-free daughter cell after division is given by p0 = 2(0.5)n =
2(1−n) [29]. In order to achieve the the 10−4 loss rate attained by the P1 plasmid
par mechanism a randomly distributed plasmid would need to have a copy number
of just over 14, as can be seen in Figure 1.6a. As such, another mechanism for
increasing plasmid persistence is to increase plasmid copy number, which is the
approach often taken in industrial biotechnology. However, this model relies on a
number of assumptions detailed below.
1.3.2.1 Copy Number Control
Variance in plasmid copy number at the point of cell division affects the rate at
which plasmid-free cells arise [29]. Figure 1.6b shows how variance in plasmid
copy number across a population increases when plasmids are binomially dis-
tributed to daughter cells on division. As the number of division cycles progress,
the copy number distribution spreads leading to an increase in cells containing a low
copy number of plasmids. As demonstrated in Figure 1.6a, as copy number goes
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down plasmid loss probability exponentially increases. This leads to the increase in
plasmid loss probability as the generations go by shown in Figure 1.6c. Thus, there
must exist mechanisms that allow plasmids to attain a target copy number before
cell division occurs again.
The pSC101 plasmid produces a protein, RepA, which binds to a site on the
plasmid itself [67]. When the plasmid copy number is too low there is a deficiency
in binding sites, leading to and excess of free RepA. The free RepA induces an
SOS response in the host E. coli which delays cellular division. This enables the
plasmids to continue to replicate until there are enough to deplete the free RepA
concentration.
Replication of the plasmid ColE1 is primed by the transcription of the repli-
cation primer precursor, RNA II [68]. During its transcription the antisense RNA,
RNA I, can form a kissing complex with RNA II, in which the unpaired bases in the
hairpin loop of RNA I pair with those in the RNA II. This can then lead to an RNA
I:RNA II duplex which causes the inhibition of primer formation and the abandon-
ment of replication. The kissing complex is stabilised by the plasmid encoded Rom
protein, which increases the likelihood of duplex formation. Using a mathematical
model it was shown that there are optimal rates of transcription and degradation of
RNA I, RNA II and the Rom protein, that strengthens their association, in order to
achieve segregational stability with minimal metabolic burden [68].
The RepA mechanism in the pSC101 plasmid places a lower bound on the copy
number by preventing cell division until a threshold copy number has been reached.
Conversely, the replication control mechanism of the ColE1 plasmid places an upper
bound on the copy number by preventing replication based on the concentration of
RNA I and Rom in the cell.
Multimer Resolution The formation of plasmid multimers by homologous recom-
bination results in an effective reduction in copy number [69]. As described above,
a reduction in copy number results in a decrease in plasmid stability. The problem is
exacerbated by the fact that a plasmid dimer, although counting as a single plasmid
for the sake of segregation, contains two origins of replication. As such, a dimer is
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twice as likely to replicate as a monomer leading to the accumulation of dimers and
larger oligomers; the ‘dimer catastrophe’ [69].
In order to protect from the destabilisation affects of oligomer formation, the
ColE1 plasmid has a mechanism for resolving those oligomers to monomers [29].
It involves the recruitment of host encoded proteins XerC, XerD, ArgR and PepA,
to the cer site on the plasmid [70, 71].
A promoter in the cer multimer resolution site of the ColE1 plasmid produces
an RNA called the regulator of cell division (Rcd) [72]. Over expression of this
transcript was shown to delay cell division as long as tryptophanase was present.
Tryptophanase catabolises tryptophan to pyruvate and indole which suggests that
indole, which is usually associated with quorum sensing behaviour, acts as the sig-
nalling molecule to prevent division [71]. Stochastic simulations show that this
delay may allow the plasmid dimers to be resolved to monomers. However, the
model seems to suggest that the main benefit comes from a reduction in metabolic
load from the dimers than from enhancing plasmid stability [73].
Plasmid Clustering An important assumption in the binomial distribution model is
that the plasmids are positioned randomly within the cell. Since high copy plasmids,
such as ColE1, do not appear to contain a par mechanism this would seem to be a
reasonable assumption. However, localisation of ColE1 to the poles of their host
cells has been observed [74]. The polar positioning of ColE1 was able to be dis-
placed by the introduction of plasmid pBAD33, which occupied the polar positions
instead. This led to the random positioning of the ColE1 plasmid and a decrease
in segregational stability. Such clustering could be explained by nuclear exclusion
combined with random diffusion but suggests that it is more likely that a regulated
process is at work [66].
RK2 plasmids have also been shown to cluster in E. coli [75]. It was observed
that the number of foci increased with cell length and growth rate, suggesting co-
ordination with the host’s cell cycle. The foci were regularly spaced as has been
seen with the parABC system present. This may lead towards confirmation of the
speculation that the origin of replication may have a role in recruiting the host cells
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partitioning factors [66].
1.4 Plasmid-free Cell Viability
Certain molecules called bactericides have the ability to kill bacteria. Other
molecules, called bacteriostats, can prevent growth and reproduction. They can
be externally introduced to the environment, as with antibiotics, or produced by the
cells themselves.
1.4.1 Environmental Selection
Environmental selection, in the form of antibiotics, is the most common form of
ensuring plasmid maintenance currently used in synthetic biology. Antibiotics are
added to the environment, complimented by an antibiotic resistance gene on the
desired plasmid. A cell’s survival is then only possible when carrying the plasmid
bearing the resistance gene. The cost of removing and deactivating antibiotics from
industrial fermentors means that they are not used [33]. Antibiotics are also un-
suitable for clinical applications for a number of reasons including horizontal gene
transfer of resistance genes [34, 35] and the disruption of the native microbiota [36].
1.4.2 Post-segregational Killing
In a similar manner to environmental selection mechanisms, post-segregational
killing (PSK) doesn’t prevent plasmid loss but instead prevents cells that have lost
a plasmid from proliferating. The difference with this system is that the plasmid
plays an active role in killing the daughter cells as well as keeping them alive.
Toxin-antitoxin (TA) systems are a type of post-segregational killing mecha-
nism that work through the production of a long lasting toxin and its shorter lived
antitoxin [76, 77], both encoded on the plasmid. While the plasmid is present in
the cell, antitoxin is being produced in excess to neutralise the toxin. If, however, a
plasmid-free daughter cell arises the antitoxin quickly degrades and is unable to be
replaced due to lack of the necessary genes. The negative effects of the toxin are no
longer prevented, leading to the killing or growth prevention of the cell.
The standard model for the function of TA systems is that a toxin, produced
by the plasmid, has its toxic effect nullified by an antitoxin, also produced by the
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Figure 1.7: Mechanism of activity of type I and type II toxin-antitoxin systems.
plasmid. The toxin has a greater stability than the antitoxin and so persists in cells
and daughter cells over a longer period. In a plasmid-bearing cell, the production
of both toxin and antitoxin are balanced so that the deleterious effects of the toxin
are not realised. If, on division, a plasmid-free daughter cell is produced, it will
initially contain balanced levels of toxin and antitoxin but as the antitoxin degrades
faster, an imbalance will develop and the toxin will have an effect.
Five types of TA system have been identified, though only one case of each
type 4 and type 5 have been detailed [78]. They differ in regards to whether the
toxin and antitoxin function post-transcriptionally or post-translationally, Figure
1.7. Further, the effects of the toxin can be either bactericidal or bacteriostatic [79].
The modes of action of the toxins differ and include the cleavage of mRNAs [80],
inhibition of cell wall synthesis [81] and the inhibition of DNA replication [82]. TA
systems have also been found in bacterial genomes, where it has been suggested
they play a role in biofilm and persister cell formation [83].
In Chapter 5 I demonstrate the use of two different TA systems, hok/sok and
axe/txe.
1.4.3 Bacteriocins
Bacteriocins are peptides and proteins that have a bactericidal affect on either a nar-
row or broad spectrum of other bacteria lacking resistance to the mechanism [84].
A common way of classifying bacteriocins is based on the size of the active protein,
with subcategories that take into account other properties such as their biochemistry
[85].
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The modes of action of bacteriocins are varied, with many interacting with the
cell wall to cause depolarisation or prevent synthesis [86]. Most groups of bacte-
riocin require extra enzymes to produce post-translational modifications, though a
group of class II bacteriocins remain unmodified.
A number of examples of use of bacteriocin mechanism in engineered bacteria
exist. Lactococcus lactis was engineered to release specific peptides when they de-
tected the cCF10 pheromone of E. faecalis [87]. It was shown that this was effective
in suppressing the E. faecalis population, even where commonly used antibiotics
were ineffective. In a study that went one step further, a novel bacteriocin was pro-
duced from two others to create a bacteriocin that would only target Pseudomonas
aeruginosa [88]. The system detected a quorum sensing molecule secreted by the
P. aeruginosa and it was able to show inhibition of the growth of the pathogenic
bacteria.
Bacteriocins have also been used explicitly as a plasmid stability mechanism
[89]. The Lcn972 bacteriocin was able to stabilise previously unstable plasmids in
L. lactis.
1.5 Metabolic Burden
Plasmid encoded genes imposes a burden on the host due its requirements for repli-
cation as well as transcription and translation. Although plasmids tend to add a
minimal extra amount of DNA to a cell, evidence exists that there is evolution-
ary pressure on them to reduce the cost of carrying and replicating the extra DNA.
The AT richness of plasmids compared to the average host chromosome suggests
that they are optimising for reduced replication burden, as those are the less energy
expensive base pairs to produce [45]. Although larger plasmids produce a greater
impact on cell growth, ATP consumption for plasmid gene expression is a far greater
source of burden [57].
A recent advance in the prediction of the burden that a given plasmid will
place on a host uses a cell-free protocol [90]. By determining the reduction in the
fluorescence of a control genetic circuit, the burden that a competing plasmid will
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place on a host bacteria can be calculated. This system, along with an earlier one
from the same group [91], can be used to design plasmids with lower burden.
An interesting example of a naturally occurring mechanism for the reduction
of host metabolic burden at the cost of, what one would have assumed would prove
to be, a plasmid fitness advantage is that of the fertility inhibition (fin) systems.
Conjugative plasmids encode the tra gene which produces the machinery for hor-
izontal gene transfer. However, the conjugative efficiency of the R1 plasmid is
reduced 1000-fold by the fin gene [92]. By blocking the conjugative machinery,
the fin system reduces the metabolic burden on the host as well as preventing the
increased susceptibility to bacteriophages caused by expression of tra genes [92].
Although increased conjugation allows plasmids to more effectively invade and per-
sist in host populations, the increased growth rate and vertical transmission of fin
expressing bacteria leads to a competitive advantage [93].
1.5.1 Host/plasmid co-evolution
An assumption that is often made, and that has been presented here, is that by
placing plasmids into a host a reduction in the host growth rate, however small,
is inevitable. However, both the host and the plasmid are evolvable and, as such,
if there is a selective pressure towards increased growth rate the two could evolve
together to increase the growth rate.
Such a result was shown after the selective growth of a strain of E. coli with a
plasmid for 500 generations [94]. It was observed that, as expected, when in com-
petition with plasmid-free bacteria, plasmid-bearing bacteria had a relatively lower
fitness. However, after 500 generations of forced co-existence, the plasmid-bearing
bacteria out-competed their plasmid-free counterparts. Further, it was shown that
even with the original unevolved plasmid, the same fitness advantages were seen,
indicating that it was the bacterial genome that altered rather than that of the plas-
mid. A later study was able to show similar results [92].
Neither of these studies directly measured growth rates, rather competition
against plasmid-free cells was used. Since growth rates are often used as a standard
measure of fitness it is difficult to extrapolate these results.
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1.6 Synthetic Microbial Communities
As the complexity of synthetic biological circuits increases, the burden that they
place on their hosts likely does as well. In addition, as the range of biological prod-
ucts that we wish to produce expands, there is a likelihood that the target product or
by-products in the chain will prove toxic to one of the standard organisms that we
use as hosts. These problems prompt the use of communities of bacteria to carry
out separate functions while interacting.
1.6.1 Coexistence of Microbial Communities
Interactions between species comprising a community can be positive or negative,
and the combinations of these interactions can be used to classify the community
relationships, as in Figure 1.8. Examples of positive interactions include the secre-
tion of a metabolite that another species is unable to produce for themselves [95]
or the degradation of environmental toxins [96]. Negative interactions include the
secretion of antimicrobials into the environment [97] or the use of a resource needed
by a competitor [98].
In many applications of microbial communities, even if the constituent species
are not competing for a substrate, space is often a limiting factor over which they
must compete. This leads to a problem, commonly known as the competitive exclu-
sion principle, in which two species competing for a single resource cannot stably
coexist. This results in many current systems having to use physical separation of
the constituent strains to maintain multispecies communities [99]. Synthetic biol-
ogy is now being used to produce communities that can stably coexist through the
addition of extra interactions that balance the existing competitive relationships.
Communication is a key tool in organising these new interactions. A predator-
prey system has been developed that uses quorum molecules to provide direct in-
teraction between a “predator” bacteria and a “prey” bacteria [100]. The quorum
molecule produced by the prey strain represses toxin production in the predator
strain, thus rescuing it. The quorum molecule produced by the predator strain in-
duces toxin production in the prey, thus killing it. This leads to the characteristic
population oscillations of a predator-prey system [101].
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Figure 1.8: Types of community relationship.
More recently, two self-limiting strains of bacteria have been shown to be able
to co-exist [102]. In this system, each strain produces and senses its own quorum
molecule. This is used to trigger the production of a lysis gene when the concen-
tration of the quorum molecule, and therefore of the producing strain, is high. The
density linked lysis leads to oscillations in each population which free up space and
substrate for the other population.
1.6.2 Industrial Applications of Microbial Communities
Production of biofuels from cellulosic mass has been one of the main applications
for the development of microbial communities. In traditional fermentation to pro-
duce bioethanol, the cellulosic material must first be hydrolysed to release the sugars
[103]. This is often done chemically but releases molecules which inhibit the later
fermentation. Further, many organisms can’t efficiently ferment all of the sugars
that are found in most cellulosic materials. A community of two E. coli strains has
been engineered to carry out the hydrolysis and fermentation of the hemicellulose
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xylan [99]. One of the strains produces the hemicellulases to break down the xylan,
while the other strain ferments the sugars that are released. A similar study used a
community of fungi and bacteria to produce isobutanol [104].
1.7 Modelling of Dynamical Biological Systems
Mathematical models provide an exact form for describing ones assumptions re-
garding a system. Detailed descriptions of molecular, atomic and even sub-atomic
interactions can be written mathematically. However, creating models with such
levels of detail are often not best for making useful predictions. A quote attributed
to John von Neumann suggests why; “With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.” Complex models with lots of un-
known parameters can be made to fit any dataset. As such, we must understand the
level of abstraction at which our models can still produce useful predictions but that
provide enough simplicity that their misuse is restricted.
There are two main forms of modelling dynamical biological systems: deter-
ministic and stochastic. Deterministic modelling uses systems of ordinary differen-
tial equations (ODEs) to describe how species within the model change over time.
One must assume that the species within the system can be modelled continuously
and as such can be described in terms of concentration rather than absolute num-
ber. When the number of a species is particularly small, this assumption does not
hold as stochastic effects can dominate. Further, one must make the assumption that
the species within the system are well-mixed, so species interact immediately and
equally. Partial-differential equations can be used if this assumption does not hold.
On the scale of bacterial cultures, where there are often > 108 cells, deterministic
modelling is usually appropriate.
Conventional wisdom suggests that biological systems are deterministic if one
has complete knowledge of the state of the system. However, the requirement of
complete knowledge is presently unattainable. Further, the computational power
necessary to simulate such a system is also not currently available. As such, the
models that we build necessarily simplify the world. The effects of those small
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details that have been removed can still be seen in the experimental data. Due to
the law of large numbers, when the number of interacting species is large, a deter-
ministic approximation is appropriate, as stated above. Stochastic modelling can be
used in domains where species numbers are low. The randomness of interactions is
modelled using a joint probability distribution for a particular reaction to happen at
a given time.
1.7.1 Stochastic Simulation
Simulating stochastic systems can be computationally intensive. The commonly
used Gillespie algorithm works by simulating every single reaction that takes place.
While this provides an exact simulation of the system, if there are a mixture of fast
and slow reactions, it can take an inordinate amount of time to run. Approximate
methods exist which determine how many reactions can be simulated at once before
the probabilities of each reaction occurring change “too much”.
In the process of carrying out the work for this thesis one such approximate
method, Tau-leaping, was implemented to run simulations in parallel on graphics
processors (GPGPUs). Although this program was not in the end used for any of
the simulations presented in this thesis, the code is available online.
1.7.2 Promoter Activity
It is often necessary to model the activities of promoters used in synthetic biological
systems. The activities, often measured through a fluorescent reporter, are depen-
dent on the concentration of an inducer or repressor. Three main paradigms exist to
model these activities when gene expression is assumed to be at steady state.
Since promoter activation curves tend to be sigmoid in form, a logistic func-
tion is sometimes fit to experimental data. The concentration of inducer at which
the promoter is half-maximally activated, the maximum promoter activity and the
steepness of the response can fitted from experimental data. This model is purely
descriptive.
The second model, the Hill function, has slightly more grounding in the mech-
anism of promoter activity. The function was developed to describe the dynamics of
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ligands binding to macromolecules but in the case of promoters describes inducing
molecules binding to promoters. Once again, the concentration of inducer at which
the promoter is half-maximally activated and the maximum promoter activity are
present. Here, however, the steepness of the curve is defined by a cooperativity pa-
rameter which conceptually describes how the binding of the first ligand affects the
binding of subsequent ligands i.e. does it increase, decrease or have no effect on the
rate.
Finally, the Shea-Ackers formalism produces models of promoter activity
based on statistical thermodynamics [105]. The binding states of transcription fac-
tors and RNA polymerase to the promoter are defined and given weights [106].
The probability of the transcription from the promoter is then given by the ratio of
states that can produce a transcript over all possible states. This formalism is the
most mechanistic of the three described and explicitly includes parameters such as
promoter leakiness.
1.8 Bayesian Parameter Inference
Once a model has been constructed, the parameters within the model need to be
given values. This can be done by searching the literature, though experimental
differences can lead to different measurements for the same parameter. For exam-
ple, the growth rate of E. coli varies drastically depending on temperature, shaking,
carbon source etc. As such, unless the conditions under which literature parameters
were ascertained can be controlled for, they should only be used as a guide. Further,
some model parameters may be impractical to directly measure experimentally.
Many optimisation methods, which infer model parameters by fitting the model
to experimental data, have been developed. All of these methods work by minimis-
ing a cost function. This is a measure of how closely the model fits the experimental
data given a set a parameters. Various forms of regression analysis enable this form
of optimisation but they have limitations, such as requiring all parameters to be
linearly independent. In many mechanistic models of biological systems, this as-
sumption can’t be met. As such, in systems in which there is correlation between
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parameters, the point estimates of those parameters can be extremely dependent on
the initial conditions of the regression.
A Bayesian approach allows for prior knowledge, such as parameters from the
literature, to be used to inform where to look for the “true” parameter values when
fitting to experimental data [107]. In addition, the Bayesian approach informs us
of the uncertainty in the parameter estimates by producing posterior distributions
rather than point estimates. This is formally written as:
p(θ |D) ∝ L(θ |D)p(θ) (1.1)
where p(θ |D) is a posterior distribution for the parameters θ given some data D,
L(θ |D) is the likelihood function and p(θ) incorporates our prior information. How
one should choose prior distributions is contentious but a reasonable recommenda-
tion is that they should be based on the researcher’s prior knowledge of the system
[108], which often includes previous experimental results and values from the liter-
ature.
It is often not possible to analytically derive an expression for the posterior
distribution. As such, Monte Carlo methods, such as Markov chain Monte Carlo
(MCMC), can be used to produce a sample from the posterior [109].
1.8.1 Approximate Bayesian Computation
For some models it can be impossible to write an expression for the likelihood. In
these situations approximate Bayesian computation (ABC) can be used to simulate
data from the model with which to provide a comparison with experimental data
[110].
The ABC rejection sampler is the simplest form of ABC algorithm. The algo-
rithm is defined as follows
where D is the experimental dataset, f produces a simulated dataset, D∗, given a set
of parameters, d is the distance function, and ε is a tolerance level. As the threshold
tends to zero, the accepted parameter vectors are a sample from the true posterior
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Algorithm 1 ABC rejection sampler
1: for i = 1 to N do
2: repeat
3: Sample θ ∗ from the prior distribution pi(θ)
4: Simulate D∗ from the model f (θ ∗)
5: until d{D∗,D} ≤ ε
6: set θi = θ ∗
7: end for
distribution, p(θ |D) [108]. However, just setting the threshold to zero would lead
to too many rejections when sampling the whole prior space. This is a weakness
of the ABC rejection sampler that is addressed with ABC-SMC (sequential Monte
Carlo) [111].
The ABC-SMC algorithm progresses through iterations, narrowing the thresh-
old for acceptance and sampling new parameters based on previously accepted pa-
rameters. The algorithm is defined as follows
Algorithm 2 ABC-SMC algorithm
1: Initialise ε1 > ε2 > ... > εT
2: for t = 0 to T do
3: for i = 1 to N do
4: repeat
5: if t = 0 then
6: Sample θ ∗∗ from prior distribution pi(θ)
7: else
8: Sample θ ∗ from {θ (i)t−1} with weights wt−1
9: Generate θ ∗∗ by applying perturbation kernel Kt(θ |θ ∗)
10: end if
11: if pi(θ ∗∗ = 0) then
12: Return to line 5
13: end if
14: Simulate D∗ from the model f (θ ∗∗)
15: until d{D∗,D} ≤ εt
16: Set θ (i)t−1 = θ
∗∗
17: Calculate weights w(i)t =
1 if t = 0pi(θ (i)t )
∑Nj=1 w
( j)
t−1Kt(θ
( j)
t−1,θ
(i)
t )
if t > 0
18: end for
19: Normalise the weights
20: end for
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In a similar fashion to the ABC rejection sampler, the ABC-SMC algorithm
rejects parameters if they produce a simulated data set that is too dissimilar from
the experimental dataset. The initial parameters that are chosen for the simulation
are based purely on the priors specified by the researcher. However, in following
rounds, the new parameters are produced by sampling the parameters that were
produced from the previous round, with a bias towards those that produced the best
fits, and perturbing them.
1.9 Thesis Outline
This thesis will focus on the control of synthetic biological systems at the plasmid
and population levels. It is organised as follows:
In Chapter 2 I detail the materials and methods used to produce and analyse
the data in this work.
In Chapter 3 I describe a system that uses competitive inhibition and the dy-
namical control of an antimicrobial peptide to stabilise two competing bacterial
populations. Using mathematical modelling I show how this system can be tuned
to produce a range of behaviours with parameters that can be simply controlled
experimentally.
In Chapter 4 I construct and characterise the population stabilisation system.
Preliminary experiments in a bioreactor are undertaken and demonstrate the ability
of the system to function as designed. Finally, a more complete mathematical model
is constructed and, using Bayesian methods, an understanding is developed as to
how to produce desired behaviours in future experiments.
In Chapter 5 I detail the examination of three systems for the enhancement
of plasmid stability. A model is developed to probe these systems and Bayesian
techniques are used to understand experimental data. The systems are tested using
a therapeutically relevant strain of E. coli in vitro and in an in vivo mouse tumour
model.
Finally, Chapter 6 provides a summary of this thesis.
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1.10 Work Carried Out by Other Individuals
The work in Chapter 5 was carried out in collaboration with Tanel Ozdemir (Barnes
Lab, UCL). He completed the cloning of the fluorescent reporter plasmids with the
toxin-antitoxin systems and all of the in vitro plasmid loss experiments were un-
dertaken together. Initial construction of the luminescent plasmids was undertaken
by Tanel Ozdemir and myself, while the promoters were cloned by Anjali Doshi
(Danino Lab, Columbia University, USA). Anjali also carried out all of the in vivo
experiments.
The search for oscillations and equilibria in the SPoCK model, using approx-
imate Bayesian computation, in Chapter 4 was carried out with Behzad Karkaria
(Barnes Lab, UCL).
Mike Sulu (UCL) and Noelle Colant (UCL) aided me with the running of the
chemostat experiment in Chapter 4.
Work carried out throughout my candidature has produced the following articles:
• Miriam Leon, Mae L Woods, Alex J H Fedorec, and Chris P Barnes. A
computational method for the investigation of multistable systems and its ap-
plication to genetic switches. BMC Systems Biology, 10(1):130, 2016
• Alex J H Fedorec, Tanel Ozdemir, Anjali Doshi, Luca Rosa, Oscar Velazquez,
Tal Danino, and Chris P Barnes. Two new plasmid post-segregational killing
mechanisms for the implementation of synthetic gene networks in E. coli
[Submitted]
• Tanel Ozdemir, Alex J H Fedorec, Tal Danino, and Chris P Barnes. Syn-
thetic biology and engineered live biotherapeutics: Toward increasing system
complexity. Cell Systems, 7(1):5–16, 2018
• Alex J H Fedorec, Behzad Karkaria, and Chris P Barnes. Dynamic stabili-
sation of multi-species bacterial consortia using bacteriocins and competitive
exclusion [In preparation]
Chapter 2
Materials and Methods
2.1 General Methods
2.1.1 Plate Reader Growth Rate Assays
Strains were spread on selective LB agar plates from glycerol stocks using an inoc-
ulation loop. The plates were grown overnight at 37°C. Single colonies were picked
and inoculated into 5mL of selective LB media in a 15mL Falcon tube. The tubes
were incubated overnight at 37°C and 200 rpm in a 2.5 cm orbital shaking incuba-
tor. The cultures were diluted 1:1000 in to 10 mL of fresh LB media without antibi-
otics. Six 200 µL replicates of each strain were pipetted in to a black clear-bottom
96-well microtitre plate (Greiner Bio-one, Germany). Any empty wells were filled
with LB media and the plate was sealed with a Breathe-Easy sealing membrane
(Sigma-Aldrich, UK). The plate was immediately placed in a POLARstar Galaxy
microplate reader (BMG LABTECH, UK) at 37°C with continuous 3mm double
orbital shaking for 20 hours with absorbance readings at 540 nm taken every 10
minutes.
2.1.2 Flow Cytometry Assays
Flow cytometry was performed on an Attune NxT Acoustic Focusing Cytome-
ter with Attune NxT Autosampler (Thermo Fisher Scientific, UK). The wells of
a round-bottomed 96-well microtitre plate (Nunc, Denmark) were filled with 200
µL of PBS. 1 µL of sample was inoculated in to each well and the solution mixed
by pipetting up and down. The plate was immediately transferred to the flow cy-
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Table 2.1: Fluorescence channels for the Attune NxT flow cytometer.
Excitation laser Emission filter (nm) Fluorescent protein
Violet (405 nm) 440/50 BFP
512/25 CFP
603/48
710/50
Blue (488 nm) 530/30 GFP and YFP
590/40 dsRed
695/40
780/60
Yellow (561 nm) 585/16 dsRed
620/15 mCherry
695/40
780/60
tometer for sampling. The Attune NxT Autosampler was set sample 20 µL from
each well with 2 mixing cycles and 4 rinses between each sample. Forward and
side scatter height and area measurements were always recorded. Height and area
measurements in the appropriate fluorescent channels were also recorded. The flu-
orescence channels are detailed in Table 2.1 and the expected emissions spectra
(http://www.spectra.arizona.edu) for each of the available lasers are shown in Fig-
ure 2.1.
2.1.3 Flow Cytometry Data Processing
In order to ensure the capture of all bacterial events in the flow cytometry sampling,
a threshold was used that also captured a considerable amount of non-bacterial
events. This can be problematic as the small size of bacteria leads to the bacterial
population appearing very close to this debris. Further, more than one bacterium
can be read as a single event due to clumping. A computational pipeline was devel-
oped to automate the gating of singlet bacteria while excluding background debris
and bacterial doublets. This process is important to automate as it removes operator
bias associated with the manual drawing of gates and speeds up the analysis when
large numbers of samples are recorded.
The method fits two dimensional mixture models of one and two clusters to
the forward-scatter-height and side-scatter-height variables with 95% confidence.
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Figure 2.1: Fluorescence emissions spectra for available flow cytometry lasers.
Using integrated completed likelihood (ICL) [115] the number of clusters that best
fits the data is determined. This allows for compatibility with experiments in which
debris has been removed by hand by an experimenter or if not many debris events
are recorded. For any clusters found, their median positions are determined and if a
cluster is below a pre-determined threshold it is considered debris and removed.
Doublets are then removed in one of two ways. Initially, a linear model was
fitted to the side-scatter-height versus side-scatter-area data and points falling too
far away were removed as doublets. An update to the Attune NxT software imple-
mented area scaling which is calibrated automatically during the start-up procedure.
The area scaling allows the assumption that singlets will lie on, or close to, the line
side-scatter-height = side-scatter-area. As such, for later experiments this method
is used for doublet discrimination.
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Figure 2.2: Processing of flow cytometry data to remove debris and doublets.
The output from this processing are standard flow cytometry .fcs files with
debris and doublets removed.
2.2 Methods for SPoCK
A number of plasmids were created for the work in Chapter 4. These plasmids are
listed in Table 2.2. All plasmid sequences were confirmed with Sanger sequencing.
Where the created plasmids have used SEVA vectors, the SEVA naming conven-
tion for antibiotic resistance and origin of replication has been adhered to, though
the “SEVA” prefix has been removed as the plasmids don’t necessarily adhere to
the SEVA standards. The SEVA convention for naming of the “cargo” region has
not been adhered to as the extensibility of this naming convention is limited. The
cloning procedures for the construction of some of these plasmids are detailed be-
low.
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Table 2.2: Plasmids used in this chapter.
Plasmid Description Source
pSEVA281 pUC ori, KnR, MCS SEVA collection
pSEVA471 SC101 ori, SmR, MCS SEVA collection
pSEVA637 BBR1 ori, GmR, GFP SEVA collection
pSEVA191 BR322 ori, ApR, MCS SEVA collection
pBAD-mTagBFP2 BR322 ori, ApR, araC ←
ParaBAD→ mTagBFP2
[116]
pTD103luxI sfGFP ColE1 ori, KnR, luxR ← PLux
→ sfGFP-LAA, luxR← PLux→
luxI-LAA
[117]
pKDL071 ColE1 ori, KnR, GFPmut3b ←
PLtetO-1, lacI ← PLtetO-1, Ptrc
→ tetR, Ptrc→ mCherry
[118]
pHK11 BR322 ori, ApR, mccV [119]
pMPES:V p15A ori, CmR, ProTeOn→ cvaC
+ cvi, mccV*
[120]
pMPES AF01 p15A ori, CmR, PLtetO-1→ GF-
Pmut3b + cvaC + cvi, mccV*
this work
p28 AF02 pUC ori, KnR, luxR ← PLux →
sfGFP-LAA + tetR
this work
p28 AF03 pUC ori, KnR, araC ← ParaBAD
→ mTagBFP2 + luxI-LAA
this work
p28 AF04 pUC ori, KnR, AF02, AF03 this work
p27 AF04 SC101 ori, KnR, AF02, AF03 this work
p23 AF04 BBR1 ori, KnR, AF02, AF03 this work
p29 AF04 BR322 ori, KnR, AF02, AF03 this work
p28 AF041 p28 AF04 with GFP removed this work
p27 AF041 p27 AF04 with GFP removed this work
p23 AF041 p23 AF04 with GFP removed this work
p29 AF041 p29 AF04 with GFP removed this work
pAF006 ColE1 ori, KnR, GFPmut3b ←
PLtetO-1, mccV ← PLtetO-1,
Ptrc→ tetR, Ptrc→ mCherry
this work
pAF0061 ColE1 ori, KnR, GFPmut3b ←
PLtetO-1, mccV ← PLtetO-1,
Ptrc→ tetR
this work
pAF0062 ColE1 ori, KnR, GFPmut3b ←
PLtetO-1, mccV← PLtetO-1
this work
pTNS1 Tn7 transposase expression, R6K
ori, ApR
[121]
pTn7-M-Pem7 mCherry R6K ori, KnR, Pem7→mCherry +
GmR transposable cassette
SEVA collection
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Table 2.3: Bacterial strains used in this chapter.
Strain Genotype Source
E. coli NEB 5-
alpha
fhuA2 ∆(argF-lacZ)U169 phoA glnV44
φ80∆(lacZ)M15 gyrA96 recA1 relA1
endA1 thi-1 hsdR17
New England
BioLabs
E. coli Top10F’ F’[lacIq Tn10(tetR)] mcrA ∆(mrr-hsdRMS-
mcrBC) φ80lacZ∆M15 ∆lacX74 recA1
araD139 ∆(ara-leu)7697 galU galK rpsL
endA1 nupG
Invitrogen
E. coli MG1655 K-12 F− λ− ilvG− rfb-50 rph-1 Prof. John
Ward (UCL)
EcM-GmRed E. coli MG1655 with chromosomal gen-
tamicin resistance and mCherry
this work
Table 2.4: Primers used in this chapter. Underlined sequences show restriction sites added
to the amplified fragments. Upper case letters show the annealing sequence.
Primer Sequence
P.XmaI.luxR.F cgatcacccgggCACCTCGAGTTAATTTTTAAAGTATGGGC
P.ApaI.GFP.R cagctggggcccTAAGCTTTTACGCTGCAAGGGC
P.ApaI.tetR.F gtgactgggcccCGGCGAAGCTAGGGAC
P.SbfI.tetR.R gtcaatcctgcaggAGTCCGAGCTCTCAAGAC
P.luxI.F AGGATCGTACAGGTTTACGCAAG
P.SpeI.luxI.R ggctcgactagtTAGCACGCGTTTACGCTG
P.delGFP.F GCATGGATGAGCTCTACAAAGC
P.delGFP.R gcactagggcccATTCGACTATAACAAACCATTTTCTTGC
P.HindIII.mccV.F tgacagaagcttTGCCCTTCCCTAGAGAATCC
P.BglII.cvaCi gcatgcagatctGTGGTAATGGGATAGAAAGTAATGGG
P.PLtetO-GFP.SacI.F atcgtagagctcCGTCTGTGCAAGTACTACTGT
P.PLtetO-GFP.XbaI.R atgctatctagaAACTGGCACGACAGGTTTC
P.SEVA.ORI.F CGGTGCTCAACGGGAATC
P.SEVA.ORI.R TGTTGTTTGTCGGTGAACGC
The bacterial strains used in Chapter 4 are detailed in Table 2.3. Electrocom-
petent cells were produced using the mannitol-glycerol step protocol [122].
The primers used for PCR amplifications are detailed in Table 2.4. The anneal-
ing sequences were designed using Primer3Plus [123] and annealing temperatures
were calculated using the NEB Tm calculator (http://tmcalculator.neb.com).
The analysis of the flow cytometry data followed the pipeline detailed in Sec-
tion 2.1.3.
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2.2.1 Cloning of AF02
The luxR← PLux→ sfGFP fragment was PCR amplified from the pTD103luxI sfGFP
plasmid using primers P.XmaI.luxR.F and P.ApaI.GFP.R with an annealing temper-
ature of 67°C. The tetR fragment was PCR amplified from the pKDL071 plasmid
using primers P.SbfI.tetR.R and P.ApaI.tetR.F with an annealing temperature of
66°C. The PCR mixes were run on a 0.7% agarose gel and the 1769 bp band was
extracted for the PLux fragment and 688 bp band for the tetR fragment. The PLux
fragment was digested with XmaI and ApaI, the tetR fragment was digested with
SbfI and ApaI and the destination vector pSEVA281 was digested with XmaI and
SbfI. The digestions were cleaned using a PCR cleanup kit. The two fragments and
the vector were ligated together to form the plasmid p28 AF02 shown in Figure
2.3, and transformed into E. coli DH5α by electroporation.
2.2.2 Cloning of AF03
The luxI fragment was PCR amplified from the pTD103luxI sfGFP plasmid using
primers P.luxI.F and P.SpeI.LuxI.R with an annealing temperature of 68°C. The
PCR mix was run on a 0.7% agarose gel and the 711 bp band was extracted for
the luxI fragment. The luxI fragment was digested with EcoRI and SpeI and the
destination vector pSEVA281 was digested with SphI and SpeI. The digestions were
cleaned using a PCR cleanup kit. The pBAD-mTagBFP2 plasmid was digested with
SphI and EcoRI and the araC← ParaBAD→ mTagBFP2 fragment at 2050 bp was
gel extracted. The two fragments and the vector were ligated together to form the
plasmid p28 AF03 shown in Figure 2.4, and transformed into E. coli DH5α by
electroporation.
2.2.3 Cloning of AF04
The p28 AF02 plasmid was digested with XmaI, SbfI and ApaLI (in order to cut
the unwanted fragment). The 2424 bp AF02 fragment, consisting of luxR← PLux
→ sfGFP tetR, was gel extracted. The p28 AF03 plasmid was digested with XmaI
and SbfI and cleaned using a PCR cleanup kit. The AF02 fragment was ligated
into the p28 AF03 plasmid, to form plasmid p28 AF04 shown in Figure 2.5, and
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transformed into E. coli DH5α by electroporation.
Versions with different origins of replication were created by PCR amplifica-
tion of the relevant SEVA plasmid with primers P.SEVA.ORI.F and P.SEVA.ORI.R.
The PCR mixes were run on 0.7% agarose gels and the bands at the expected lo-
cations were extracted. The fragments and plasmid p28 AF04 were digested with
AscI and FseI and cleaned with a PCR cleanup kit. The plasmid p28 AF04 was
digested with AscI and FseI and the band at 6654 bp was extracted. The respective
origin of replication fragments and the digested plasmid were ligated together and
transformed into E. coli DH5α by electroporation.
2.2.4 Cloning of AF041
The plasmid p28 AF04 was PCR amplified using primers P.delGFP.F and
P.delGFP.R with an annealing temperature of 65°C. The PCR mix was run on a
0.7% agarose gel and the band at 6871 bp was extracted. The fragment was di-
gested with ApaI and cleaned with a PCR cleanup kit. It was then ligated to create
the re-circularised p28 AF041 plasmid, shown in Figure 2.6, and transformed into
E. coli DH5α by electroporation.
Versions with different origins of replication were created in the same way as
for AF04.
2.2.5 Cloning of pAF006, pAF0061 & pAF0062
The mccV cassette from plasmid pHK11 was PCR amplified with primers
P.HindIII.mccV.F and P.BglII.cvaCi with an annealing temperature of 67°C. The
PCR mix was then cleaned using a PCR cleanup kit, digested with HindIII and BglII
and cleaned again. Plasmid pKDL071 was digested with HindIII and BamHI, run
on a 0.7% agarose gel and the band at 5795 bp was extracted. The mccV fragment
was ligated into the digested pKDL071 vector to create plasmid pAF006, shown in
Figure 2.7, and transformed into E. coli DH5α by electroporation.
pAF0061 was created by digestion of pAF006 with XhoI and SacI, which was
then run on a 0.7% agarose gel and the band at 8262 bp was extracted. The fragment
was then end-blunted using T4 DNA polymerase, after which the fragment was
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cleaned using a PCR cleanup kit. The fragment was then ligated with electroligase
and transformed into E. coli Top10F’ by electroporation.
pAF0062 was created in the same way but the original digestion was with XhoI
and NcoI to produce a fragment of 7523 bp.
2.2.6 Cloning of pMPES AF01
The PLtetO-1 promoter and GFPmut3b fragment was PCR amplified from plasmid
pKDL071 with primers P.PLtetO-GFP.SacI.F and P.PLtetO-GFP.XbaI.R with an an-
nealing temperature of 66°C. The PCR mix was run on a 0.7% agarose gel and the
band at 980 bp was extracted. The fragment was digested with XbaI and SacI and
cleaned using a PCR cleanup kit. Plasmid pMPES:V was digested with XbaI, SacI,
and BamHI. It was digested into three parts to avoid loss of DNA when cleaning
large fragments in Qiagen QIAquick columns. The digested plasmid was run on a
0.7% agarose gel and the bands at 3.9 Kbp and 9.4 Kbp were extracted. The GFP
fragment and the two vector fragments were ligated together using electroligase and
transformed into E. coli Top10F’ by electroporation.
2.2.7 Insertion of GmR and mCherry into E. coli MG1655
Genome
A gentamicin resistance gene and mCherry driven by the Pem7 promoter were in-
serted into the genome of E. coli MG1655 to produce a selectable and detectable
strain. This was done using the mini-Tn7 transposon system which inserts a cas-
sette, flanked by the Tn7L and Tn7R sequences, downstream of the glmS gene
[121]. The method requires the double transformation, of the strain to be engi-
neered, with a plasmid carrying the insertion cassette and a plasmid carrying the
transposition machinery, TnsABCD. This was done by electroporation. The plas-
mids both had an R6K origin of replication was is incapable of replicating in strains
that do not express the pir gene. This means that the plasmids are lost quickly and
one can select for successful chromosomal insertion with antibiotics. Successful
insertion was also checked by PCR with one primer annealing within the chromo-
somal glmS gene and one within the insert.
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2.2.8 Characterisation of Genetic Circuits
Unless otherwise stated, all plasmids were transformed into E. coli MG1655 by
electroporation for characterisation. Overnight cultures of the relevant strains were
grown in supplemented M9 media with the appropriate antibiotics in a shaking in-
cubator at 37°C and 200 rpm. After 16 hours of growth, the cultures were diluted
1:1000 into fresh supplemented M9 media with antibiotics and grown for 5 hours
in a shaking incubator at 37°C and 200 rpm. After 5 hours the cultures were di-
luted 1:100 into fresh supplemented M9 media with antibiotics and induced with
the relevant concentration of inducer. 200 µL of each of the induced culture were
then pipetted into a clean 96 well microtitre plate and sealed with a Breathe-Easy
sealing membrane. The plate was immediately placed in a plate reader and run with
a program that recorded absorbance at 540 nm and fluorescence with excitation at
480 nm and emission at 540 nm every 10 minutes for 20 hours. It was incubated at
37°C and had constant double orbital shaking while not taken measurements. After
completion of the plate reader program, the microtitre plate was removed from the
plate reader and 1 µL of culture from each well was used to inoculate 200 µL of PBS
in a clean round-bottom 96 well microtitre plate. This plate was used to take flow
cytometry recordings as detailed in Section 2.1.2. Data from the flow cytometer
was analysed as detailed in Section 2.1.3.
2.2.9 Characterisation of Genetic Circuits in PBS
In order to ascertain circuit function at a constant cell density some characterisation
was carried out in PBS rather than media. The protocol was identical to that carried
out above except that before the 1:100 dilution into M9 media, the cultures were
washed twice with PBS before being diluted 1:100 into fresh PBS. These 1:100
dilutions were then serially diluted 1:2 into PBS. All of these dilutions were then
induced with the relevant concentrations of inducer and pipetted into the microtitre
plate as before. The plate reader recordings were only carried out for 6 hours.
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2.2.10 Agar Plate Spot Inhibition Assay
Cultures of bacteriocin producing strains were grown overnight in supplemented
M9 media without antibiotics but with the recorded concentration of inducer. A
culture of a bacteriocin sensitive strain, E. coli MG1655 unless otherwise stated,
was also grown overnight. Using a sterile swab, a lawn of sensitive bacteria was
spread on an antibiotic free LB-agar plate. This was allowed to dry at room tem-
perature for an hour. 3 µL of each culture was spotted on to the surface of the lawn
and the plate was allowed to dry for a further hour. The plate was placed in an
incubator at 37°C for 20 hours. The plate was visualised in a BioRad GelDoc using
the epi-white light source.
2.2.11 Chemostat Competition Experiment
The SPoCK strain was spread on LB agar plates containing kanamycin and chlo-
ramphenicol, from glycerol stocks using an inoculation loop. The EcM-GmRed
strain was spread on LB agar plates containing gentamicin, from glycerol stocks us-
ing an inoculation loop. The plates were grown overnight at 37°C. Single colonies
were picked and inoculated into 5 mL of selective LB media in a 15 mL Falcon
tube. The tubes were incubated overnight at 37°C and 200 rpm in a 2.5 cm orbital
shaking incubator.
The Eppendorf DASbox was prepared as per the manufacturers instructions.
The feed media was M9 media with glycerol as the sugar source and 0.2% arabi-
nose. All four chambers were filled with 150 mL of media. The overnight cultures
of killer and competitor were mixed together and 2 mL was used to inoculate each
chamber. After 6 hours of growth, the chambers had reached an optical density of
∼ 1. At this point the dilution pumps were switched on; chambers 1 and 2 were
diluted at 15 mL h−1, chambers 3 and 4 at 7.5 mL h−1. At sample timepoints 1 mL
of culture was taken from each chamber and the optical density was measured. 2 µL
of the sample was used to inoculated 100 µL of PBS and the single cell fluorescence
was measured in the flow cytometer.
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Table 2.5: Plasmids used in this chapter.
Plasmid Description Source
pSEVA246 hybrid pRO1600/ColE1 ori, KnR,
luxCDABE
SEVA collection
pSF SC101 OXB20-
daGFP
SC101 ori, KnR, OXB20→ daGFP,
MCS
Oxford Genetics
pKG1022 A plasmid carrying hok/sok from
pPR633.
[124]
pREG531 A plasmid carrying axe/txe from
pRUM.
[125]
pHK11 BR322 ori, ApR, microcin-V [119]
p28 OXB20 pSF SC101 OXB20-daGFP with
the ori swapped for pUC
this work
p28 OXB20-HS p28 OXB20, hok/sok this work
p28 OXB20-AT p28 OXB20, axe/txe this work
p28 OXB20-MCC p28 OXB20, microcin-V this work
p28 OXB20-CVA p28 OXB20, microcin-V without
transport genes
this work
p24 help-Lux pSEVA246 with phelp promoter up-
stream of luxCDABE
this work
p24 help-Lux-HS p24 help-Lux, hok/sok this work
p24 help-Lux-AT p24 help-Lux, axe/txe this work
p24 help-Lux-MCC p24 help-Lux, microcin-V this work
pTNS1 Tn7 transposase expression [121]
pUC18T-mini-Tn7T-
Gm-dsRedExpress
GmR mini-Tn7 vector, mobilizable,
for RFP tagging bacteria
[126]
2.3 Methods for Plasmid Stability Experiments
A number of plasmids were created for the work in Chapter 5. These plasmids are
listed in Table 2.5. All plasmid sequences were confirmed with Sanger sequencing.
Where the created plasmids have used SEVA vectors, the SEVA naming conven-
tion for antibiotic resistance and origin of replication has been adhered to, though
the “SEVA” prefix has been removed as the plasmids don’t necessarily adhere to
the SEVA standards. The SEVA convention for naming of the “cargo” region has
not been adhered to as the extensibility of this naming convention is limited. The
cloning procedures for the construction of some of these plasmids are detailed be-
low.
The bacterial strains used in Chapter 5 are detailed in Table 2.6. Chemically
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Table 2.6: Bacterial strains used in this chapter.
Strain Genotype Source
E. coli NEB 5-
alpha
fhuA2 ∆(argF-lacZ)U169 phoA glnV44
φ80∆(lacZ)M15 gyrA96 recA1 relA1
endA1 thi-1 hsdR17
New England
BioLabs
EcN E. coli Nissle 1917 Prof. Ian
Henderson,
UK
EcN-Red E. coli Nissle 1917 with chromosomal
dsRedExpress and gentamicin resistance
this work
EcN-Lux E. coli Nissle 1917 with chromosomal lux-
CDABE and erythromycin resistance
[13]
Table 2.7: Primers used in this chapter. Underlined sequences show restriction sites added
to the amplified fragments. Upper case letters show the annealing sequence.
Primer Sequence
P.SacI.mccV.FOR tgacgcgagctcTGCCCTTCCCTAGAGAATCC
P.XbaI.mccV.REV actgtctctagaGGGTCAGTGCAGAATTTTTA
P.SacI.cvaC.FOR tgtcgcgagctcACGAGCCTTATACCGGAAA
P.HS.SacI.F atctgagagctcTCCGGCCGAACAAACTCC
P.HS.BamHI.R atgtcaggatccAAGGAGAAAGGGGCTACCG
P.glmS.F CGCTGCAACTACTGGCTTA
P.Tn7.R CACAGCATAACTGGACTGATTTC
competent cells were produced using a standard protocol. The primers used for PCR
amplifications are detailed in Table 2.7. The annealing sequences were designed
using Primer3Plus [123] and annealing temperatures were calculated using the NEB
Tm calculator (http://tmcalculator.neb.com). The analysis of the flow cytometry
followed the pipelines detailed in Section 2.1.3.
2.3.1 Chromosomal Insertion of Antibiotic Resistance and Flu-
orescence Reporter in to E. coli Nissle
The plasmid loss experiments could not be carried out using antibiotic selection for
plasmid-borne resistance genes as this would prevent plasmid loss. Therefore, in or-
der to prevent external contamination during prolonged experiments, an antibiotic
resistance gene, along with a fluorescence reporter, was inserted in to E. coli Nissle
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using the mini-Tn7 transposon system. A plasmid carrying the transposon machin-
ery, pTNS1, and a plasmid carrying the sequence to be inserted, pUC18T-mini-
Tn7T-Gm-dsRedExpress, were transformed in to electrocompetent E. coli Nissle
by electroporation. Correct insertion was then tested by colony PCR using primers
P.Tn7.R and P.glmS.F. Unfortunately, absence of the two plasmids was not checked
for until after 25 days of a plasmid-loss experiment at which point it was discovered
that the pUC18T-mini-Tn7T-Gm-dsRedExpress plasmid was still present. Further
attempts to cure the strain of the plasmid failed, therefore, the plasmid-loss experi-
ment was redone in EcN-Lux.
2.3.2 Cloning of p28 OXB20 Based Plasmids
All of the below DNA manipulations were performed in E. coli NEB 5-alpha and
followed the instruction detailed by the reagent manufacturers unless otherwise
stated.
Plasmid p28 OXB20-HS was created by digesting pKG1022 with HindIII and
SacI and gel extracting the 633 bp fragment. This was ligated in to p28 OXB20
which had been digested using the same restriction enzymes. Plasmid p28 OXB20-
AT was created by digesting pREG531 with BamHI and SacI and gel extracting the
1390 bp fragment. This was ligated in to p28 OXB20 which had been digested us-
ing the same restriction enzymes. Plasmid p28 OXB20-MCC was created by PCR
amplification of pHK11 with primers P.SacI.mccV.FOR and P.XbaI.mccV.REV to
amplify the microcin-V fragment and anneal restriction enzyme recognition sites to
the ends. This fragment was then digested with XbaI and SacI and a fragment at 4.8
Kbp was extracted. This was ligated in to p28 OXB20 which had been digested us-
ing the same restriction enzymes. Plasmid p28 OXB20-CVA was created by PCR
amplification of pHK11 with primers P.SacI.cvaC.FOR and P.XbaI.mccV.REV to
amplify the cvi-cvaC fragment and anneal restriction enzyme recognition sites to
the ends. This fragment was then digested with XbaI and SacI and a fragment at
1.2 Kbp was extracted. This was ligated in to p28 OXB20 which had been digested
using the same restriction enzymes. The plasmid p28 OXB20 and the inserted frag-
ments are shown in Figure 2.9. These plasmids were transformed in to EcN-Lux
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using a standard heat-shock transformation method.
2.3.3 Cloning of p24 help-Lux Based Plasmids
The p24 help-Lux based plasmids were produced in two steps; first the PSK sys-
tems were cloned in to the MCS of plasmid pSEVA246, then the phelp promoter
was cloned upstream of the luxCDABE cassette. p28 OXB20-HS was PCR am-
plified with P.HS.SacI.F and P.HS.BamHI.R to amplify the hok/sok fragment and
anneal restriction enzyme recognition sites to the ends. This fragment was then
digested with SacI and BamHI and ligated in to pSEVA246. p28 OXB20-AT was
digested with SacI and BamHI and the 1.3 Kbp fragment was gel extracted and lig-
ated in to pSEVA246. p28 OXB20-MCC was digested with SacI, XbaI and ApaLI;
the third enzyme was added to cut the unwanted fragment and enable the gel extrac-
tion of the microcin-V 4.8Kbp fragment. This was ligated in to pSEVA246 which
had been digested with SacI and XbaI. The plasmid pSEVA246 and the inserted
fragments are shown in Figure 2.10. The phelp promoter was then cloned upstream
of the luxCDABE cassette for the PSK bearing plasmids and the pSEVA246 using
Gibson Assembly [127] by Anjali Doshi (Danino Lab, Columbia University, USA)
These plasmids were transformed in to EcN using a standard heat-shock transfor-
mation method.
2.3.4 Growth Rate Assays - p24 help-Lux Based Plasmids
Two changes had to be made to the general protocol when recording growth curves
for the luminescent plasmids. Firstly, they had to be grown in selective media to pre-
vent the rapid plasmid loss in p24 help-Lux. Secondly, absorbance measurements
were additionally taken at 410 nm due to the frequency of the luminescence.
2.3.5 Plasmid Stability Assays in Liquid Culture
Assays were performed in LB media in sterile deep square 96-well (2.2 mL)
polypropylene plates. The edge wells were used for LB media controls so that the
strains weren’t affected by any potential plate edge conditions [128]. The 96-well
plate was split into two sections; one section with 500 mL LB media containing ery-
thromycin (100 µg/mL) and kanamycin (25 µg/mL) and the second with LB media
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containing only erythromycin The erythromycin was used to prevent external con-
tamination as the resistance gene is encoded on the chromosome of the EcN-Lux
bacterial strain. The kanamycin is used to ensure plasmid maintenance, generating
a plasmid-bearing control throughout the experiment.
Three double selective wells for each strain were inoculated by picking single
colonies from selective LB agar plates. Six single selective wells were inoculated
with EcN-Lux, as a plasmid-free control, by picking single colonies from selective
LB agar plates. The plate was covered with a System Duetz breathable silicon
sandwich (EnzyScreen, The Netherlands) and clamped down in a shaking incubator
at 37°C and 350 rpm for 24 hours. This produced the time point 0 cultures. The
procedure is shown in Figure 2.11.
These cultures were then used to inoculate 1:500 a fresh plate, arranged with
the same selective layout. Each double selective cultures were used to inoculate 3
replicates in single selective media. This produced 9 replicates of each plasmid-
bearing strain in single selective media and 3 in double selective media. The EcN-
Lux plasmid-free control had 6 replicates in single selective media. Although the
double selective media was inoculated with the EcN-Lux strain, as expected, no
bacteria grew. This plate was covered and incubated as before. For subsequent
passages the plate was replicated 1:500 in to fresh media with a one-to-one mapping
between wells.
At each passage, 200 µL of the overnight culture was transferred in to a black
clear-bottom 96-well microtitre plate (Greiner Bio-one, Germany) and absorbance
(540nm), fluorescence (ex=480 nm, em=540 nm), and luminescence were measured
in a microplate reader. In addition, 1 µL of the overnight culture was transferred in
to a round-bottom 96-well microtitre plate containing 200 µL of PBS and the single
cell fluorescence was measured using a flow cytometer.
The assay for the luminescent plasmids differed slightly from that described
above for the fluorescent plasmids. The assays could not be performed with ery-
thromycin as the EcN bacterial host did not contain the resistance gene. In order
to prevent external contamination in LB cultures without any antibiotic, the entire
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plate was additionally exposed to UV light for 40 minutes before inoculation at each
passage [129]. Further, only absorbance and luminescence could be measured so
the preparation of the plate for flow cytometry was not carried out. Absorbance was
additionally measured at 410 nm.
2.3.6 Luminescent Plasmid Stability Assays in vivo
This work was carried out by Anjali Doshi and others in the research group of Tal
Danino (Columbia University, USA).
All animal work was approved by the institutional committee on animal care
(Columbia, AC-AAAN8002). The protocol requires animals to be euthanised when
tumours reach 2 cm3, or under veterinary staff recommendation. The cell line
(MC26-LucF, Tanabe laboratory, Massachusetts General Hospital) was obtained
from, and authenticated by, the Tanabe laboratory, MGH. The cell line was tested to
be mycoplasma-free before implantation in mice. Sample sizes for mice were de-
termined by expected effect size to produce a power of 0.8-0.9. Mice were blindly
randomized into various groups using a random number generator.
Animal experiments were performed on 6-week-old female BALB/c mice
(Taconic Biosciences) with bilateral subcutaneous hind flank tumours from an im-
planted mouse colon cancer cell line (MC26-LucF). The concentration for implan-
tation of the tumour cells was 108 cells per ml in DMEM (no phenol red). Cells
were then implanted subcutaneously at a volume of 100 µL per flank, with each im-
plant consisting of 107 cells. The MC26 cells where given 14 days to graft and grow
until they reached a size of approximately 150-200 mm3. Along with an EcN-Lux
strain as a control, EcN:p24 help-Lux, EcN:p24 help-Lux-HS, EcN:p24 help-Lux-
AT and EcN:p24 help-Lux-MCC were grown up in LB with kanamycin until expo-
nential phase, washed three times in sterile PBS and then injected intravenously at
a dosage of 1x106 bacteria in 100 µL. After bacterial colonisation of the tumours,
animals were monitored via IVIS (IVIS 200, Caliper Life Sciences) to detect the
presence of the plasmid via bioluminescence. Briefly, this involved anaesthetising
the mice with isoflurane and imaging with an open filter on the auto-exposure set-
ting. After 7 days, each of the tumours were sterilely extracted and homogenised
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using a tissue dissociator (Miltenyi), an aliquot of which was seeded on each of
LB plates and LB with kanamycin plates. The ratio was calculated by compar-
ing the mean counts of plasmid bearing colonies on LB plates and LB plates with
kanamycin from each tumour [13].
2.3.7 Strain Dilution Assays
Overnight cultures of each strain were grown, from single colonies picked from
selective LB agar plates, in 5 mL of selective LB media. Different dilutions of
plasmid-bearing to plasmid-free strains were then produced by pipetting different
volumes of plasmid-bearing overnight culture in to EcN-Lux overnight culture in
percentages from 10% through to 100%, keeping a total volume of 100 µL. For
example, to produce a 30% culture 30 µL of plasmid-bearing overnight culture was
added to 70 µL of EcN-Lux overnight culture. Note that the overnight cultures
were not normalised to the same optical density, so a 30% culture does not mean
that 30% of the cells are plasmid-bearing. Assays were performed in LB media
in sterile autoclaved deep square 96-well (2.2 mL) polypropylene plate. Each well
was filled with 500 µL of LB media with erythromycin (100 µg/mL). The wells were
then inoculated in a random pattern with 3 replicates of each of the diluted cultures.
The deep well plate was then sealed and incubated as above. At the same time a 96-
well microtitre plate was prepared with 200 µL of PBS in each well and inoculated
from the same diluted cultures and measured using the same flow cytometry set up
as above. After 24 hours the plate was taken from the incubator and passaged, as
above, while a flow cytometry plate was also prepared and measured. This was
carried out for a total of 2 passages. The data from passage 1-2 was used for the
model fitting as this allowed the cells time to get used to growing in the deep-well
plate. However, for the MCC strain it was necessary to use data for passage 0-1
because after 24 hours all plasmid-free bacteria had been killed.
2.3.8 Plasmid-bearing Cell Clustering
After the flow cytometry data was processed to select only the singlet bacteria, cells
were classified as plasmid-bearing or plasmid-free. This classification was achieved
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by clustering on the GFP fluorescence measurement as only plasmid-bearing cells
are still producing GFP. Two methods for clustering were tested; one dimensional
mixture models and a minimum density estimator.
The mixture model method is equivalent to that used to remove debris in the
initial flow cytometry processing. Mixture models of one and two clusters are fitted
to the data and integrated completed likelihood (ICL) [115] is used to determine
which model fits the data best. If two clusters are found, the one with the higher
fluorescence level is classified as the plasmid-bearing population and the other as
plasmid-free. If only one cluster is found, the cluster is classed as plasmid-bearing
if the median is above a user defined threshold. The minimum density estimator
fits a kernel density estimate to the data and identifies the two largest peaks. A
threshold is drawn at the minima between those two peaks and the cluster at the
higher fluorescence level is classed as plasmid-bearing.
Neither of these methods works particularly well when one of the peaks is
very small. As such, it was determined that a user defined threshold produced more
reliable results, particularly at the key experimental points when the plasmid-free
population is just establishing.
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p28_AF04
7587 bp
rrnB T1 luxR
Plux
sfGFP-LAA
tetR
araC
ParaBAD
mTagBFP2
luxI-LAA
lambda T0
KanR
oriT
pUC ori
p28_AF02
4916 bp
rrnB T1
luxR
Plux
sfGFP-LAA
tetRlambda T0
KanR
pUC ori
oriT
XmaI
SbfI
p28_AF03
5182 bp
rrnB T1
araC
ParaBAD
mTagBFP2
luxI-LAA
lambda T0
KanR
oriT
pUC ori
XmaI SbfI
HindIII digest
p28_AF04
N
EB 2-log ladder
Figure 2.5: Cloning to produce p28 AF04.
p28_AF04
7587 bp
rrnB T1
luxR
Plux
sfGFP-LAA
tetR
araC
ParaBAD
mTagBFP2
luxI-LAA
lambda T0
KanR
oriT
pUC ori
P.delGFP.F
P.delGFP.R
p28_AF041
6803 bp
rrnB T1
luxR
Plux
tetR
araC
ParaBAD
mTagBFP2
luxI-LAA
lambda T0
KanR
oriT
pUC ori
XbaI + StuI digest
p28_AF041
N
EB 2-log ladder
Figure 2.6: Cloning to produce p28 AF041.
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pAF006
9155 bp
GFPmut3b
PLtetO-1
cvaA
cvaB
cvaC
cvi
PLtetO-1
Ptrc-2
tetR
Ptrc-2
mCherry
rrnB T1
ColE1 ori
lambda T0
KanR
pKDL071
5795 bp
GFPmut3b
PLtetO-1
lacI
PLtetO-1
Ptrc-2
tetR
Ptrc-2
mCherry
rrnB T1
ColE1 ori
lambda T0
KanR
HindIII
BamHI
pHK11
12829 bp
cvaA
cvaB
cvaCcvi
pBR322 ori
AmpR
rop
bom
P.HindIII.mccV.F
P.BglII.cvaCI
SacI digest
pAF006
N
EB 2-log ladder
Figure 2.7: Cloning to produce pAF006.
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pMPES:V
14696 bp
BamHI
XbaI
SacI
cvaA
cvaB
cvaC*
cvi
CmR
p15A ori
ProTeOn promoter
ProTeOn
cvaC
cvi
pMPES_AF01
14290 bp
cvaA
cvaB
cvaC*
cvi
CmR
p15A ori
PLtetO-1
GFPmut3b
cvaC
cvi
pKDL071
5795 bp
GFPmut3b
PLtetO-1
lacI
PLtetO-1
Ptrc-2
tetRPtrc-2
mCherry
rrnB T1
ColE1 ori
lambda T0
KanR
P.PLtetO-GFP.SacI.F
P.PLtetO-GFP.XbaI.R
EcoRI digest
pM
PES_AF01
N
EB 1Kb ladder
Figure 2.8: Cloning to produce pMPES AF01.
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 p28_OXB20
4729 bp
HindIII 285
SacI 297
XhoI 344
XbaI 353
T7
T7
rrnG
pUC ori
OXB20
daGFP
rrnG
KanR
rrnG
cvaA cvaB cvaC cviSacI XbaI
mccV
4848 bp
txe axeSacI XhoI
axe-txe
1793 bp
mok
hoksok SacIHindIII
hok-sok
633 bp
 p28_O
XB20
 p28_O
XB20_H
S
 p28_O
XB20_AT
 p28_O
XB20_M
C
C
N
EB 2-log ladder
N
EB 2-log ladder
NdeI digest
Figure 2.9: Cloning of p28 OXB20 based plasmids. Restriction enzyme cut sites for the
insertion of the TA and bacteriocin fragments are marked on the plasmid.
pSEVA246
9351 bp
SacI 66
BamHI 77
XbaI 83
luxC
luxD
luxA
luxBluxE
lambda T0
KanR
oriT
ColE1 ori
pRO1600 Rep
pRO1600 oriV
rrnB T1
mok
hoksok BamHISacI
hok-sok
603 bp
txe axeSacI BamHI
axe-txe
1339 bp
cvaA cvaB cvaC cviSacI XbaI
mccV
4848 bp
pSEVA246
 p246_H
S
 p246_AT
 p246_M
C
C
N
EB 2-log ladder
NdeI + ApaLI digest
Figure 2.10: Cloning of p24 help-Lux based plasmids. Restriction enzyme cut sites for the
insertion of the TA and bacteriocin fragments are marked on the plasmid.
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Figure 2.11: Inoculation layout and passage procedure. Strains are streaked from glycerol
stocks on to LB agar plates with appropriate antibiotics. Three colonies of
each strain are used to inoculate a 96-well plate; the plasmid-bearing strains
are inoculated in to wells containing kanamycin and erythromycin (orange -
LB+Kn+Er), the EcN-Lux controls are inoculated in to wells containing only
erythromycin (yellow - LB+Er). The plate is grown for 24 hours after which
a fresh 96-well plate is inoculated from the overnight cultures; the plasmid-
bearing strains are used to inoculate three replicate (LB + Er) wells from each
(LB + Kn + Er) biological replicate. All wells from the overnight plate are
sampled, with optical density, fluorescence and luminescence being recorded.
The newly inoculated plate is grown for another 24 hours after which it is
passaged and sampled.
Chapter 3
A System for Stabilising Competing
Populations of Bacteria
Competition between heterogeneous populations of engineered bacteria or engi-
neered and wild type strains is a topic that is becoming increasingly relevant with
the expansion in the complexity of synthetic circuits and the environments in which
they are used. Increasing system complexity implies increasing burden, making en-
gineered strains less competitive. In addition, intermediary products in pathways
can be toxic to certain strains of microbes, further reducing fitness. Division of
labour between bacteria will become necessary. However, as soon as there are mul-
tiple sub-populations, with different growth rates, within an environment, compe-
tition between those populations becomes a challenge. Thus, one has to overcome
the competitive exclusion principle, which states that two species competing for the
same resource cannot coexist [130]. This is because, even with a very slight differ-
ence in fitness, the stronger competitor will dominate leading to the extinction, or
adaptation to a new niche, of the weaker species. The principle should, perhaps, in-
clude the caveat: “in stable environments and in the absence of other interactions”.
This caveat may help to explain supposed problems with the competitive exclusion
principle such as the “paradox of the plankton” [131, 132].
Wild bacteria live in complex communities [133] with mutualistic and compet-
itive interactions producing complex dynamics [134]. Previous attempts to design
synthetic microbial communities have relied on spatial segregation [96] or mutual-
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Figure 3.1: Designs for synthetic community control systems.
ism [95] to maintain multiple sub-populations. The control of the density of single
species populations has been achieved through the use of quorum sensing to control
self-killing [135] and more recently this has been extended to a two species system
[102], as in Figure 3.1a. More complex predator-prey systems have also been de-
veloped which produce oscillatory populations of two strains [100] using a design
similar to that shown in Figure 3.1b. These systems involve the engineering of all
strains within the community. However, this requirement may not be desirable in
industrial settings and is clearly not possible when working in natural environments
such as the human gastrointestinal tract.
With the restriction that only one of the strains within a synthetic community
can be engineered, new approaches need to be taken. Bacteriocins, as described
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previously, are a competition mechanism that is widely used by wild-type bacteria
in complex environments such as the human gastrointestinal tract [136, 137, 138].
These bacteriocins can be harnessed to reduce the fitness of a competitor strain in
a community, while allowing the producer to continue growing. Indeed they have
been used in engineered systems to eliminate pathogenic strains [88]. If the assump-
tion is made that the engineered strain will grow more slowly than the competitor
strain, bacteriocins can be produced while the engineered strain has a low popula-
tion density, producing a niche for it to grow into. Once the population has grown
above a desired threshold, the bacteriocin can be turned off and the competitor can
grow again. A cartoon of this system is shown in Figure 3.1c. This is the inverse
of a system discovered in Burkholderia thailandensis in which the production of a
bacteriocin was induced by an endogenous quorum sensing system [139, 140]. A
slight modification to this system would be to sense a native signal from the com-
petitor, though this would restrict the potential environments into which the system
could be introduced. This would allow the engineered strain to turn on bacteriocin
production only when the competitor population is high, Figure 3.1d. Combin-
ing both of these systems would limit bacteriocin production to states in which the
engineered strain’s density is low and the competitor’s density is high, preventing
the extermination of the competitor population when both densities are low, Figure
3.1e.
With a further modification to the bacteriocin producing system, the assump-
tion that the competitor grows faster can be removed. The addition of a quorum
controlled self-killing mechanism to the engineered strain would place an upper
limit on the engineered strain’s density, Figure 3.1f. This, in addition to the lower
limit produced by the bacteriocin system, would ensure niches are available for
both strains while only requiring the engineering of a single strain. The combina-
tion of all of these constituent parts, Figure 3.1g, would ensure the viability of the
competitor population regardless of its relative fitness.
In this Chapter I will show, using mathematical models, that the system shown
in Figure 3.1c, which from here will be called Stabilised Populations by Commu-
3.1. A Model of SPoCK in Chemostat 74
arabinose
AHL
bacteriocin
KILLER COMPETITOR
Figure 3.2: A simple cartoon of the SPoCK system.
nity Killing (SPoCK), is capable of producing both stable and oscillating popula-
tions dependent on parameters that can be controlled in a chemostat environment.
In the following Chapter I will construct an example of this system and through
characterisation experiments and Bayesian computational methods, determine the
behaviours that this instantiation is capable of.
3.1 A Model of SPoCK in Chemostat
The SPoCK system can be described as a dynamic competition mechanism in which
the mechanism for reducing the fitness of competitor is controlled dynamically de-
pendent on the population density of the engineered strain. A simple schematic of
an implementation of the SPoCK system is shown in Figure 3.2. The bacteriocin
secreted by the killer strain kills the competitor strain, allowing the killer to out-
compete it. The bacteriocin expression is turned off by a quorum sensing molecule
produced by the killer strain. This results in the bacteriocin being expressed only
when the killer population is low, and turned off when the population is high. In
this implementation, the production of the quorum sensing molecule is placed un-
der the control of an inducible promoter. This allows for the tuning of the rate of
production of the quorum sensing molecule, which allows for exogenous control of
the population density at which the bacteriocin production will be switched off.
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The system shown in Figure 3.2 can be described using a mathematical model.
In this simple model, the two bacterial populations grow at different rates which
are dependent on the concentration of a substrate for which they compete. The
environment has a constant dilution rate which removes cells and molecules from
the environment but introduces fresh substrate. Finally, the competitor strain is
susceptible to the bacteriocin produced by the killer strain which results in a death
rate of competitor dependent on bacteriocin concentration. This leads to an ODE
model in which the strain concentrations vary according to:
dX
dt
= (µX(t)−D)X(t) (3.1)
dC
dt
= (µC(t)−D−ω β (t))C(t) (3.2)
where X is the killer strain containing the SPoCK system and C is the competitor
strain. The µ are the respective growth rates, D is the dilution rate, and ω is the
death rate of the competitor strain per M of bacteriocin, β . The growth rates, µX
and µC, are given by Monod growth laws:
µX(t) =
µXmaxS(t)
KX +S(t)
(3.3)
µC(t) =
µCmaxS(t)
KC +S(t)
(3.4)
where the µmax are the respective maximal growth rates, S is the substrate con-
centration, and KX and KC are the half saturation constants. The concentration of
substrate, S, varies according to:
dS
dt
= D(S0−S(t))− µX(t)X(t)γX −
µC(t)C(t)
γC
(3.5)
where S0 is concentration of substrate in the feed media, and the γ are the respective
yield coefficients.
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The concentration of bacteriocin varies according to:
dβ
dt
= kβ (t)X(t)−Dβ (t) (3.6)
where kβ is the rate of bacteriocin production. This rate is inversely dependent on
the concentration of AHL in the environment. This relationship is described using
the inverse Hill function:
kβ (t) =
kβmax K
nβ
β
K
nβ
β +A(t)
nβ
(3.7)
where kβmax is the maximal expression rate of bacteriocin, Kβ is the concentration of
AHL at which bacteriocin is half-maximally expressed and nβ is the Hill coefficient.
In this simple model the expression rate of AHL is modelled as constitutive at a rate
kA that would conceptually be varied by changing the arabinose concentration in
the media. A further simplification in this model is that kA is not considered to be
time dependent as it is assumed that the concentration of arabinose in the media
would not vary. However, under real world conditions, if another preferable sugar
source was not present and the arabinose was not being replenished quickly through
dilution, the arabinose may be consumed and the concentration would decrease. The
concentration of AHL, therefore, varies with time according to:
dA
dt
= kAX(t)−DA(t) (3.8)
Some values of the parameters can be found in the literature or given sensible values
based on similar systems, Table 3.1.
3.1.1 The SPoCK System at Steady-State
By analysing the system at steady state it is possible to determine whether there are
any conditions under which the two strains can reach an equilibrium and co-exist
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Table 3.1: Model parameters for the simple chemostat model.
Parameter Description approx. value unit
D* Dilution rate 0-µCmax h−1
S0* Reservoir substrate concentration 1−4 gL−1
kA* Expression rate of AHL from
killer strain
∼ 10−21 mol cell−1 h−1
µXmax Maximum growth rate of killer
strain
0.4-3 h−1
µCmax Maximum growth rate of competi-
tor strain
0.4-3 h−1
γX , γC Yield coefficient of killer and
competitor strains
1012 cells g−1
KX , KC Concentration of substrate at
which killer and competitor
strains growth is half-maximal
2 gL−1
ω Death rate of competitor by bacte-
riocin
∼ 108 M−1 h−1
kβmax Maximum expression rate of bac-
teriocin from killer strain
∼ 10−22 mol cell−1 h−1
Kβ Concentration of AHL at which
bacteriocin expression is half-
maximal
∼ 10−7 M
nβ Hill coefficient of bacteriocin pro-
duction
2 -
* Parameters are easily experimentally controllable.
stably.
When the killer strain X is at steady state:
X˙ = (µX −D)X = 0
µX = D (3.9)
Using Equation 3.3:
D = µX
=
µXmaxS
KX +S
S =
D KX
µXmax−D
(3.10)
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In the above Equation S is constant, since the right-hand-side (RHS) are all con-
stants. As such, the nullcline for dX/dt = 0 is a point in S-space. Further, since S
must be constant:
S˙ = D(S0−S)− µX XγX −
µC C
γC
= 0
S = S0− µX XD γX −
µC C
D γC
(3.11)
The µX and µC can be replaced with the RHS’s of Equations 3.3 and 3.4 and the S’s
can be replaced with the RHS of Equation 3.10. The subsequent Equation can be
rearranged to give solutions for X or C as a function of the other:
X = γX(
D KX
D−µXmax
+
C KX µCmax
DγCKC−DγCKX − γCKCµXmax
+S0) (3.12)
C =
γC(D(KC−KX)−KC µXmax)( D KXµXmax−D −S0 +
X
γX )
KX µCmax
(3.13)
When the competitor strain C is at steady state:
C˙ = (µC−D−ωβ )C = 0
µC = D+ωβ (3.14)
Using Equation 3.4:
D+ωβ = µC
=
µCmaxS
KC +S
β =
µCmax S
ω(KC +S)
− D
ω
(3.15)
The nullcline for C at steady state is therefore represented by a line on the β vs S
plane, shown in Figure 3.3.
Equation 3.15 gives the relationship between the bacteriocin concentration β
and the substrate concentration S when C is at steady state and Figure 3.3 shows
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Figure 3.3: Nullclines of dX/dt = 0 (Equation 3.10, red line) and dC/dt = 0 (Equation
3.15, blue line) at two different dilution rates on the S versus β plane. The
dashed line shows the concentration of substrate below which the competi-
tor strain cannot grow faster than the dilution rate. (KC = KX = 2, µXmax =
1, µCmax = 1.2, ω = 108)
the intersection of the nullcline of dX/dt = 0 and dC/dt = 0 in β -S state space.
The two Equations 3.10 and 3.15 can be combined to give an expression for the
bacteriocin concentration β when both X and C are at steady state:
β =
D(D(KX −KC)−KX µCmax +KC µXmax)
(D(KC−KX)−KC µXmax)ω
(3.16)
As all of the terms on the RHS are constants, β must be a constant when X and C
are at steady state, as can be seen from the single point of intercept of the nullclines
in Figure 3.3. As such,
β˙ = (kβX−Dβ ) = 0
β =
kβX
D
(3.17)
Equations 3.16 and 3.17 can be combined, and noting the expression for kβ given
in Equation 3.7, can be rearranged to give an Equation for X :
X =
D2K
−nβ
β (D(KX −KC)−KXµCmax +KCµXmax)(K
nβ
β +A
nβ )
kBmax(D(KC−KX)−KCµXmax)ω
(3.18)
This expression is in terms of X , A and a number of constants. Since X is at steady
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state, and therefore constant, so must A. This gives:
A˙ = (kAX−DA) = 0
A =
kAX
D
(3.19)
which can be used to replace the A in Equation 3.18. Finally, using the expression
for X at steady state given in Equation 3.12, expressions for C and X when both
species are at steady state can be produced. These equations are rather unwieldy so
they will not be written out here but can be found in Appendix A.
The roots of the system at steady state were calculated using rootSolve in R
which uses a Newton-Raphson method [141]. The Jacobian of the system at steady
state, shown below, was determined using Mathematica and the eigenvalues at each
root were calculated in R. The steady states were classified based on the number
of negative real parts of the eigenvalues and whether they were complex or not, as
with two-dimensional systems. If all five of the eigenvalues had negative real parts
the steady state was classified as stable. If it had a mix of negative and positive
real parts it was classified as unstable. If none of the eigenvalues were complex, the
steady state was classified as a node and if there were complex eigenvalues it was
classified as a foci. For all parameter values tested below, there were at least two
complex eigenvalues. As such, all steady states plotted below are foci.

µXmax S
KX+S
−D 0 0 0
(
µXmax
KX+S
− µXmax S
(KX+S)2
)
X
0 µCmax SKC+S −D−βω −Cω 0 C
(
µCmax
KC+S
− µCmax S
(KC+S)2
)
K
nβ
β kBmax
A
nβ +K
nβ
β
0 −D − A
nβ−1K
nβ
β kBmax nβ X(
A
nβ +K
nβ
β
)2 0
kA 0 0 −D 0
− µXmax SγX (KX+S) −
µCmax S
γC(KC+S)
0 0 µXmax SXγX (KX+S)2 −
CµCmax
γC(KC+S)
+
CµCmax S
γC(KC+S)2
− µXmax XγX (KX+S) −D

(3.20)
There are three model parameters that are easily changed in a real world ex-
periment: the dilution rate D, the richness of the media S0, and the expression rate
of AHL from the killer strain kA. Relative growth rates may also be changed by
increasing or decreasing the burden on the engineered strain but this is not as easily
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Figure 3.4: Steady state analysis of simple SPoCK in chemostat model for S0 = 4 gL−1
and D = 0.1 h−1. The different colours show the behaviour with different rates
of AHL expression; a parameter controllable in the real system by changing
arabinose concentration. The steady state concentrations of each species are
shown as circles with empty circles showing unstable foci and filled circles
(none present in this parameter space) showing stable foci. (µXmax = 1 h−1,
µCmax = 1.2 h−1)
controlled as the other parameters. Figure 3.4 shows a steady state analysis us-
ing S0 = 4 gL−1, the standard sugar concentration in supplemented M9 media, and
the dilution rate D = 0.1 h−1 which is 10% of the value chosen as the maximal
growth rate of the killer strain. Steady states are present for AHL production rates
of kA ≤ 10−20 mol cell−1 h−1, though all of the states in which both species present
are unstable, and therefore undesirable.
Figure 3.5 shows the steady states of the system over a range of values of S0, D
and kA. As S0 is increased, so too does the population level of the competitor strain
at steady state. Similarly, as D increases, so too does the population level of the
killer strain at steady state. This is intuitive as the richer media, being replenished
more frequently, would be expected to support larger populations. An interesting
point that arises from this analysis is that the only stable steady states present are at
low dilution rates and an AHL production rate of kA = 10−19 mol cell−1 h−1. Under
these conditions one unstable and one stable foci are present; with a higher killer
population at the stable steady state.
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Figure 3.5: Steady state analysis of simple SPoCK in chemostat model over a broad range
of system conditions. The different colours show the behaviour with different
rates of AHL expression; a parameter controllable in the real system by chang-
ing arabinose concentration. The steady state concentrations of each species
are shown as circles with empty circles showing saddle nodes and filled circles
showing stable nodes or foci. (µXmax = 1 h−1, µCmax = 1.2 h−1)
The range over which the AHL production rate, kA, is varied in Figure 3.5 is
10,000 fold, yet the dynamic range of the bacteriocin expression is unlikely to be
close to that. Figure 3.6 shows the steady state analysis over a narrower range of
kA in order to capture some more of the bacteriocin expression range. One can see
that there are now many more stable steady states present. At lower values of kA
the steady states are at higher killer densities and very slightly lower competitor
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Figure 3.6: Steady state analysis of simple SPoCK in chemostat model over a narrow range
of AHL expression conditions. The different colours show the behaviour with
different rates of AHL expression; a parameter controllable in the real system
by changing arabinose concentration. The steady state concentrations of each
species are shown as circles with empty circles showing saddle nodes and filled
circles showing stable nodes or foci. (µXmax = 1 h−1, µCmax = 1.2 h−1)
densities. Further, stable steady states are present at slightly higher dilution rates.
It is also possible to determine whether there are any steady states present at
different levels of growth advantage for the competitor strain. Figure 3.7 shows
the steady states with varying competitor growth rates over different media and
dilution conditions. Interestingly, when the competitor has a higher maximal growth
rate, stable nodes are present that do not exist at the lowest competitor growth rate.
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Figure 3.7: Steady state analysis of simple SPoCK in chemostat model with different levels
of competitor fitness. The different colours show the behaviour with different
maximal growth rates of the competitor strain. The steady state concentrations
of each species are shown as circles with empty circles showing saddle nodes
and filled circles showing stable nodes or foci. (µXmax = 1 h−1, kA = 10−20 mol
cell−1 h−1)
Further, the position of the steady states moves towards a higher killer and lower
competitor population level.
Plotting the trajectories of the killer versus competitor strains shows the pro-
gressions towards the stable steady states, Figure 3.8. However, a cluster of stable
and unstable steady states identified when kA = 5−20 mol cell−1 h−1 and µCmax = 1.5
h−1 does not seem to act as an attractor; instead the killer population, X , is lost. The
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Figure 3.8: Trajectories of the killer and competitor strain in chemostat with varying levels
of competitor fitness µCmax and AHL production kA. All the trajectories start
at X(0) = C(0) = 1012 cells L−1. The steady states are shown as circles with
empty circles showing unstable nodes and filled circles showing stable foci.
(S0 = 4 gL−1, D = 0.02 h−1, µXmax = 1 h−1)
spirals towards the stable steady states, prominent when µCmax ≥ 2 h−1, will ap-
pear as damped oscillations over time, as will be shown in the next section. Again,
these simulations show that it is possible to produce stable populations of compet-
ing cells and tune the relative densities of the two populations using only the rate of
AHL production.
3.1.2 Oscillations in the Simple SPoCK Model
Finding an analytical solution to the system of equations making up the SPoCK
model is not possible. In addition, techniques for finding limit cycles and other
oscillatory states in non-linear systems are either restricted to two species systems or
non-trivial. As such, numerical integration of the system over a restricted parameter
space is used here to observe conditions under which oscillatory behaviour can
be observed. However, in the next Chapter I use statistical methods to examine
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oscillations in a more complete model.
Figure 3.9 shows dampened oscillations occurring when the maximal growth
rate of the competitor strain is large, µCmax ≥ 1.6. The speed of the dynamics is de-
pendent on dilution rate, which is intuitive as in this simple model dilution provides
the only means of removal of molecules and species. The maximal bacteriocin pro-
duction rate and AHL production rate have to be correspondingly increased along
with the dilution rate.
3.2 Addition of Self-Regulation
The SPoCK system as described relies on the competitor strain to grow at a faster
rate than the killer. In certain industrial applications the “competitor” strain may
be producing a recombinant protein that causes a great deal of burden, leading to
slow growth. As shown in Figure 3.1F, the addition of a self-regulation mechanism,
along with the bacteriocin competitor regulation could allow the SPoCK system to
function under a broader range of circumstances.
A simple, abstract addition to the model will suit as a proof of concept of this
self-regulation. The killer strain has an extra negative regulation parameter added
which is dependent on the AHL concentration, A. This leads to a change to Equation
3.1:
dX
dt
= (µX(t)−D−ωX A(t))X(t) (3.21)
where ωX is the rate of killing of the killer strain due to an AHL induced toxin. A
more complete way to model this would be to add a new intracellular toxin species
to the set of equations and model it’s change due to AHL induction. Figure 3.10
shows how the addition of this self killing leads to a population cap on X which is
dependent the rate of AHL production, kA, and the rate of AHL induced killing. As
the rate of AHL production decreases, the set-point for a stable killer population
increases. Similarly, as the rate of AHL induced killing increases, the stable set-
point decreases.
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Figure 3.9: Discovering oscillations of the killer (red line) and competitor (blue line) over
time across different values of maximal competitor growth rate, µCmax , and AHL
production rate, kA. (A) Low dilution rate, D = 0.02 h−1, and slow maxi-
mal bacteriocin production rate, kβmax = 10
−22 mol cell−1 h−1, lead to slow
population dynamics and a necessity for lower AHL production rates. (B)
Faster dilution rate, D = 0.2 h−1, requires a faster bacteriocin production rate,
kβmax = 10
−20, and faster AHL production to achieve the same behaviour.
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Figure 3.10: SPoCK with self-regulation. With no competitor present, the self-regulation
mechanism can produce different stable levels of killer bacteria. The coloured
lines show different rates of self-killing, ωX .
When the model is run with competition the self-regulation mechanism is able
to create several stable population levels, including when the competitor is slower
growing. Such simulations can be seen in Figure 3.11.
3.3 Discussion
In this Chapter I have described the need for systems that can overcome competi-
tive exclusion to allow heterogeneous communities of bacteria to stably coexist. I
have shown that current approaches involve the engineering of all species within the
environment, which in some circumstances can be undesirable or impossible. Us-
ing bacteriocins to target competing species within an environment, and relieve the
exclusionary pressure, is one possible approach to producing a system that enables
stable communities while only necessitating the engineering of a single strain. The
use of quorum sensing as a modulator on the production of the bacteriocin and the
inherent fitness advantage of the non-engineered competitor prevents the engineered
strain from overtaking.
Using a simple mechanistic model of the SPoCK system in a chemostat envi-
ronment, I have shown that the system can stabilise two populations. Stable steady
states can be found over a wide range of realistic environmental conditions. Im-
portantly, parameters that are theoretically easy to control in an experiment can be
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Figure 3.11: SPoCK with self-regulation in competition. The red line shows the killer
strain and the blue line shows the competitor.
used to tune the population levels of the two strains. Finally, oscillatory states with
different periods have been identified. The period is dependent on the dilution rate,
with faster dilution resulting in faster turnover of cells, AHL and bacteriocin in
the environment. However, this must be correspondingly matched with increased
production rates of AHL and bacteriocin and competitor growth rates.
The complexity of the model, even this simplified one, limits the types of anal-
yses that can be used to explore its dynamics. As extra layers of complexity are
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added, as in Figure 3.1, the complexity of the model will duly increase.
A model was produced showing a simple addition of a self-regulation mecha-
nism in to the killer strain. Simulations with this model showed that changes in AHL
production and killing rate could produce stable population over a wide range of lev-
els. When in competition, the self-regulation allowed the stable maintenance of two
populations, even when the non-killing competitor grew more slowly. Although
this model was a simple and abstract extension of the original SPoCK chemostat
model, it does show that additional feedback systems can be used to create a variety
of different behaviours.
In the next Chapter I will show the construction and characterisation of the
SPoCK system in E. coli. A more realistic, and complex, model is built which
will rely on Approximate Bayesian Computation (ABC) to predict the system’s
dynamics.
3.4 Conclusion
In conclusion, I have described how the construction of planktonic, multi-species
populations in synthetic biology are becoming increasingly necessary. However,
I have detailed how, currently, the design of such system is not possible due to
competitive exclusion. I have designed and modelled the first system to use dynamic
production of bacteriocins to counteract competitive exclusion. This is also the first
system in which control of multiple species within a community is possible through
the engineering of a single constituent strain. The modelling demonstrated that this
system is able to produce stable equilibria or oscillating populations, tunable via
easily controllable parameters. Finally, I demonstrate how such a system could be
made more robust through the addition of a negative feedback loop on the controller
population.
3.5 Future Work
Several models for population control were suggested at the beginning of this Chap-
ter. Exploration of the behaviours that these systems are capable of producing may
reveal that one of these models can more robustly produce a desired set of be-
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haviours. This can be done using approximate Bayesian computation [111]. Many
of the systems suggested can reuse modules from the SPoCK system.
Chapter 4
Construction and Characterisation of
Stabilised Populations by
Community Killing (SPoCK)
In the previous Chapter I detailed a theoretical system for the stabilisation of a com-
munity of competing bacterial strains. The system involved the density dependent
production of a bacteriocin by a slow growing strain to inhibit the growth of a fitter
competitor. In this Chapter I will describe the construction and characterisation of
such a system.
4.1 Controllable Bacteriocin Production
The microcin-V system, that was used in Chapter 5, provides a simple bacteriocin
system to work with; comprised of just four genes and no post-translational mod-
ification of the bacteriocin peptide [119]. This simplicity has meant microcin-V
has been used to explore the hybridisation of bacteriocins from different sources
to increase the spectrum of activity [142, 143]. It has also been used as the basis
of a modular bacteriocin delivery system due to the transport mechanisms requir-
ing a simple glycine-glycine signal peptide for secretion [120]. There is a large
amount of literature on how bacteriocins are induced in competitive environments
[144, 145, 146], but, to my knowledge, there is no literature on the creation of an
inducible or repressible bacteriocin system.
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In this work the PLtetO-1 promoter is used in place of the native putative pro-
moter upstream of the cvi immunity and cvaC bacteriocin genes. The PLtetO-1
promoter was chosen as it provides very low leakiness in its “off” state and a large
regulatory range [147]. A system in which the expression of the microcin-V bacte-
riocin gene, cvaC, is repressible by TetR was constructed, Figure 4.1a. The expres-
sion of the transport proteins, CvaA and CvaB, were kept under the control of the
native promoter. The expression of the immunity, cvi, and bacteriocin, cvaC genes
was driven by the PLtetO-1 promoter, with the native putative RBSs of both genes
maintained. The plasmid expressed tetR from a Ptrc promoter which is repressible
by LacI and derepressed through the addition of IPTG. Additionally, GFPmut3b is
expressed from a second PLtetO-1 promoter as a proxy for bacteriocin expression.
The dynamics of the system were explored using flow cytometry to measure GFP
levels 24 hours after induction with varying levels of aTc, Figure 4.1b. Low lev-
els of induction occur at 10−8 g/mL of aTc and increase with increasing inducer
concentration. To determine whether bacteriocin was being produced, the induced
culture was spotted on a lawn of E. coli MG1655 and incubated overnight, Figure
4.1c. This shows that even at very low concentrations of inducer, some inhibition
of growth occurs. This inhibition increases as aTc concentration increases.
Analysis of the native 5’ upstream region of the cvi and cvaC genes using
promoter identification software BPROM [148] indicates that, in addition to the
promoter upstream of the cvi start codon, there may be a promoter region within
the cvi gene upstream of the cvaC start codon, Figure 4.2. This means that in the
TetR repressible system shown in Figure 4.1a, complete inhibition of the PLtetO-1
promoter may not be enough to prevent expression of the bacteriocin.
In light of this finding, a new TetR repressible bacteriocin plasmid was con-
structed based on the pMPES:V plasmid [120]. In this system, the start codon of
cvaC in the native microcin-V cassette is mutated to prevent expression of the bac-
teriocin from the cassette but allowing native expression of the transport proteins
and immunity. Separate cvaC and cvi genes, with non-native RBSs, were synthe-
sised and placed under the control of the ProTeOn expression system [149]. In this
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Figure 4.1: Inducible expression of microcin-V. a) A schematic of the inducible bacteriocin
system. The expression of the bacteriocin, cvaC, and immunity, cvi, are from
the PLtetO-1 promoter. This is repressed by TetR which is expressed from a
Ptrc promoter. aTc can be added to dis-inhibit expression of the bacteriocin.
IPTG is added to ensure that expression of TetR is maximal. Production of the
transport proteins, cvaA and cvaB, are driven by the native promoter. GFP-
mut3b is also expressed from a PLtetO-1 promoter as a proxy for bacteriocin
expression. b) Flow cytometry data showing GFP expression after 24 hours
after induction with different concentrations of aTc. c) Inhibition zones on a
lawn of E. coli MG1655. Bacteriocin producing cultures were induced for 24
hours with varying levels of aTc and then spotted on to the lawn and incubated
overnight.
work, this plasmid was altered by replacing the ProTeOn expression system with
a PLtetO-1 promoter and GFPmut3b gene upstream of the functional cvaC gene.
This plasmid does not carry it’s own mechanism for the production of TetR. The
characterisation of this system will be described in Section 4.3.
4.2 A Tunable Quorum Sensing System
The SPoCK system requires a quorum signal to produce the TetR protein which re-
presses the production of the bacteriocin, as shown above. There are many quorum
sensing systems found in nature that have been adapted for use in synthetic circuit
4.2. A Tunable Quorum Sensing System 95
TTCACTCTTGACTATGTTAACGATAATCATTATCGTTAGT
GTTTGTGTGGTAATGGGATAGAAAGTAATGGGATAAAAAG
TAATGGATAGAAAAAGAACAAAATTAGAGTTGTTATTTGC
ATTTATAATAAATGCCACCGCAATATATATTGCATTAGCT
ATATATGATTGTGTTTTTAGAGGAAAGGACTTTTTATCCA
TGCATACATTTTGCTTCTCTGCATTAATGTCTGCAATATG
TTACTTTGTTGGTGATAATTATTATTCAATATCCGATAAG
ATAAAAAGGAGATCATATGAGAACTCTGACTCTAAATGA...
-35 -10
cvi
cvaC cvi|
-35
-10
rpoD17
tyrR
fur
argR
Figure 4.2: The cvi and cvaC native promoter region. Putative -35, -10, translation start
sites and transcription factor binding sites identified using BPROM. -35 and
-10 sites are highlighted with light blue font. Translation start sites for cvi
and cvaC are highlighted in green font. The translation stop codon for the cvi
gene is highlighted in red font. The transcription factor binding sites for fur
(blue), argR (green), rpoD17 (red) and tyrR (orange) are underlined with solid
lines. The primer binding site used for the construction of plasmid pAF006 is
highlighted in orange font and underlined with an orange dashed line.
engineering. The important issues to consider when choosing which system to use
are simplicity/complexity and orthogonality. The simplest systems require a pro-
tein to produce diffusible quorum molecules and a transcription factor which, when
bound to those molecules, controls the activity of a promoter [150]. More com-
plex systems utilise multiple membrane bound receptors which are able to integrate
multiple signals, or produce complex signalling cascades [151]. Orthogonality con-
cerns impact whether other cellular mechanisms within a chosen host are regulated
by quorum sensing molecules or the host produces quorum molecules that may in-
terfere with predictable circuit behaviour. Further orthogonality concerns may be
present when choosing multiple quorum sensing systems to use in a circuit or group
of circuits [152].
Here the well understood luxR-luxI system is used. The wild-type lux sys-
tem incorporates a bi-directional promoter producing LuxI, the quorum molecule
synthase, in the forward direction and LuxR, the transcription factor, in the re-
verse direction as shown in Figure 4.3a. LuxI produces the quorum molecule
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Figure 4.3: Design of an inducible quorum sensing system. a) The wild-type lux system.
The PLux promoter transcribes the quorum molecule synthase, LuxI, in the
forward direction and the transcription factor, LuxR, in the reverse direction.
The quorum molecule binds to LuxR which activates the forward transcription
of the PLux promoter. b) An arabinose inducible quorum system. Two distinct
parts of the system are separated by the grey dashed line; the inducible quorum
molecule production and the sensing of the quorum molecule.
3-oxohexanoyl-homoserine lactone (3OC6HSL), abbreviated here to AHL, which
freely diffuses in and out of the producing cells. The transcription factor, LuxR,
forms a complex with the AHL and dimerises with another ligand bound LuxR to
form the active transcription factor. This active transcription factor dimer binds to a
region within the lux promoter, known as the lux-box, and greatly increases forward
transcription. The LuxR-AHL complex also represses transcription in the reverse
direction [153].
In order to make this system tunable the production of LuxI is placed under the
control of the arabinose inducible promoter ParaBAD [154]. Previously designed
inducible quorum sensing systems have also placed the production of LuxR under
a controllable promoter [155]. However, here LuxR is left under the control of the
PLux promoter as in [156], as shown in Figure 4.3b.
In order to characterise the dynamics of this inducible quorum sensing system,
the circuit was constructed with fluorescent proteins as readouts from the two for-
ward promoters. The circuit was constructed in two steps; the arabinose inducible
luxI section and the lux promoter section were first built on separate plasmids, after
which the sections were combined onto a single plasmid. The cloning process is
described in detail in Section 2.2.
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4.2.1 Lux Promoter Dynamics
The response of the lux promoter to AHL is examined in Figure 4.4. The fluores-
cence response after 20 hours can be seen in the flow cytometry data in Figure 4.4b.
There is a ∼ 1000 fold increase from basal expression to maximal expression. The
data also show that rather than a homogeneous population response of increasing
expression with increasing inducer concentration, there is a binary cellular response
of expression being on or off and a threshold concentration, at 10nM AHL, at which
the we can observe a heterogeneous population. The growth data in Figure 4.4c
shows that at higher levels of induction growth may be slightly impacted. The flu-
orescence time-course in Figure 4.4d and the per cell fluorescence time-course in
Figure 4.4e demonstrate that inducer concentrations of 100nM and above saturate
the system, leading to identical dynamics. There is a dip in fluorescence in all popu-
lations showing expression after∼ 7 hours. This indicates that expression rate from
the lux promoter has dropped below the degradation rate of the sfGFP-LAA. This
may be due to growth phase dependant repression of the promoter by one of the
LysR-family transcriptional regulators [157] or a lack of resource availability such
as RNAP or ribosomes [158].
4.2.2 araBAD Promoter Dynamics
The second constituent part of the tunable quorum sensing system is the inducible
expression of LuxI. Here the inducible promoter used is the ParaBAD system which
takes arabinose as an input to de-repress the promoter. To determine dynamics of
expression from the ParaBAD system, a blue fluorescent protein (mTagBFP2) was
used, with luxI with an LAA-ssrA degradation tag cloned downstream, as shown in
Figure 4.5a. Expression of BFP at various induction levels was measured using flow
cytometry, Figure 4.5b. This shows a system inducible over a ∼ 1000 fold dynamic
range, though with an expression increase of less than 100 fold. The expression at
the maximum inducer concentration used here may not be the maximum achiev-
able expression level; the plot doesn’t show the expression plateauing. However,
as shown in Figure 4.5c, at the highest level of inducer concentration used here,
the growth dynamics change. This may be due to the bacteria using the arabinose
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Figure 4.4: The dynamics of the lux promoter. a) Forward transcription from the lux pro-
moter, induced by the addition of AHL to the growth media, expresses su-
perfolder GFP with the LAA-ssrA degradation tag. b) Flow cytometry data
showing the expression of GFP following 20 hours of induction with different
concentrations of AHL. The red, green and blue lines show are three separate
replicates at each concentration. The grey dashed line shows the median flu-
orescence of MG1655 with no plasmid. c, d, e) Time-course of induction at
various concentrations of AHL. Three replicates for each inducer concentra-
tion. The lines are Loess curves through data sampled every 10 minutes. c)
Absorbance at 540nm. d) log10 fluorescence measurement with excitation at
480nm and emission 510nm. e) log10 fluorescence per unit absorbance as a
proxy of GFP per cell.
as a carbon source. Due to equipment limitations, it was not possible to measure
BFP expression concurrently with absorbance. Instead the bacteria were induced
with 1.33mM arabinose in phosphate buffered saline (PBS), as in [159], at different
population densities, Figure 4.5d. The BFP fluorescence was measured using flow
cytometry after 6 hours, Figure 4.5e. The results show comparable BFP expres-
sion across all dilution levels demonstrating expression is independent of population
density.
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Figure 4.5: The dynamics of the ParaBAD promoter. a) Forward transcription from the
ParaBAD promoter, induced by the addition of arabinose to the growth media,
expresses mTagBFP2 and luxI. b) Flow cytometry data showing the expression
of BFP following 20 hours of induction with different concentrations of arabi-
nose. The red, green and blue lines show are three separate replicates at each
concentration. c) Time-course of growth at various induction concentrations
of arabinose. Three replicates for each inducer concentration. Absorbance at
540nm. Due to instrument limitations it was not possible to measure BFP fluo-
rescence during the time-course Instead various dilutions of cells in phosphate
buffered saline (PBS) were induced with 1.33 mM arabinose. d) Cell density is
maintained over 6 hours of induction in PBS. e) Flow cytometry measurements
of BFP expression after 6 hours of induction in PBS show that expression is
density independent.
4.2.3 Dynamics of the Tunable Quorum Sensing System
The two parts of the system, described above, were cloned into a plasmid with an
SC101 origin of replication and kanamycin resistance. This was transformed into
E coli MG1655. The dynamics of the system were determined through induction
with different concentration of arabinose. Figure 4.6a shows how introduction of
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arabinose leads to expression of BFP and GFP through the activation of the two
different promoters. The BFP expression, Figure 4.6b, shows the same dynamics
as described above. GFP expression shows the same minimal and maximal induc-
tion levels as with induction by AHL, Figure 4.6c, indicating that the arabinose
inducible part of the system is capable of triggering the production of enough AHL
to saturate the lux promoter, even with the LAA-ssrA degradation tag on the LuxI
protein. The correlation between BFP and GFP expression, Figure 4.6d, shows that
the threshold for maximal expression of GFP from the lux promoter requires a very
small increase from basal levels in expression of BFP from the ParaBAD promoter.
However, using the Operon Calculator (v1.0) [160] the translation rate of LuxI is
∼ 10 fold greater than that of BFP in this system. The growth time-course, Figure
4.6e, shows again that at the highest concentration of arabinose there is increased
growth but at all other concentrations growth dynamics are comparable. The popu-
lation level fluorescence time-course, Figure 4.6f, and “per cell” fluorescence, Fig-
ure 4.6g, show some unexpected dynamics. At 0.133mM, the lowest concentration
to illicit a BFP or GFP response, the expression of GFP occurs early followed by a
dip similar to that seen in Figure 4.4d. After this dip, expression of GFP increases
at a slower rate than for higher concentrations of arabinose induction, as one would
expect. At the highest level of induction, 13.3mM arabinose, production of GFP
matches the increase in population density until the cells begin to reach stationary
phase, as can be seen by the flat period from the 5 hour mark in Figure 4.6g. At
1.33mM arabinose induction, there is a similar but shorter period of GFP produc-
tion matching growth rate. However, the expression rate increases sooner than for
the higher inducer concentration. This may be due to the slightly lower growth rate
leading to greater availability of cellular resources.
4.2.4 Plasmid Copy Number Effects on Quorum Sensing System
Experiments up to this point have been carried out using a plasmid with an SC101
low copy origin of replication. The only lever for control for this system is the
concentration of arabinose. In order to gain access to a wider landscape of quorum
sensing dynamics, the plasmid copy number was varied. It has been shown that copy
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Figure 4.6: a) The full tunable quorum sensing circuit. b, c & d) The BFP and GFP fluo-
rescence measured by flow cytometry after 20 hours of induction with varying
levels of arabinose. e, f & g) Absorbance and fluorescence time-courses with
induction at various concentrations of arabinose.
number is an important parameter in the functioning of synthetic biological circuits
[22] though this doesn’t make available the continuous scale of tunability that the
inducible promoter offers. Here, in addition to the low copy SC101, the BBR1 and
BR322 medium copy and pUC high copy origins of replication are tested, as show
in Figure 4.7a. The high copy nature of the pUC based plasmid and the leakiness
4.2. A Tunable Quorum Sensing System 102
0
2
4
6
MG1655
BBR1
SC101
pUC
BR322
lo
g1
0(
BF
P)
0
2
4
6
MG1655
BBR1
SC101
pUC
BR322
lo
g1
0(
G
FP
)
- arabinose
0
2
4
6
MG1655
BBR1
SC101
pUC
BR322
lo
g1
0(
BF
P)
0
2
4
6
MG1655
BBR1
SC101
pUC
BR322
lo
g1
0(
G
FP
)
+ arabinose
a
b
d
- arabinose
c
e
+ arabinose
araC luxIluxR
Plux
ParaBAD
LuxR AHL LuxI
AraC arabinose
BFPGFP
SC101
BBR1
BR322
pUC
{ }
Figure 4.7: Copy number changes to tunable quorum sensing system. a) A cartoon of the
plasmid with different origins of replication. b & c) BFP and GFP expression
after 20 hours of growth with no induction. d & e) BFP and GFP expression
after 20 hours of growth with 1.33mM of arabinose.
of the two promoters leads to the expression of BFP and GFP even without any
arabinose induction, Figure 4.7 b & c. The lower copy number plasmids remain in
an off state when uninduced, though some BR322 based systems show low levels
of GFP expression. When induced with 1.33mM of arabinose, as shown in Figure
4.7 d & e, the BBR1 based system behaves in much the same way as the SC101
based system, though with fewer cells expressing fluorescence of BFP and GFP at
low levels.
The BR322 and pUC based systems produced heterogeneous populations with
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some cells expressing BFP and GFP to very high levels and some not expressing
either fluorescent protein. This indicates that the burden caused by induction of the
system has lead to the mutation of one or both parts of the quorum sensing sys-
tem. Figure 4.8 shows the failure of the BR322 based system with increasing levels
of arabinose induction. At the lowest inducer concentration the system functions
as expected, with BFP and GFP both being expressed. However, with increasing
arabinose concentrations, a sub-population expressing neither BFP nor GFP arises.
This indicates that the ParaBAD part is malfunctioning, preventing the expression
of BFP and LuxI. The lux part of the system must also be malfunctioning since
there is still a population that is producing, secreting and responding to AHL. At
higher levels of induction a third population arises, producing BFP but no GFP.
4.3 The Complete SPoCK System
The complete SPoCK system consists of a plasmid carrying the TetR repressible
bacteriocin, as detailed in Section 4.1, and a plasmid carrying the tunable quorum
sensing system, detailed in Section 4.2. Both plasmids were transformed into E.
coli MG1655, as shown in Figure 4.9, and the dynamics were explored with a range
of origins of replication on the quorum sensing plasmid.
Initially the system was tested with AHL induction to determine that TetR was
being produced at a level that could repress the production of the bacteriocin, as
measured through GFP expression, Figure 4.10. Although the arabinose inducible
part of the quorum sensing system is present on the plasmid, induction with AHL
bypasses it, Figure 4.10a. Figure 4.10b confirms using flow cytometry that the
arabinose promoter is not induced. The expectation is that GFP expression is high
without AHL present and decreases as more AHL is added. This is shown in the
flow cytometry data in Figure 4.10c. At the highest inducer concentration, GFP
levels are still higher than the control E. coli MG1655. This may be due to the long
time required for degradation of the GFPmut3b [161] leading to the expression
measurements reflecting earlier expression levels.
Next, the SPoCK system is tested using arabinose induction. As with the char-
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Figure 4.8: Failure of BR322 based quorum sensing system. a) A schematic of the quorum
sensing plasmid. b & c) The BFP and GFP expression measured by flow cy-
tometry 20 hours after induction with arabinose. d) The co-expression of BFP
and GFP 20 hours after induction with arabinose.
acterisation of the quorum sensing system, arabinose induces luxI expression with
mTagBFP2 as a measurable proxy. The LuxI protein is a synthase that produces the
diffusible AHL molecule that leads to activation of the lux promoter. The lux pro-
moter drives expression of tetR which inhibits the PLtetO-1 promoter. GFPmut3b is
used as a measurable proxy for expression from the PLtetO-1 promoter, which also
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Figure 4.9: The two plasmids of the SPoCK system. The quorum sensing plasmid
p2X AF041 was tested with several origins of replication providing a range
of copy numbers. For each origin of replication the ‘X’ in the plasmid name is
replaced with its corresponding SEVA identifier i.e. the SC101 based plasmid
is p27 AF041. The killing plasmid, pMPES AF01, carries the mccV cassette
with a mutated cvaC start codon, preventing the production of the bacteriocin
from the cassette. Instead bacteriocin is produced from an operon driven by the
PLteO-1 promoter.
drives the expression of the bacteriocin, cvaC, and immunity, cvi, Figure 4.11. BFP
expression dynamics, Figure 4.11b, are comparable to those measured in the char-
acterisation of the quorum sensing system. Expression of GFP from the PLtetO-1
promoter, Figure 4.11c, is high when there is no arabinose induction, as expected
and comparable to the results in Figure 4.10c. However, GFP expression is not in-
hibited to the same extent at higher levels of arabinose induction. The growth curve
time-courses, Figure 4.11d, show comparable results to the arabinose inductions of
the quorum sensing system; the highest concentration of arabinose leads to greater
growth but all other concentrations show similar dynamics. The fluorescence ex-
pression timecourse, Figure 4.11e, and fluorescence “per cell”, Figure 4.11f, show
a similar binary behaviour to that seen with AHL induction of the SPoCK system in
Figure 4.10e. However, the arabinose induction leads to a less pronounced differ-
ence between the high and low induced populations. Further, the replicates at the
highest arabinose concentration have the highest total fluorescence levels through-
out the time-course. This is only slightly offset when divided by the absorbance to
give an estimate of per cell fluorescence. The flow cytometry data, Figure 4.11c,
does show that the highest arabinose concentration leads to the greatest repression
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Figure 4.10: Inhibition of bacteriocin production in the SPoCK system with AHL. a) A
cartoon illustrating the mechanism of inhibition of bacteriocin production
through AHL. The arabinose inducible part of the system is present but re-
mains uninduced. b & c) Flow cytometry data showing BFP and GFP ex-
pression at varying concentrations of AHL. The grey dashed line shows the
median level of fluorescence of the empty E. coli MG1655 strain. d, e & f)
Time-course data of the SPoCK system at varying AHL induction concentra-
tions.
in GFP expression.
The mild repression of GFP expression shown in Figure 4.11c may indicate
that, with the quorum sensing construct on a low copy SC101 plasmid, complete
repression is not possible. To determine whether increasing the copy number of
the quorum sensing plasmid is able to provide more complete repression, charac-
4.3. The Complete SPoCK System 107
a
b c
araC luxItetRluxR
Plux
ParaBAD
cvicvaC
PLtetO
LuxR AHL LuxI
AraC arabinoseTetR
BFP
GFP
d e f
0.0
0.3
0.6
0.9
0 5 10 15 20
time (hours)
ab
so
rb
an
ce
2.0
2.2
2.4
2.6
0 5 10 15 20
time (hours)
lo
g1
0(
flu
or
es
ce
nc
e)
2.4
2.5
2.6
2.7
2.8
2.9
0 5 10 15 20
time (hours)
lo
g1
0(
flu
/a
bs
)
[mM]
0
0.00133
0.0133
0.133
1.33
13.3
0
2
4
6
MG1655
lo
g1
0(
G
FP
)
0
0.00133
0.0133
0.133
1.33
13.3
ara [mM]
0
2
4
6
MG1655
lo
g1
0(
BF
P)
0
0.00133
0.0133
0.133
1.33
13.3
ara [mM]
p15A
SC101
Figure 4.11: Inhibition of bacteriocin production in the SPoCK system with arabinose. a)
A cartoon illustrating the mechanism of inhibition of bacteriocin production
through arabinose induction of the quorum sensing system. b & c) Flow cy-
tometry data showing BFP and GFP expression at varying concentrations of
arabinose. The grey dashed line shows the median level of fluorescence of
the empty E. coli MG1655 strain. d, e & f) Time-course data of the SPoCK
system at varying arabinose induction concentrations.
terisation of the system under arabinose induction was carried out with a variety of
origins of replication. The BFP flow cytometry data, Figure 4.12a, shows expres-
sion increasing with copy number at all inducer concentrations. Similarly, the GFP
data, Figure 4.12b, shows increasing repression with copy number across all in-
ducer concentrations. However, even when uninduced the system shows repression
of GFP expression in the higher copy number BR322 and pUC plasmids; indeed
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Figure 4.12: SPoCK with different copy number plasmids. a & b) BFP and GFP expres-
sion at various arabinose concentrations. The grey dashed line shows the me-
dian fluorescence level of empty E. coli MG1655. c) Inhibition by uninduced
SPoCK strains.
the pUC plasmid shows complete repression. The inhibition zones produced by
uninduced SPoCK systems, Figure 4.12c, show that all of the systems can produce
bacteriocins except for the highest copy number pUC system, confirming the GFP
cytometry data. This also confirms that the bacteriocin production can be turned
off, which is crucial for the system to function dynamically.
4.4. A More Complete Model of SPoCK Dynamics 109
RNAP
ParaBAD
AraC-arabinose
complex
O2 I1 - I2
Term
1
K1
K2C
O2 I1 - I2
O2 I1 - I2
I1 - I2
O2
K3CF
free AraC
RNAP
Plux
LuxR-AHL
complex
lux box
Term
1
K1
K2C
lux box
lux box
RNAP
RNAP
PLtetO-1
free TetR
O1 O2
Term
1
K1
K2CF
K32CF2
O1 O2
O1 O2
K2CF
O1 O2
O1 O2
RNAP
A B C
Figure 4.13: States of the SPoCK promoters.
4.4 A More Complete Model of SPoCK Dynamics
The model presented in the previous Chapter contained abstractions of parts of the
system that can now be detailed; specifically the production of AHL and bacteri-
ocin by the killer strain. Here, the Shea-Ackers formalism is used to model the
expression from promoters in the system. This is chosen over other description
of promoter activity such as Hill functions and logistic curves as it offers a more
mechanistic understanding of the behaviour of the promoters [162, 105].
4.4.1 Shea-Ackers Characterisation of SPoCK Promoters
The AHL expression rate was previously described by a constant, kA. In reality
AHL is produced by the LuxI protein which is, in this system, expressed from
the ParaBAD promoter driven by arabinose. Using the Shea-Ackers formalism
for describing promoter activity, a model of the probability of expression from the
ParaBAD promoter, with states shown in Figure 4.13A, can be written as:
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PB(t) =
K1B +K2BCB
1+K1B +K2BCB +K3BCFB
(4.1)
CB =C0B
LnBB
KnBdB +L
nB
B
(4.2)
CFB =C0B−CB (4.3)
where PB is the probability of expression from the ParaBAD promoter, C0B , CB and
CFB are the total, ligand bound and ligand free concentrations of AraC in each cell,
LB is the concentration of arabinose in the system, KdB is the dissociation constant
of arabinose-AraC, and nB is the cooperativity of ligand binding. The intra-cellular
concentration of the ligands for all transcription factors is assumed to be equal to
the environmental concentrations.
In the simple model in the previous Chapter, bacteriocin expression was de-
scribed by a repressive Hill function with activity dependent on AHL. The system
constructed in this Chapter requires an intermediate step to invert the AHL signal;
the bacteriocin is repressed not by AHL directly but by AHL activated TetR. The
TetR is expressed from the PLux promoter, with states shown in Figure 4.13B, the
activity of which can be written as:
PL(t) =
K1L +K2LCL
1+K1L +K2LCL
(4.4)
CL =C0L
LnLL
KnLdL +L
nL
L
(4.5)
LL = A(t) (4.6)
where PL is the probability of expression from the PLux promoter, C0L and CL are the
total and ligand bound concentrations of LuxR in each cell, LL is the concentration
of AHL in the system, KdL is the dissociation constant of AHL-LuxR, and nL is the
cooperativity of ligand binding.
Finally, the bacteriocin is expressed from the PLtetO-1 promoter which is re-
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pressed by TetR, as shown in Figure 4.13. The expression from this promoter can
be written as:
PT (t) =
K1T
1+K1T +2K2T CFT +K
2
2T C
2
FT
(4.7)
CFT ∝ PL(t) (4.8)
where PT is the probability of expression from the PLtetO-1 promoter and CFT
is the ligand free concentration of TetR in each cell. Since no ligand for TetR is
added to the environment, no consideration needs to be made regarding the binding
of ligand to transcription factor as has to be done for the other promoters.
Using the flow cytometry data for the activity of each of these promoters after
24 hours of induction, assumed to be at steady state, with a range of inducer con-
centrations, values for the parameters in the above models can be ascertained. Often
these models are fit using regression methods that return point estimates of each pa-
rameter [2, 163]. However, by using Bayesian methods it is possible to get a better
understanding of the interplay between different parameters in the system through
looking at posterior correlations. It also allows one to understand the constraints on
particular parameters in order to achieve a given behaviour. Here, I use Stan [164]
to produce fits for the flow cytometry data, with a log-likelihood given by:
L(θ |x) =
R
∑
r
I
∑
i
Pp
∑
p
log(P(xr,i,p|θ)) (4.9)
P(xr,i,p|θ) = N(Pi,p,σp) (4.10)
where i ∈ I are the inducer concentrations, r ∈ R are the replicates of each measure-
ment, p ∈ Pp are each of the promoters, θ is the parameter set and x ∈ x are the
flow cytometry data. The model fits are shown in Figure 4.14 and a correlogram
of the parameters is shown in Appendix B. The promoters are fitted concurrently,
rather than individually, as the output from the PLux promoter is the input into the
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Figure 4.14: Fits of the Shea-Ackers models to flow cytometry data of SPoCK promoter
activity.
PLtetO-1 promoter. Unfortunately, concurrently fitting the PLux and PLtetO-1 pro-
moter activities to arabinose induction data was unsuccessful. This is most likely
due to this method assuming steady-states have been reached in promoter expres-
sion but due to the density dependence of the PLux promoter, steady state may not
have been reached.
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4.4.2 Finding Equilibria and Oscillations Using Approximate
Bayesian Computation
The models of promoter activity can be combined with the simple SPoCK model
described in the previous Chapter in order to understand how the system that has
been built will behave. The changes to the simple model are small:
kβ (t) = PT (t) kβmax (4.11)
and
kA(t) = PB(t) kAmax (4.12)
where kβmax and kAmax are the maximal rates of expression of bacteriocin and AHL.
Note that there is a simplification here in that the expression rate of AHL, kA is
modelled as proportional to the activity of the ParaBAD promoter, rather than the
concentration of intracellular LuxI. Due to the degradation tag fused to the LuxI,
the concentration of LuxI should be closely related to current ParaBAD activity. As
such, it is felt that this simplification is a reasonable one.
The effect of the bacteriocin on the rate of killing of competitor cells is also
updated. Previously the relationship between bacteriocin concentration and cell
death was linear, with a constant ω giving a death rate per unit of bacteriocin. A
more realistic approach is used here in which the death rate is related to bacteri-
ocin concentration by a Hill function. This prevents death rates from becoming
unrealistically fast if bacteriocin concentration becomes higher than expected. As
such:
ωC(t) =
ωCmaxβ (t)nω
Knωω +β (t)nω
(4.13)
Prior distributions for each of the model parameters, Table 4.1, were ascer-
tained either from the literature, from experimental data or from sensible estimates.
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Table 4.1: Prior distributions of SPoCK model parameters for ABC simulations
Parameter Description Prior unit
D Dilution rate U(0.01,0.5) h−1
LB Arabinose concentration U(10−6,10−2) M
µXmax Maximum growth rate of killer strain U(0.7,0.9) h−1
µCmax Maximum growth rate of competitor
strain
U(0.7,0.9) h−1
ωCmax Maximum death rate induced by bac-
teriocin
U(0.5,2) h−1
Kω Half-saturation concentration con-
cerning bacteriocin induced death
U(10−16,10−12) M
nω Hill coefficient of bacteriocin in-
duced death
U(1,2) -
KX Concentration of substrate at which
killer strain growth is half-maximal
10−5 gL−1
KC Concentration of substrate at which
competitor strain growth is half-
maximal
10−5 gL−1
S0 Reservoir substrate concentration 4 gL−1
γx Yield coefficient of killer strain 1012 cells g−1
γc Yield coefficient of competitor strain 1012 cells g−1
kAmax Maximum expression rate of AHL 10
−15 mol h−1
kβmax Maximum expression rate of bacteri-
ocin
10−22 mol h−1
The priors for the promoter parameters are given by the posterior distributions from
the model fitting above.
In order to look for equilibria states, the gradients of the killer and competitor
populations at the last time-point were used for the distance function. Examples of
equilibria time-series are shown in Figure 4.15 and the posteriors for key parameters
are shown in Figure 4.17.
In order to search for oscillatory states a method was used to classify peaks in
a simulated time-series by identifying time-points of local maxima. Three tests are
used to create a distance function:
1. Are there at least N peaks in the time-series with amplitude above a threshold?
2. Is the amplitude of the final peak above a threshold?
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Figure 4.15: Simulated equilibria of the killer (red line) and competitor (blue line) popula-
tions in the implemented SPoCK system.
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Figure 4.16: Simulated oscillations of the killer (red line) and competitor (blue line) popu-
lations in the implemented SPoCK system.
3. Are the amplitudes of the peaks within a threshold standard deviation?
These tests do not necessarily identify stable limit cycle oscillations but do require
oscillations to be sustained for a specifiable amount of time. Examples of such
time-series are shown in Figure 4.16. The posterior distributions produced for the
key parameters by the ABC algorithm are shown in Figure 4.17.
The posterior distributions in Figure 4.17 show clear differences between the
stable and oscillatory behaviours. As was seen with the simple model, oscillatory
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Figure 4.17: Posterior distributions for key parameters to achieve oscillations and equilib-
ria. The posteriors to achieve oscillations are far more constrained than those
for stable equilibria.
states require fast dynamics in the system produced by a high dilution rate and high
competitor growth rate. Here the dilution rate and competitor growth rate must be
high and the arabinose concentration must be at the lower end of the prior range.
4.5 SPoCK in Chemostat
Now that a functioning SPoCK system has been implemented it can be tested in
competition. The competitor strain was E. coli MG1655 with mCherry expression
and gentamicin resistance integrated into the chromosome. An Eppendorf DASbox
mini bioreactor was used which allows four experiments to run in parallel with
control over dilution rate, gas mixing and pH.
Two chambers were run at a dilution rate 0.1 hr−1 and two at 0.05 hr−1. All
chambers were inoculated with identical volumes of killer and competitor culture.
The single cell fluorescence was measured at several time points across 51 hours
using flow cytometry. The data was put through the same analysis pipeline as previ-
ously described to select singlet bacteria. Figure 4.18 shows an example of the flow
cytometry data for a single chamber at a single timepoint.
The single cells were then clustered on fluorescence, with cells expressing BFP
and/or GFP classified as killer and those expressing mCherry or no fluorescence as
competitor. The non-fluorescing cells were classified as competitor as it was noted
in later experiments that the chromosomally integrated mCherry reporter produced
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Figure 4.18: Example flow cytometry data for a single chamber at a single timepoint of
SPoCK in chemostat. The dashed lines show an arbitrary threshold for classi-
fying cells as on or off for a given fluorescent protein.
very low levels of fluorescence when growing exponentially. The results, in Figure
4.19, show the data from the two chambers diluted at 0.05 hr−1. The killer popu-
lation initially overtakes the competitor population. After 30 hours, the competitor
begins to out-compete the killer and its population increases relative to the killer.
Using the parameters inferred previously for the constructed SPoCK system, i.e.
those for the Shea-Ackers promoter activities, the model detailed above was fitted
to the chemostat data using a using Bayesian methods. Table 4.2 shows the values
for the parameter fits.
The model fitting predicts that, under the conditions used here, the killer pop-
ulation will go to extinction after roughly 250 hours. However, using the fitted pa-
rameters, a prediction for the outcome of competition between the two strains with
no SPoCK system present, shows that the “killer” strain would go to extinction far
faster. The model fitting indicates that the SPoCK system causes a very large bur-
den on the killer strain leading to a far lower maximal growth rate, µXmax = 0.85,
compared to the the maximal growth rate of the competitor strain, µCmax = 2.83.
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Table 4.2: Fitted parameters for SPoCK model to chemostat data. U(x,y) indicates a uni-
form distribution between x and y.
Parameter Prior Mean of Posterior
µXmax U(0.6, 2.85) 0.85
µCmax U(0.6, 2.85) 2.83
ωmax 10U(0,9) 100.31
Kω 10U(−10,−4) 10−4.44
kAmax 10
U(−21,−16) 10−18.51
kβmax 10
U(−23,−17) 10−21.58
β (0) 10U(−15,−3) 10−4.37
nω U(1, 2.5) 2.46
The two chambers diluted at 0.1 hr−1 suffered from pump issues at various points
through the experiment but the data can be seen in Appendix C.
The cultures at the end of the chemostat experiment were assayed for the pres-
ence of bacteriocin in the media and the ability of the remaining cells to still produce
bacteriocin when arabinose is not present. The results can be seen in Figure 4.20.
The cultures, from all chambers, that were filtered to remove bacterial cells, pro-
duced no inhibition of a susceptible E. coli MG1655 strain. This indicates that no
bacteriocin is present in the media of any of the chambers at the final time-point.
This reinforces the data in Figure 4.19 showing recovery of the competitor strain.
The cultures, when unfiltered allow the bacteria present in the culture to grow and, if
possible, produce bacteriocin. The cultures in chambers 3 and 4 show zones of inhi-
bition, proving that they still have the ability to produce bacteriocin when not being
inhibited. However, the cultures from chambers 1 and 2 do not show any inhibition,
indicating that this ability is lost. Further, the morphology of the colony produced
from chamber 2 is rather different than that of the other cultures suggesting drastic
change in the bacteria present. A similar assay carried out on the cultures from the
chambers 24 hours before hand showed that the bacteria in chamber 1 were still
capable of producing bacteriocin but those in chamber 2 were already producing a
bright colony.
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Figure 4.19: SPoCK in a bioreactor with competition between the killer strain (red) and the
competitor strain (blue). In the top panel, the black circles show samples from
two replicate chambers with dilution rate set to D = 0.05hr−1 that were used
to fit the model. The lines show the fitted model. The bottom panel shows a
prediction of what would happen to the two strains if the SPoCK system were
not present to counteract competitive exclusion.
4.6 Discussion
In this Chapter I have described the construction and characterisation of a system
for the density dependant killing of competitors by an engineered bacterial strain.
Each element of the system has been characterised using flow cytometry data, Shea-
Ackers models of promoter activity and Bayesian model fitting. The system was
tested in competition in chemostat and the results, though preliminary, showed be-
haviour that suggests the SPoCK system is behaving dynamically. Finally, using
ABC, conditions were discovered under which one might expect to produce oscil-
lating or stable communities.
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Figure 4.20: Inhibition assay of chemostat cultures at the end of the competition experi-
ment. The top row shows no inhibition when cultures are filtered to remove
bacterial cells, indicating no bacteriocin present in the media. The bottom row
shows unfiltered cultures. The bacteria growing in chambers 3 and 4 are still
able to produce bacteriocin causing inhibition when arabinose is not present.
The cultures in chambers 1 and 2 produce no zones of inhibition, suggesting
a loss of bacteriocin production capability.
An inducible bacteriocin production system was constructed, the first to my
knowledge, using a the TetR repressible PLtetO-1 promoter and the microcin-V
bacteriocin. This was shown to function over a range of inducer concentrations;
though the GFPmut3b used as an expression level proxy did not provide a useful
proxy. However, computational prediction of promoters in the microcin-V cassette
found a putative promoter within the cvi gene, upstream of the cvaC bacteriocin
gene. This potentially means that repression of the synthetic promoter cloned up-
stream of the cvi gene may not be enough to repress expression of the bacteriocin.
As such, a plasmid was created using synthesised cvaC and cvi genes, separated
and placed in the opposite order to the wild-type operon.
A quorum sensing system was constructed from two parts. The receiver part
consisted of a lux promoter with luxR being transcribed in the reverse direction and
sfGFP-LAA transcribed in the forward direction. This was demonstrated in a low
copy SC101 plasmid to have ∼100 fold dynamic range of AHL induction. Time-
courses demonstrated that the higher levels of induction had a small but noticeable
impact on growth. Further, a transient repression of the promoter was recorded at
all inducer concentrations at a similar point in growth. This may be indicative of
the presence of one of the known growth phase dependant transcriptional regulators
that repress the lux promoter.
The sender part of the the quorum sensing system consisted of an ParaBAD
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promoter driving expression of its transcription factor araC in the reverse direction
and mTagBFP2 and luxI-LAA in the forward direction. Again, this system was
inducible with at least a ∼1000 fold dynamic range with arabinose. The growth
curves showed that, at the highest concentrations of arabinose, growth rate increased
possibly due to utilisation of the arabinose as a carbon source [165]. A plate reader
assay could not be used due to a lack of filters to detect BFP but using PBS as a
medium, it was shown that the induction of this sender part of the circuit was not
density dependant. Unfortunately the same assay couldn’t be used to demonstrate
the density dependence of the receiver part of the circuit as the lux promoter did not
turn on in PBS.
The sender and receiver system were combined on a single plasmid and the
ability to induce the receiving lux promoter by arabinose induction of the sending
system was demonstrated. The dynamic range on a low copy SC101 plasmid was
shown to be < 100 fold with arabinose. BFP proved to be a poor marker for expres-
sion from the sender part, with very small increases in expression from the basal
level correlated with virtually maximal expression of GFP from the receiver part.
Plasmid copy number was identified as a further manipulable parameter so
three additional origins of replication were characterised. The medium copy BBR1
origin of replication behaved in a similar fashion to that of SC101, producing greater
fluorescence homogeneity. The high copy BR322 plasmid appeared to be in an off
state when uninduced, though the GFP expression distribution showed a tail of GFP
expressing cells. However, when induced with arabinose, at a concentration deter-
mined from the SC101 system to produce maximal GFP induction, the population
split with a large non-functioning population. This was further explored with a
range of arabinose concentrations revealing that at low inducer levels the system
behaved as desired. A non-functioning sub-population was detectable at the sec-
ond lowest inducer concentration tested. At the two highest concentrations tested, a
third population was detectable in which BFP expression was functioning but GFP
expression was not. It is clear that the sender part is malfunctioning in the popu-
lation without BFP expression. It is less obvious whether, in this population, the
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receiver part is also malfunctioning. However, in all of these samples there are pop-
ulations still producing the fluorescent proteins expected so it can be assumed that
there is AHL in the environment. This leads to the conclusion that the receiver part
is malfunctioning as well. At the two highest concentrations, there is a third sub-
population in which BFP expression is on but GFP expression is not. This clearly
indicates malfunctioning of the receiver only. It is well understood that pushing
cells to produce large quantities of proteins exerts a pressure which selects for those
cells which manage to accrue loss of function mutations in non-essential operons
[32]. The very high, uncontrolled plasmid copy number of the pUC based plasmid
produced high levels of GFP and low level BFP expression when uninduced and
malfunctioned in a similar way to the BR322 system when induced. The BFP ex-
pression when uninduced indicates that the leakiness of the ParaBAD promoter is
amplified by the very high copy number. However, some of the BFP expression
detected may be spill over from the extremely high GFP fluorescence into the BFP
detection channel. As such, it is difficult to determine to what extent the known
leakiness of the lux promoter or the supposed leakiness of the ParaBAD promoter
contribute to this expression pattern. The experiments with the full SPoCK system
using the pUC plasmid indicate that the leakiness of the lux promoter is the domi-
nant factor; though it has been shown earlier that very low levels of BFP expression
can result in high GFP expression.
The full SPoCK system, consisting of the quorum sensing and bacteriocin plas-
mids was tested in E. coli MG1655. It was shown that GFP expression, the marker
used for bacteriocin production, was repressible by induction of the quorum receiver
with exogenous AHL. GFP expression was not completely eliminated, even at the
highest AHL concentration, though with no degradation tag on the GFPmut3b its
half-life was roughly the same length of time as the induction. Induction of the
system with AHL had a small positive impact on growth, indicating that bacteriocin
and GFP production are, unsurprisingly, more costly than TetR production.
Arabinose induction of the full SPoCK system resulted in expected BFP ex-
pression dynamics. The repression of GFP expression was not as dramatic as when
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the system is induced with AHL. However, as noted before, the half-life of GFP-
mut3b is long and the additional time required for the population density to increase
before repression of the PLtetO-1 promoter occurs would result in a lag before GFP
production is turned off.
Plasmid copy number of the quorum sensing plasmid was again explored as a
system parameter. The first point to note is that the uninduced pUC plasmid pro-
duces no BFP expression, as was seen when characterising the quorum plasmid
alone. This lends greater weight to the supposition that the high GFP signal leaked
into the BFP channel rather than a great deal of leakiness from the ParaBAD pro-
moter. This is reinforced by the total lack of GFP expression from the bacteriocin
plasmid in the uninduced pUC system and lack of inhibition zone on the inhibition
assay, indicating total repression of the PLtetO-1 promoter through leaky produc-
tion of TetR. The differences in expression for each origin of replication correspond
to the expected patterns given previous results. Here, though, there is minimal het-
erogeneity in population behaviour and that which is seen is in the BFP expression
from the ParaBAD promoter which is a known binary fate phenomena [166].
The full system was tested in a chemostat with competition. Flow cytometry
measurements showed initial removal of the competitor population followed by re-
covery. Inhibition assays indicated that bacteriocin production can be turned off
inside the bioreactor and that the ability to produce bacteriocin is maintained. How-
ever, this was not the case in all four experiments. The results should only be viewed
as preliminary as there were several weaknesses in the experiment. Firstly, the flu-
orescence marker used to identify the competitor strain produced weak variably
fluorescing cells. As such, non-fluorescing cells were classified as the competitor
strain based on an assumption that the killer strain must be fluorescing in either the
BFP or GFP channel at all times. Secondly, the DASbox system that was used did
not seem to maintain perfect pump accuracy for feed of media and removal of waste.
As such, the volume within each chamber varied over the course of the experiment.
As such, dilution rates can’t be considered to be stable. Finally, the limited num-
ber of chambers that can be run in parallel meant that for this preliminary run, no
4.7. Conclusion 124
controls of the competitor and killer alone were made.
Each of the components of the SPoCK system were characterised using flow
cytometry data and Bayesian model fitting to Shea-Ackers models. These param-
eters were then used to make the simple model, shown in the previous Chapter,
more representative of the system as implemented. Using ABC, conditions under
which one could expect to see oscillating and equilibria states were found. The
key parameters to achieve these different states were the dilution rate and growth
rate of the competitor and the concentration of arabinose in the system. While the
growth rate may not be easily modifiable for some possible applications, the arabi-
nose concentration is an easily changeable parameter and was designed to be used
to modify system function. Further, though the dilution rate may be easily changed
in laboratory experiments, in an industrial setting dilution rate is likely to have been
carefully designed to achieve the goal of the industrial process.
Some weaknesses remain in the model. The production of AHL remains a
simplification from the real mechanism which involves the intermediate production
of LuxI. Further, no time delay is modelled in the system through the accumulation
and degradation of transcription factors and ligands, other than AHL. This means
that the instantaneous activity of the PLtetO-1 promoter is dependent on the instan-
taneous activity of the PLux promoter, not on the accumulated level of TetR in each
cell. For the production of AHL this may be a valid abstraction due to the ssrA
degradation tag on the LuxI protein. However, the half-life of non-tagged proteins
can be considerable and may cause differences to the dynamics modelled here.
4.7 Conclusion
In conclusion, I have produced the first dynamically controllable bacteriocin expres-
sion system, with versions that can be induced with the addition of aTc or repressed
through the addition of an AHL. Using this system I have developed a tunable den-
sity dependent bacteriocin expression system; the first synthetic system of its kind.
I have characterised all parts of this system using a Shea-Ackers formalism and a
novel Bayesian fitting approach. Finally, I have made the first steps towards demon-
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strating the abilities of this system to dynamically control a two species community
in a chemostat.
4.8 Future Work
The SPoCK system, detailed in Chapter 3 and constructed in this Chapter, was
shown theoretically to produce stable coexistence of two bacterial populations. The
system was tested in a chemostat and the results demonstrated the ability for the
killer strain to compete against the competitor strain and for the competitor to re-
bound once bacteriocin production was turned off in the killer. However, the limited
number of chambers in the chemostat and reliability problems meant that the results
should only be viewed as preliminary. I have begun the construction of an 8 cham-
ber chemostat/turbidostat [167]. This will allow for the concurrent testing of the
system along with suitable controls and a reasonable number of replicates; some-
thing that was not possible with the equipment available. An alternative approach
would be to use microfluidics, as was done with another system for producing sta-
bilised populations [102].
In addition to further experimentation with the currently constructed system,
adaptations to that system can be made. One adaptation was the addition of self-
regulation, as modelled at the end of Chapter 3. This can be done by adding a toxin
under the control of the Plux promoter. It is likely that the translation rate of the
toxin gene would need to be carefully tuned in order to prevent unwanted cell death.
Chapter 5
Stabilisation of Synthetic Circuits
with Post-Segregational Killing
Manipulation techniques for creating DNA based synthetic circuits have allowed
the creation of a wide variety of functional synthetic biological system with appli-
cations from industrial scale chemical production through to live bacterial therapeu-
tics. The DNA that encodes these circuits is often developed using plasmids. This
is usually due to the fact that plasmids have been widely used historically in molec-
ular and cellular biology research, which has lead to a plethora of methods for their
isolation and manipulation [23, 24]. Further, plasmids offer the modularity that
has been one of the main aims of the field of synthetic biology since its inception
[25, 3]. Finally, it has been shown that circuit copy number is an important parame-
ter in the functioning of genetic circuits [22]. Transferring a system developed on a
multi-copy plasmid to a single location within the chromosome while maintaining
identical function is not trivial [22]. Inserting genetic circuits into the chromosome
of bacterial species is not necessarily simple, though new methods using lambda-
Red [16] and CRISPR-Cas9 [17] are making the process easier. The location in the
chromosome one inserts genetic circuits can also have a big impact on their function
and in bacteria is likely to disrupt native cell function to some degree [20, 21].
However, ensuring the stable inheritance of plasmids when cells divide is a
fundamental problem when using plasmids. Plasmid free cells can be produced if
plasmids are distributed unevenly within a cell at division. Since the majority of
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synthetic circuits carried on plasmids produce a burden on their host cells, the new
plasmid-free cell will outgrow the plasmid-bearing cells in the environment. This
can quickly lead to the effective removal of the plasmid-bearing population, and the
functioning circuit, from the environment [29]. For synthetic bacterial systems to
be of any use, one must be able to ensure the predictable presence of that system
within its intended environment. It should be noted here that there is a second type
of plasmid stability; structural stability. This refers to the faithfulness with which
the DNA sequence of the plasmid remains unaltered across rounds of replication.
This form of stability is not the topic of this thesis. However, it is of fundamental
importance to the continued function of synthetic genetic circuits which is a concern
of this work.
Antibiotic selection of bacteria containing plasmids carrying the correspond-
ing antibiotic resistance genes is commonly used in a research environment. How-
ever, antibiotics are not used in industrial fermentation due to the financial impact
of removal and deactivation [33]. Antibiotics are also unsuitable for clinical ap-
plications for a number of reasons including horizontal gene transfer of resistance
genes [34, 35] and the disruption of the native microbiota [36]. In light of these
limitations, efforts have already been made to re-use a variety of existing microbial
machinery to ensure plasmid persistence in more complex environments [33, 79].
Successful alternatives have been demonstrated with the use of toxin-antitoxin (TA)
systems [37, 13], active-partitioning mechanisms [13, 38] and auxotrophy [40, 39].
In this Chapter I will describe the use of two toxin-antitoxin (TA) systems and
one bacteriocin system to stabilise burdensome plasmids in a therapeutically rel-
evant strain of E. coli, both in vitro and in an in vivo mouse tumour model. As
described in Chapter 1, TA systems are a type of post-segregational killing mecha-
nism that work through the production of a plasmid encoded long lasting toxin and
its shorter lived antitoxin [76, 77]. In this Chapter I will focus on two TA systems;
the commonly used E. coli native hok/sok and the axe/txe system isolated from a
gram-positive bacteria, E. faecium.
Hok/sok is a type I TA system originating from the parB locus of the E. coli
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plasmid R1 that has been shown to be effective in its native E. coli as well as the
gram-negative Pseudomonas putida [124]. It consists of three genes: the host-
killing (hok) gene produces the toxic protein which causes cell membrane perme-
abilisation [168], the suppressor-of-killing (sok) gene produces an RNA which pre-
vents the translation of the hok mRNA, and the modulation-of-killing (mok) gene
which is required for hok translation. Figure 5.1a shows the layout of the sequences
within the system. A forward promoter drives the transcription of the mok-hok
mRNA and a reverse promoter drives the transcription of the sok RNA. In the full
length mok-hok mRNA the 5’ and 3’ ends are the inverse of each other leading to a
blunt-end pairing and a stably folded structure with a half-life of 20 minutes [169].
In this folded form the ribosome binding sites are hidden so the mRNA is inactive.
Only after processing of the 3’ end with RNase II to remove a short nucleotide
sequence, and following refolding, does the mRNA become active. Although the
translated mok protein does not seem to have any known function, the translation
of mok and hok are coupled in such a way that without translation of mok, there is
no translation of hok [170]. The sok RNA, with a very short half-life of 30 sec-
onds, is antisense to a region on the mok-hok mRNA which includes the ribosome
binding site for mok. This region only becomes exposed once the mok-hok mRNA
becomes active. The binding of the sok RNA to the mok-hok mRNA prevents the
transcription of mok and, indirectly, hok. The RNA duplex is quickly cleaved by
RNase III [171]. This process is shown in Figure 5.1b.
Axe/txe is a proteic, type II TA system originating from the axe-txe locus of
the gram-positive Enterococcus faecium plasmid pRUM [125]. The txe toxin is an
endoribonuclease which cleaves mRNA, preventing cells from producing proteins
[173]. It has been used to stabilise luminescent reporter plasmids in gram-positive
E. faecium [125], E. faecalis [174], and B. thuringiensis as well as in gram-negative
E. coli [125]. The axe/txe system had been found in 75% of isolates of the common
hospital pathogen vancomycin-resistant enterococci (VRE) [175].
A potential alternative to TA systems are bacteriocins, which are bacterially
secreted peptides with a bactericidal affect on either a narrow or broad spectrum of
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Figure 5.1: The hok/sok toxin-antitoxin system. a) The layout of the hok, sok and mok
sequences. Forward and reverse transcription start sites are indicated with black
arrows, transcribed sequences are shown as coloured sequences and the putative
genes are shown with arrows above and below the double stranded DNA. b)
Functional process leading to cell killing or survival. Adapted from [172].
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Figure 5.2: The axe/txe toxin-antitoxin system. The layout of the axe and txe genes is
shown with the putative transcriptional start sites indicated with black arrows.
The axe antitoxin and the axe-txe complex act to repress the promoter upstream
of the axe gene.
other bacteria lacking immunity [176]. The secretion of these antimicrobial pro-
teins in to the environment acts to police the plasmid-bearing population, prevent-
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ing plasmid-free cells which lack immunity from growing. Bacteriocins, such as
the Lcn972 system in L. lactis [89] and the colicins A and E2 in E. coli [177], have
already been used to stabilise plasmids. A potential benefit of bacteriocins over
TA systems is their increased robustness to mutational instability. A mutation in
the production of a toxin in a TA system would remove the selective pressure on
that cell, leading to the loss of the plasmid. However, the selective pressure in a
bacteriocin producing population is maintained by the population, even when sin-
gle cells stop producing the toxin. The only requirement is that some cells maintain
bacteriocin production and all cells encode immunity to avoid death [177]. It has al-
ready been demonstrated that E. coli Nissle carries two bacteriocins, microcins H47
and M, in its chromosome [178]. Additionally, these bacteriocins have been deter-
mined to be vital in mediating inter- and intra-species competition in the inflamed
gut [179].
In this work I use the E. coli native microcin-V system, which has not been
characterised as a plasmid-stability mechanism before. The toxin is a low molec-
ular weight, pore forming peptide which is secreted from the producing cell by an
ABC-transporter [180]. There is only one small post-translational modification, a
disulfide bond in the C-terminal region [180], but it does not require any extra en-
zyme encoding genes. The dynamics of production from the putative promoters has
only been partially explored and it is understood that fur binding sites within the
promoters lead to repression when iron is plentiful in the environment [181]. The
bacteriocin gene itself has a modular structure which has allowed its hybridisation
with other bacteriocins, enabling targeting of other bacterial strains [142, 143]. The
transport mechanism is an ABC-transporter with two of the genes encoded within
the microcin-V cassette and the third, TolC, endogenous to E. coli [182, 183]. A
third transport protein, cvaA*, maybe transcribed from within the cvaA gene, which
stabilises the secretion of the bacteriocin [184, 183]. The transport mechanism of
the E. coli Nissle chromosomal microcin H47 is similar enough to that of microcin-
V that it can secrete the active microcin-V bacteriocin [180], suggesting that the
large transport genes do not need to be encoded on the plasmids. The bacteriocin
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Figure 5.3: The microcin-V bacteriocin system. a) The layout of the cvaA and cvaB trans-
port genes as well as the putative shortened cvaA* gene. The cvaC toxin and
cvi immunity genes are transcribed in the reverse direction. Putative transcrip-
tional start sites are indicated with black arrows including one within the cvi
gene that has not previously been annotated. b) The transport of the bacteriocin
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outer membrane receptor Cir and TonB.
recognises the Cir outer membrane receptor [182] and may also use it for transloca-
tion in to the cell [185]. It is thought that the TonB-ExbB-ExbD complex, used for
iron uptake along with Cir, is necessary for transporting CvaC across the periplasm
to allow pore formation in the inner membrane [186]. It has also been shown that a
protein involved in serine uptake, sdaC, is important for the insertion of CvaC into
the inner membrane [187].
In this Chapter I develop a mathematical model of plasmid loss and use sim-
ulations to show how the toxin-antitoxin and bacteriocin systems enhance plasmid
stability. Three plasmid stability mechanisms are tested, using the probiotic host
strain E. coli Nissle, in vitro and in an in vivo mouse tumour model to determine
their stabilising ability in real settings. Bayesian methods are used to infer the
killing efficacy and metabolic burden of the three mechanisms.
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5.1 AModel of Plasmid Stability with Post-Segregational
Killing
An early model of plasmid stability included two populations, plasmid-bearing and
plasmid-free, growing exponentially at different rates with a constant probability of
plasmid loss from the plasmid-bearing population [188]. The model can be written
as a set of ODEs:
dX+
dt
= k+X+−λk+X+
dX−
dt
= k+λX++ k−X−
where, (X−) and (X+) are the number of plasmid-free and plasmid-bearing cells,
k+ and k− are the growth rates, and λ is the loss frequency per cell per generation.
This model was further explored with a particular interest in applying it to the
determination of plasmid loss rates from experimental data [189, 190]. The model
was also extended to describe plasmid-loss within a chemostat in which growth
rates depend on a substrate [191]. A more detailed, biologically accurate model was
devised that takes into account the age distribution of bacteria within a population,
although the predictions produced were virtually indistinguishable from simpler
models [192]. However, this model did highlight the difficulties of trying to infer
the plasmid loss rate from measured population data as, due to the exceedingly
small plasmid loss rates of most systems, the growth rate differences dominate the
dynamics and lead to over-estimation of plasmid loss [192].
A simple model of plasmid loss, assuming a random spatial distribution of n
plasmids within a cell, describes plasmid segregation within a dividing cell as a se-
ries of n Bernoulli trials [29]. This leads to a probability of producing a plasmid-free
daughter cell at division as p0 = 2(1−n). The assumption of random spatial distri-
bution is important in this model and it was shown that the formation of plasmid
dimers changes the plasmid-loss probability [29, 69]. Indeed, dimer formation can
prove so bad for plasmid stability that mechanisms for multimer resolution have
evolved to prevent the “dimer catastrophe” [69, 73]. The plasmid-loss probability
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model would therefore suggest that greatly increasing plasmid copy number would
lead to ever greater plasmid stability. However, models have been used to show
how plasmids carry mechanisms to prevent excessive plasmid replication in order
to maintain stability without too great a metabolic effect on the host bacteria [68].
Here, I extend the early plasmid loss model [188] to include post-segregational
killing by a toxin-antitoxin system. In this model there are two populations;
plasmid-bearing (X+) and plasmid-free (X−):
dX+
dτ
= γX+︸︷︷︸
growth
− λγX+︸ ︷︷ ︸
plasmid-loss
dX−
dτ
= X−︸︷︷︸
growth
+ λγX+︸ ︷︷ ︸
new plasmid
free cells
−ωλγX+︸ ︷︷ ︸
PSK
(5.1)
where λ is the probability of producing a plasmid-free daughter cell when a
plasmid-bearing cell divides, γ is the ratio of plasmid-free generation time to
plasmid-bearing generation time, and ω is the probability of successful post-
segregational killing. The time-step τ is equal to one plasmid-free generation. This
model shows that, with every plasmid-free generation the extant plasmid-free cells
double and new plasmid-free cells are produced by plasmid-loss from the plasmid-
bearing population but some of those newly created plasmid-free cells are killed
through PSK.
An analytical equation for the proportion of plasmid-bearing cells, φ , at time-
point t, is given by:
φt (λ ,γ,ω) =
X+(t)
X+(t)+X−(t)
=
e(γ−γλ )τ
νeτ + e(γ−γλ )τ + (e
τ−e(γ−γλ )τ )γλ (1−ω)
1−γ+γλ
(5.2)
where ν = X
−(0)
X+(0) and τ is the number of plasmid free generations at time t. For
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the purposes of the plasmid loss curves it is assumed that the initial population is
entirely plasmid-bearing, ν = 0. Further, in the plasmid loss experiments, detailed
later, the populations are grown for 24 hours after which they are diluted 500 fold.
As such the simplifying assumption is made that there are ln(500) plasmid-free
generations per passage so τ = ln(500) t24 .
Bacteriocins do not produce post-segregational killing in the traditional sense.
Instead there is a constant killing pressure on the plasmid-free population rather than
specific killing of newly plasmid-free cells. As such, the equation for the change in
plasmid-free population differs to take in to account the different point at which the
bacteriocin causes the death of plasmid-free cells:
dX−
dτ
= X−+λγX+− 2ωX−︸ ︷︷ ︸
bacteriocin
killing
(5.3)
The analytical solution for the bacteriocin model is:
φt (λ ,γ,ω) =
e(γ−γλ )τ
νe(1−2ω)τ + e(γ−γλ )τ + (e
(1−2ω)τ−e(γ−γλ )τ )γλ
1−γ+γλ−2ω
(5.4)
The effects of varying each of these model parameters can be seen in Figure 5.4.
The plasmid loss parameter, λ , has an effect on the gradient early on. However,
once the first plasmid-free cells arise it is the growth parameter, γ , that has most
effect. This can be seen in the strong effect that small changes in γ has on the shape
of the curves. When γ = 1, the plasmid-bearing and plasmid-free cells are growing
at the same rate and the only change in population proportion comes plasmid loss,
which can be seen in a very shallow gradient. The death parameter, ω , in the TA
model has a similar effect to the plasmid loss parameter, λ . It has very little effect
once plasmid-free cells have escaped; its effect is lengthening the time before those
cells do arise. Intuitively, this is a similar effect to reducing the loss probability, λ .
The death parameter in the bacteriocin model has a more drastic effect than in the
TA model and doesn’t require order of magnitude variation for those changes to be
visible. Over a single order of magnitude for the bacteriocin killing the plasmid-loss
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Figure 5.4: Effects of model parameters on plasmid-loss curves. a) Varying the plasmid-
loss probability, λ , and b) the doubling time ratio, γ , without post-segregational
killing or bacteriocin killing. These are identical for the TA and the bacteriocin
models when ω = 0. c) Varying the efficacy of the toxin, ω , in the TA model.
d) Varying the efficacy of the bacteriocin, ω , in the bacteriocin model.
curve changes from virtually total plasmid maintenance to almost no extra plasmid
stabilising effect.
5.1.1 Modelling Noise in Plasmid Loss Curves
The experimental method used to determine plasmid stability, the protocol for
which is detailed in Chapter 2, relies on sampling a population of cells and classify-
ing each one as plasmid-bearing or plasmid-free. Every one of the n cells sampled
is equivalent to a Bernoulli trial where “success” is a cell being plasmid-bearing and
the probability parameter corresponds to the proportion of plasmid-bearing cells in
the culture from which the sample was drawn. As such, a binomial distribution can
be used to describe the number of plasmid-bearing cells in any sample:
X+ ∼ Binomial(n,φ) (5.5)
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where n is the number of cells sampled and φ is the true proportion of plasmid-
bearing cells in the population from which the sample was drawn. In fact, using
flow cytometry, the sampling is performed without replacement and as such a hy-
pergeometric model is a more apt description. However, since the fraction of the
total population being sampled is very small, ∼ 1/5000, a binomial model is a rea-
sonable approximation.
The binomial model can describe the noise introduced in sampling the plasmid
loss experiments but does not incorporate any intrinsic biological noise, which will
result in overdispersion of the data. The “true proportion of plasmid-bearing cells”,
φ , from which the sample was taken, is the parameter that is affected by this biolog-
ical noise. The uncertainty in this parameter is traditionally modelled using a beta
distribution and the binomial and beta model can be combined into a beta-binomial
model:
X+ ∼ Beta-Binomial(n,α,β ) (5.6)
where
α = φ
(
1
ρ
−1
)
(5.7)
β =
α−α φ
φ
(5.8)
thus the parameter ρ is used to reflect the uncertainty in φ . Simulated plasmid loss
curves can be produced by sampling r replicates from the beta-binomial model at t
timepoints. The plasmid-bearing population fraction is then given by:
φˆr,t(λ ,γ,ω,ρ,n) =
X+r,t
n
(5.9)
where X+r,t are r replicate samples at t timepoints from the beta-binomial distribution
in Equation 5.6. φ in Equations 5.7 and 5.8, is generated at each timepoint using
either the TA model in Equation 5.2 or the bacteriocin model in Equation 5.4. The
effects of the sample size, n, and the uncertainty parameter, ρ , are shown in Figure
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Figure 5.5: Effects of noise parameters on plasmid-loss curve simulated with the TA model.
Nine replicates for each plasmid-loss curve. Varying a) sample size, N, and b)
the uncertainty parameter, ρ .
5.5.
5.1.2 Bayesian Model Fitting to Plasmid Loss Curves
The models detailed by Equations 5.2 and 5.4 can be fit to experimental plasmid loss
curves in order to understand the differences between the tested plasmid stability
mechanisms. Here I use a Bayesian method of parameter inference to produce
posterior distributions for each parameter, rather than point estimates.
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At each timepoint, t, there are r replicates for which analysis of the flow cy-
tometry data produces the number of plasmid-bearing cells X+r,t in a sample of size
nr,t . Note that the sample size varies for each sample as all cells within a specified
volume are measured rather than cutting off after a given number of events have
been recorded.
The aim here is to determine the set of model parameters, {λ ,γ,ω}, and noise
parameter, ρ , which are most likely to produce the data observed using flow cy-
tometry. Using the beta-binomial model, outlined previously, the log likelihood for
each strain can be written as:
L
(
λ ,γ,ω,ρ|X+)= r∑ t∑ log(P(X+r,t |λ ,γ,ω,ρ)) (5.10)
where
P(X+r,t |λ ,γ,ω,ρ) = Beta-Binomial(nr,t ,αt ,βt)
αt = φt (λ ,γ,ω)
(
1
ρ
−1
)
βt =
αt−αt φt (λ ,γ,ω)
φt (λ ,γ,ω)
Markov chain Monte Carlo (MCMC) algorithms and the Stan statistical mod-
elling package [164] are used to produce posterior distributions for each of the
model parameters, λ , γ and ω , and the fitting parameter ρ . Two chains of 2000
iterations were produced, with the first 1000 being discarded as burn-in. Conver-
gence was verified by observation that all Rˆ values were close to 1.
Simulated data is used to determine the effectiveness of this method for in-
ferring true parameter values. Figure 5.6 shows that, for simulated data without
post-segregational killing i.e. ω = 0, this method is able to capture the true parame-
ters even with a large amount of noise. This is true even though very broad uniform
priors were used; log10(λ ) =U(−10,0),γ =U(0,1),ρ =U(0,1).
When fitting to the flow cytometry data, it is possible to produce a prior es-
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Figure 5.6: Bayesian fitting of simulated data with noise parameter ρ equal to a) 0.05,
b) 0.5. Grey lines show each of the 9 simulated trajectories, the blue line
shows the true curve, the solid red line shows the median model fit and the
dashed red lines show the 95% confidence intervals. Simulated data produced
with λ = 10−5,γ = 0.8,ω = 0,N = 1000. Priors for fitting were log10(λ ) =
U(−10,0),γ =U(0,1),ρ =U(0,1).
timate for the γ parameter, the ratio of plasmid-bearing to plasmid-free generation
time, by measuring growth rates of plasmid-bearing and plasmid-free cells.
p(γ|Dg) =
p(µ+|D+g )
p(µ−|D−g )
By inspection of the posterior distributions, Figure 5.7, one can see that using a
normal prior for γ when fitting to simulated data yields little benefit. This suggests
that this methodology may be used to ascertain growth rate ratios from competition
curves as an additional check to, or instead of, growth curve data.
When fitting the model to the flow cytometry data from the control plasmid, in
which there is no PSK mechanism, the PSK death probability parameter ω can be
set to 0. This enables the removal of ω from the model fitting which reduces the
effects of any potential parameter correlation between ω and the other parameters
which may lead to unidentifiability of the model. An assumption can be made
that carrying a PSK mechanism does not significantly reduce plasmid copy number
[188] which means that the plasmid loss probability is unlikely to change. This
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Figure 5.7: Bayesian fitting of simulated data with a) a broad uniform prior γ = U(0,1)
or b) a tighter normal prior γ = N(0.8,0.05). Grey lines show each of the
9 simulated trajectories, the blue line shows the true curve, the solid red line
shows the median model fit and the dashed red lines show the 95% confidence
intervals. Simulated data produced with λ = 10−5,γ = 0.8,ω = 0,ρ = 0.5,N =
1000. Other priors for fitting were log10(λ ) =U(−10,0),ρ =U(0,1).
allows for the posterior λ , ascertained from fitting the control plasmid with ω = 0,
to be used as a prior for λ when fitting the plasmids carrying PSK mechanisms. The
importance of producing a prior estimate for λ can be seen in Figure 5.8. Without a
tight prior, correlation between the λ and ω parameters leads to very poor inference
of the true parameters, even though Rˆ values suggest the chains have converged.
5.1.3 Hierarchical Model Fitting of Plasmid Loss Curves
The method of model fitting described above performs reasonably well when fitting
to simulated data. However, it assumes that there is a single true value for each
parameter in a given strain. In reality one would expect that there is a distribution
of behaviours possible for each strain and as such there is a distribution, rather than
point value that each parameter can take. Further, one could expect that some of the
parameters show similarities between strains and some are unique to the strain. For
example, the plasmid loss probability λ is, assuming no partitioning mechanisms,
predominantly defined by the plasmid copy number. As such, one would assume
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Figure 5.8: Bayesian fitting of simulated data in which there is PSK. The priors used for
the fitting are shown above each panel. a) With very broad uniform priors or b)
with a tight prior for γ , estimation of λ and ω is very poor. c) With a tight prior
on λ , the estimation of ω is improved. d) The addition of a tight prior on γ , as
before, yields little benefit. Grey lines show each of the 9 simulated trajectories,
the blue line shows the true curve, the solid red line shows the median model
fit and the dashed red lines show the 95% confidence intervals. Simulated data
produced with λ = 10−5,γ = 0.8,ω = 0.99,ρ = 0.5,N = 1000. Other priors
for fitting were ρ =U(0,1), though the posteriors are not shown.
that the small fluctuations that occur in copy number will create a distribution of
plasmid loss probabilities. Further, plasmids based on the same backbone are likely
to have similar copy numbers and, therefore their distributions can be thought of a
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log10 λ ~ U(-10,0), σλ ~ Exp(100)global
strain
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log10 λ1 ~ N(log10 λ, σλ), σλ1 ~ Exp(100)
log λ1,1~ N(log λ1,σλ1) ... log λ1,r~ N(log λ1,σλ1)
log10 λs ~ N(log10 λ, σλ), σλs ~ Exp(100)...
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γ1,1 ~ N(γ1,σγ1) ... γ1,r ~ N(γ1,σγ1) 
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...
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ω1 ~ U(0,1), σω1 ~ U(0,0.1)
ω1,1 ~ N(ω1,σω1) ... ω1,r ~ N(ω1,σω1) 
ωs ~ U(0,1), σωs ~ U(0,0.1)...
...
log λs,1~ N(log λs,σλs) ... log λs,r~ N(log λs,σλs)
γs,1 ~ N(γs,σγs) ... γs,r ~ N(γs,σγs) 
ωs,1 ~ N(ωs,σωs) ... ωs,r ~ N(ωs,σωs) 
Figure 5.9: Hierarchical model for fitting parameters of the plasmid loss model.
being drawn from a higher level distribution. This is a standard method in Bayesian
statistics to model uncertainty in data.
Here I use this concept to build a hierarchical model for the three plasmid loss
model parameters, Figure 5.9. As suggested above, the log of the plasmid loss prob-
ability λ has a global distribution for all strains with plasmids based on the same
backbone. The posterior distribution for this global λ is determined by sampling
from a uniform prior, U(−10,0) and the posterior distribution for the standard de-
viation, σλ , in the global λ is sampled from an exponential prior, Exp(100), which
produces a shrinkage pressure on the distribution, making the posterior distributions
narrower. Below the global level, there is a distribution on λ for each strain, sam-
pled from a normal distribution with a mean sampled from the global distribution on
λ and a standard deviation sampled from the global distribution on σλ . There is a
strain level standard deviation on the strain level λ which is sampled from an expo-
nential prior in the same manner as the global one. Finally, at the lowest level, each
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replicate of a strain has a posterior distribution on λ which is sampled from a nor-
mal distribution with mean sampled from the strain level λ and standard deviation
sampled from the strain level standard deviation.
The growth ratio parameter, γ could be modelled in the same way because one
could assume that the major effector of burden due to the plasmid is in the strong
production of the recombinant protein rather than the plasmid stability mechanisms.
This assumption is borne out in the growth rate measurements shown later. How-
ever, since the growth rates can be directly measured, the strain level distributions
can be directly determined. As such, the replicate level posterior distributions for γ
are sampled from a normal distribution with mean sampled from the strain level γ
and standard deviation given by the standard deviation of the strain level γ .
The parameter encapsulating the efficacy of the killing mechanisms, ω , cannot
be said to be globally linked. This is particularly true when considering the differ-
ences between the bacteriocin and TA systems but also applies between different
TA systems as they function in distinct ways. As such, each strain has a poste-
rior distribution on ω and standard deviation sampled from uniform priors. Each
replicate then has a posterior distribution on ω sampled from a normal distribution
with mean and standard deviation sampled from the the strain level ω and standard
deviation.
The fitting is performed for all data for all strains concurrently. As such, the
log likelihood can be written as a sum over all timepoints, t, for all replicate, r, for
all strains, s:
L(θ |X+) =
s
∑
r
∑
t
∑ log
(
P
(
X+s,r,t |θ
))
(5.11)
where θ is the full set of parameters, {λs,r,λs,σλs ,λ ,σλ ,γs,r,γs,σ γs ,ωs,r,ωs,σωs ,ρs,r}
and:
P(X+s,r,t |θ) = Beta-Binomial(ns,r,t ,αs,r,t ,βs,r,t)
αs,r,t = φs,r,t (λs,r,γs,r,ωs,r)
(
1
ρs,r
−1
)
βs,r,t =
αs,r,t−αs,r,t φs,r,t (λs,r,γs,r,ωs,r)
φs,r,t (λs,r,γs,r,ωs,r)
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Figure 5.10: Fits of the hierarchical model at the replicate level to simulated plasmid loss
curves with PSK. Simulated data are created with parameters λ = 10−5,γ =
0.8,ω = 0.99,ρ = 0.5,N = 1000. These timecourses are fitted concurrently
with simulated data without PSK, ω = 0.
This hierarchical method of fitting can be demonstrated using simulated data of
two strains, with and without PSK. The data shown in Figure 5.7 is the data without
PSK and the data shown in Figure 5.8 is that with PSK. Both of these data sets
are simulated using the same plasmid loss probability, λ , growth rate ratio, γ , and
noise, ρ . The difference is in the PSK efficacy parameter, ω . Figure 5.10 shows the
ability of this hierarchical method to fit the individual timecourses for the dataset
with PSK. Note that each fitted curve is different. This is enabled by the replicate
level parameters.
Figure 5.11 shows the model fit to the full set of timecourses for each simulated
strain, using the strain level parameter posteriors.
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Figure 5.11: Fits of the hierarchical model at the strain level to simulated plasmid loss
curves a) without PSK and b) with PSK. Since the ω parameter is not relevant
to the fitting of the timecourses without PSK, the posterior distribution of the
noise parameter ρ is shown below the plasmid loss curve of (a) instead.
5.1.4 MCMCModel Fitting - Strain Dilution Curves
The models in Equations 5.2 and 5.4 can also be used to fit the data from the strain
dilution assays. Whereas, for the plasmid loss curves the data is plasmid-bearing
fraction over time, here the initial plasmid-bearing fraction is the varied parameter
and plasmid-bearing fraction after 24 hours is the measured variable. Previously
the initial population was regarded as entirely plasmid-bearing, ν = 0. Here ν is
determined by the initial plasmid-bearing fraction, ν = 1φ0 − 1. Further, the data
is over a single passage which, as discussed previously, is considered to equate to
500 plasmid-free generations, so τ = ln(500). As such, the log likelihood is nearly
identical to that for the plasmid loss curve fitting but summed over ν rather than t:
L(λ ,γ,ω,ρ|X+) =
r
∑
ν
∑ log(P(xr,ν |λ ,γ,ω,ρ)) (5.12)
The priors for γ are calculated in the same way as in the plasmid loss curve fitting.
However, the effects of the plasmid loss parameter, λ , are insignificant in com-
parison to the effects of the growth difference parameter γ once plasmid-free cells
exist, as was discussed previously. As such, λ and consequently the PSK efficacy
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parameter ω are removed from the fitting for the TA systems. ω is reintroduced
for fitting the bacteriocin system as its effects are not reliant on plasmid loss in this
experiment.
5.2 Experimental Determination of Plasmid Stability
A number of bacterial strains were produced in which the stabilising effects of
toxin-antitoxin and bacteriocin systems could be experimentally determined, both
in vitro and in vivo. The constructed plasmids, detailed in Section 2.3, include the
expression of fluorescent or luminescent proteins that induce a burden on the host
strain. Two toxin-antitoxin system, hok-sok and axe-txe, alongside the bacteriocin
microcin-V, were tested to determine their stabilising effects. The plasmids were
tested in the therapeutically relevant strain E. coli Nissle 1917 [178].
5.2.1 Effect of Plasmid Stability Mechanisms on Growth
Initially, plasmids expressing dasher GFP from the strong, constitutive OXB20 pro-
moter in order to produce a burden on plasmid-bearing host cells, were produced.
These plasmids were cloned in to a strain of E. coli Nissle with the luxCDABE cas-
sette and Erythromycin resistance gene in the chromosome (EcN-Lux) [13]. This
allows for the growth of the plasmid bearing strain in selective media, to reduce the
chance of external contamination while still allowing for plasmid loss.
A microplate reader was used to collect growth data of the plasmid-bearing
and plasmid-free strains in LB media with Erythromycin but without Kanamycin.
A non-parametric Gaussian process [193] was fitted to the growth curves, Figure
5.12A. This enables the determination of growth rates throughout the growth curve,
Figure 5.12B, without having to make the assumptions necessary when fitting stan-
dard growth models [194].
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Figure 5.12: Growth curves and model fits for the fluorescent plasmids in EcN-Lux grown
in LB media with Erythromycin. (A) Logged optical density measured at
540nm. The points show 6 replicates for each strain with the different colours
indicating each replicate. The blue line shows the non-parametric Gaussian
process fit with standard error shown by the light blue area around the line. (B)
Estimated growth rate as a function of time. (C) Estimated maximal growth
rates and (D) growth rate ratios. The points show the mean and the lines show
the standard deviation of the mean.
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The maximal growth rates of the fluorescent plasmids are shown in Figure
5.12C and the ratio of plasmid-bearing to plasmid-free growth rates in Figure 5.12D.
The results show that the burden of expressing GFP from the high copy plasmid re-
sults in a growth rate∼ 70% of the plasmid-free EcN-Lux. Further, the results show
that the extra burden of carrying and expressing the plasmid stability mechanisms
have minimal impact on growth rates. These results demonstrate the problem for
plasmid stability; once the plasmid is dropped, the significantly higher growth in
the plasmid-free strain causes the plasmid-bearing population to be outcompeted.
In addition to the fluorescent plasmid, a set of luminescent plasmids constitu-
tively expressing the LuxCDABE operon from the phelp promoter [195] were pro-
duced for determining the ability of the PSK systems to improve stability in vivo.
These were transformed in to the wild-type E. coli Nissle 1917. The growth rates
were determined using the same method as for the fluorescent strains, though the
plasmid-bearing strains had to be grown with Kanamycin to ensure retention of the
plasmids. This was due to the instability of the control plasmid p24 help-Lux.
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Figure 5.13: Growth curves and model fits for the luminescent plasmids in EcN grown in
LB media. (A) Logged optical density measured at 540nm. The points show
6 replicates for each strain with the different colours indicating each replicate.
The blue line shows the non-parametric Gaussian process fit with standard
error shown by the light blue area around the line. (B) Estimated growth rate
as a function of time. (C) Estimated maximal growth rates and (D) growth rate
ratios. The points show the mean and the lines show the standard deviation of
the mean.
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Figure 5.14: GFP fluorescence measurements throughout fluorescent plasmid loss experi-
ment. The black lines (3 replicates) show the trajectories of strains passaged
in LB media with Erythromycin and Kanamycin to ensure plasmid mainte-
nance. The red lines (9 replicates for plasmid-bearing strains and 6 replicates
for EcN-Lux control) show the trajectories in LB media with Erythromycin
but without Kanamycin, allowing for plasmid loss. The data is normalised
by negating the mean fluorescence of the EcN-Lux in LB+Er (plasmid-free
control) at each passage and scaling so that the lowest recorded measurement
is equal to 0.
The growth rate results, Figure 5.13C, show that there is a similar impact on
growth rates compared to the fluorescence based plasmids. While the metabolic bur-
den of the LuxCDABE operon is thought to be greater than that of GFP, the growth
rates are most likely similar due to the lower copy ColE1 origin of replication on
the luminescent plasmids compared to the pUC origin on the fluorescent plasmids.
5.2.2 Plasmid Stability Assays in vitro
The three stability mechanisms investigated were the E. coli native hok/sok type I
toxin-antitoxin mechanism, the type II toxin-antitoxin mechanism axe/txe, native to
a gram positive bacteria, and the E. coli native bacteriocin microcin-V. The fluores-
cent plasmids containing these stability mechanisms were assayed for their stability
in EcN-Lux using a protocol of daily passaging of cultures with samples from each
replicate checked for population level fluorescence in a microtitre plate reader, Fig-
ure 5.14, and single fluorescence in a flow cytometer, Figures 5.15-5.18.
The flow cytometry data was passed through an automated pipeline to remove
5.2. Experimental Determination of Plasmid Stability 151
events classified as background debris and cell clumps, returning only single cell
events, see Section 2.1.3. The single cell flow cytometry data shows that when
plasmid maintenance is enforced through the use of antibiotics the fluorescence
levels remain stable across the full 37 passages for all but the microcin-V bearing
strain. For the control plasmid and two TA system plasmids, this suggests that the
plasmid copy number is stable and the fluorescent output of the plasmid is muta-
tionally stable. It also indicates that samples that are categorised as plasmid-free
cells, below, are not the result of loss-of-function mutations leading to a loss of flu-
orescence. This conclusion is further supported by the population level fluorescence
data recorded using a microplate reader remaining stable throughout the experiment,
Figure 5.14. However, a reduction in fluorescence is seen in the flow cytometry and
microplate reader data for the microcin-V system. The flow cytometry popula-
tions are homogeneously fluorescing indicating that, although fluorescence levels
are being reduced, it is unlikely that cells being categorised as plasmid-free have
undergone a loss-of-function mutation to remove any fluorescence. A reduction in
the plasmid copy number is one possible explanation.
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Figure 5.15: Flow cytometry samples of EcN-Lux:p28 OXB20. A) 3 replicates grown in
LB media with Erythromycin and Kanamycin, ensuring plasmid maintenance.
The black dashed line indicates the median fluorescence at passage 0. B) 9
replicates grown in LB media with Erythromycin only, allowing for plasmid
loss.
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Figure 5.16: Flow cytometry samples of EcN-Lux:p28 OXB20-HS. A) 3 replicates grown
in LB media with Erythromycin and Kanamycin, ensuring plasmid mainte-
nance. The black dashed line indicates the median fluorescence at passage
0. B) 9 replicates grown in LB media with Erythromycin only, allowing for
plasmid loss.
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Figure 5.17: Flow cytometry samples of EcN-Lux:p28 OXB20-AT. A) 3 replicates grown
in LB media with Erythromycin and Kanamycin, ensuring plasmid mainte-
nance. The black dashed line indicates the median fluorescence at passage
0. B) 9 replicates grown in LB media with Erythromycin only, allowing for
plasmid loss.
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Figure 5.18: Flow cytometry samples of EcN-Lux:p28 OXB20-MCC. A) 3 replicates
grown in LB media with Erythromycin and Kanamycin, ensuring plasmid
maintenance. The black dashed line indicates the median fluorescence at pas-
sage 0. B) 9 replicates grown in LB media with Erythromycin only, allowing
for plasmid loss.
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Figure 5.19: Plasmid loss curves for fluorescence based plasmids in EcN-Lux. The grey
lines show the trajectories of 9 replicates for each strain. The solid red line
shows the model fit and the dashed red lines show the 95% confidence inter-
vals.
The single cell flow cytometry data was then clustered on the GFP fluorescence
signal to classify cells as plasmid-free or plasmid-bearing, see Section 2.3.8. This
data was used to produce the plasmid loss curves shown in Figure 5.19. For the
control plasmid, without a PSK system (EcN-Lux:p28 OXB20), the plasmid-free
cells start to become apparent after only ∼ 4 passages, with the populations be-
coming entirely plasmid-free after ∼ 12 passages. The results show that the toxin-
antitoxin systems improve the stability of the plasmid, though the commonly used
hok/sok (EcN-Lux:p28 OXB20-HS) only provides stability for∼ 16 passages, with
one replicate beginning to drop as soon as passage 10 and one lasting for nearly 30
passages. Strikingly, axe/txe (EcN-Lux:p28 OXB20-AT) remains stable throughout
the experiment, clearly demonstrating its efficacy over the other systems. Because
no plasmid loss is observed, the model fitting is essentially non-identifiable. Finally,
the results demonstrate that the microcin-V system (EcN-Lux:p28 OXB20-MCC)
outperforms the hok/sok system, although the results are heterogeneous, with four
of the nine replicates remaining entirely plasmid-bearing for the length of the ex-
periment and in five of the replicates the plasmid-free population takes over.
The posterior of the killing parameter, ω , produced from the model fitting,
Figure 5.20, show that even though the hok/sok system has a high killing efficacy it
still loses out to competition from the few plasmid-free cells that escape the toxin.
On the other hand, even though the bacteriocin system seems to produce a higher
plasmid loss rate, perhaps due to a reduction in copy number to compensate for
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Figure 5.20: Model posteriors for fluorescence based plasmids in EcN-Lux.
increased burden, it needs a far lower killing efficacy to produce better results than
hok/sok. The posteriors for the control strain, EcN-Lux:p28 OXB20, show tight
control of growth rate but a very wide distribution for the plasmid loss probability,
λ . This again may indicate that the pUC based plasmid, with no control on plasmid
replication, may be changing copy number to compensate for burden.
Plasmid-stability for the luminescent p24 help-Lux plasmids were then deter-
mined using the same growth protocol as for the p28 OXB20-X strains. However,
measurements could only be carried out using population luminescence in EcN
rather than single cell fluorescence in EcN-Lux. This means that we are unable
to fit the model to the data as it is not possible to determine the plasmid-bearing and
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Figure 5.21: Luminescence measurements throughout luminescent plasmid loss experi-
ment. The black lines (3 replicates) show the trajectories of strains passaged
in LB media with Kanamycin to ensure plasmid maintenance. The red lines (9
replicates for plasmid-bearing strains and 6 replicates for EcN control) show
the trajectories in LB media but without Kanamycin, allowing for plasmid
loss. The data is normalised by negating the mean luminescence of the EcN
in LB (plasmid-free control) at each passage and scaling so that the lowest
recorded measurement is equal to 0.
plasmid-free population proportions. Figure 5.21 shows the population lumines-
cence at each passage measure using a microplate reader. The control population
(EcN:p24 help-Lux) had almost stopped luminescing by the end of the first pas-
sage. The two TA strains and the microcin-V carrying strain perform better than
the control and rank in the same order as for the fluorescent plasmids. However, the
luminescence loss occurs faster and even affects the axe/txe bearing strain. Even the
samples in which the media contained Kanamycin, enforcing plasmid maintenance,
showed reductions in luminescence and in one of the EcN:p24 help-Lux replicates
luminescence was completely lost. Unfortunately, as it wasn’t possible to record
single cell data it cannot be said whether this is a general reduction in luminescence
across the whole population, as was seen with the fluorescent microcin-V plasmid,
or whether there are populations with no luminescence and populations with stable
luminescence.
If one looks at just the luminescence changes in the Kanamycin controls, Fig-
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Figure 5.22: Luminescence measurements of Kanamycin control replicates throughout lu-
minescent plasmid loss experiment. Three replicates of each plasmid-bearing
strain are shown.
ure 5.22, it is apparent that the populations are tending to a similar lower lumines-
cence state, with the exception of two outliers.
5.2.3 Plasmid Stability Assays in an in vivo Tumour Model
Strains of E. coli Nissle containing the luminescent plasmids were tested to deter-
mine whether the stabilisation mechanisms were functional in vivo as well as in
vitro. The strains were intravenously injected into a mouse tumour model for in
vivo characterisation [13]. Within 3 days of administration the strains colonised the
tumours in the mouse flanks, see Figure 5.23A. Luminescence measurements were
taken every day using an in vivo imaging system (IVIS) to determine the location
and stability of luminescence production from the strains (Figure 5.23).
Seven days after the injection the tumours were excised, homogenised and
colony counts were performed in selective and non-selective plates in order to deter-
mine the plasmid-bearing proportion of the bacteria within the colonised tumours.
Figure 5.24 shows that without any stabilising system ∼ 50% of the population had
dropped the p24 help-Lux plasmid after intravenous injection and tumour colonisa-
tion. In comparison, the p24 help-Lux-AT was significantly stabilised (P = 0.0013)
with nearly 100% of the population maintaining the plasmids after colonisation.
The strain p24 help-Lux-HS also showed significant stability over p24 help-Lux
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Figure 5.23: Luminescence expression of stabilised plasmids in vivo. a) An example of
a mouse being imaged in the IVIS system. b) Luminescence measurements
of tumours colonised with EcN carrying luminescent plasmids. The control
strain EcN-Lux carries a copy of the luxCDABE operon on the chromosome.
The boxplots show data in measurements of 7 days in which each mouse was
implanted with two tumours, one on each flank and for each strain there were
5 mice. Outliers are marked with black points. The black lines show the
luminescence measurement of a one blank region on a mouse from each group
each day.
control (P = 0.034) with ∼ 80% of the population maintaining the plasmids after
colonisation. The bacteriocin plasmid p24 help-Lux-MCC did not show a signif-
icant improvement over the control though the mean plasmid-bearing population
was ∼ 70%. There was also no significant difference between the plasmid fraction
bearing population in p24 help-Lux-AT and p24 help-Lux-HS.
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Figure 5.24: Fraction of bacterial population remaining plasmid-bearing 7 days after
colonisation, calculated from colony counts on selective and non-selective
media performed in triplicate for each tumour. (*P=0.034, **P=0.0013 in the
Mann-Whitney U test for p24 help-lux n=9 tumours, p24 help-lux-HS n=7
tumours, p24 help-lux-AT n=8 tumours, p24 help-lux-MCC n=5 tumours)
5.2.4 Restoration of Plasmid-bearing Population with Bacteri-
ocins
As can be seen from the plasmid loss experiments with the fluorescent hok/sok
plasmids, once plasmid-free cells arise in the population the toxin-antitoxin sys-
tem has no way to restore the plasmid-bearing population. Bacteriocins, however,
through the secretion of toxin in to the environment provide a general policing of
the population. As such, when plasmid-free cells arise or if the culture becomes
contaminated the bacteriocin system can push the population back towards entirely
plasmid-bearing. To test this, cultures of the fluorescent plasmid based strains were
diluted in different ratios with plasmid-free EcN-Lux. The single cell fluorescence
was measured using flow cytometry to determine the plasmid-bearing population
proportions immediately after the dilutions. The cultures were grown for 24 hours
under the same conditions as for the plasmid loss curves, passaged and grown for
a further 24 hours. At each passage, single cell fluorescence data was gathered
using flow cytometry and the plasmid-bearing population proportions were deter-
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Figure 5.25: Plasmid-bearing strains are diluted with plasmid-free EcN-Lux at different
ratios. The dilutions are sampled after 24 hours and show that the faster
growth rate of the plasmid-free cells leads to further dilution of the plasmid-
bearing population. In the case of EcN-Lux:p28 OXB20-MCC, however, the
secreted bacteriocin allows the plasmid-bearing population to out-compete the
plasmid-free cells. Blue points show the median of 3 replicates at each initial
dilution; the bars show the minimum and maximum plasmid-bearing fraction
at each passage. The solid red line shows the model fit and the dashed red
lines show the 95% confidence intervals. Each replicate was passaged once
initially to allow for the cells to acclimatise to the growth conditions. How-
ever, for the EcN-Lux:p28 OXB20-MCC replicates, most plasmid-free cells
were dead after 1 passage so the data from passage 0 to passage 1 were used.
mined as previously detailed. Figure 5.25 shows that, when a population of TA
plasmid-bearing cells is diluted with plasmid-free EcN-Lux, as stated above the
plasmid-free population outgrows the plasmid-bearing population, further diluting
it. However, when the EcN-Lux:p28 OXB20-MCC cells are diluted, they quickly
kill the plasmid-free cells and restore the population to plasmid-bearing. In fact
within 24 hours there are no plasmid-free cells detectable in all but one anomalous
sample.
5.3 Discussion
In this Chapter I have outlined the problem of plasmid stability and described one
commonly used system and two alternatives for its improvement. ODE models were
developed that describe how toxin-antitoxin and bacteriocin systems affect plasmid
stability and a Bayesian methodology was established for fitting the models to sim-
ulated and experimental data. The PSK systems were tested in the therapeutically
relevant E. coli Nissle in vitro and in an in vivo mouse tumour model. Finally,
inter-cellular killing by the bacteriocin system was shown to be able a reinstate the
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plasmid-bearing population after dilution with plasmid-free bacteria.
The simple Bayesian method developed was able to accurately fit models to
systems without PSK systems, even with very limited prior information. This has
previously been described as a challenge [192]. The introduction of a PSK system
in to the simulated data necessitated the use of prior information for the plasmid
loss probability. This demonstrates the correlation between plasmid-loss and post-
segregational killing. However, a PSK-free control system can be used to produce
this prior information if the assumption that carrying a PSK system doesn’t change
copy number holds. This assumption is reasonable for plasmids with copy num-
ber control but for plasmids without such control it is possible that copy number
does change to compensate for increased burden. An unexpected outcome from
the Bayesian fitting methodology is the robustness with which growth rate ratios
can be determined. This method could conceivably be used to ascertain growth
rate differences between strains in competitive cultures rather than using individual
growth curve experiments. This may prove incredibly useful when growth rates are
dependant on the other strain, such as through cross feeding.
The hierarchical Bayesian fitting method implicitly takes advantage of simi-
larities between strains but also allows for the variability between replicates to be
more robustly accounted for. The posterior distribution produced for the plasmid
loss probability is more constrained than that produced using the simple approach,
given the same level of noise in the simulated data. Although the method, as pre-
sented here, used the ability to directly produce strain level growth rate posteriors,
this could also be modelled in a way that takes advantage of global similarities.
A set of plasmids were constructed for both fluorescence and luminescence
determination of plasmid stability. The fluorescence plasmids enabled the measure-
ment of single cell fluorescence using flow cytometry and, therefore, the determina-
tion of plasmid-bearing population proportion without the need for time-consuming
and statistically weaker colony-counting methods. The luminescent plasmids al-
lowed the detection of plasmid activity in vivo when the plasmid-bearing strains
were in the anoxic environment of a tumour, which disqualifies the use of tradi-
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tional fluorescent proteins.
Using a microplate reader to measure absorbance and a method for fitting a
Gaussian process, growth rates for each of the plasmid bearing strains were de-
termined. This showed that the fluorescent and luminescent reporters expressed
on the plasmids produced significant reduction in growth rate. However, the PSK
systems did not produce significant extra burden. There was also no significant dif-
ference between the fluorescent and luminescent strains. This is unexpected as the
expression of luminescence is more costly than that of fluorescence. The promot-
ers driving their expression are rather different, however, with the OXB20 promoter
driving GFP expression being particularly strong. Further, the origins of replication
on the plasmids are not the same; though they are both high copy, the pUC origin on
the fluorescent plasmids is uncontrolled and can produce a far higher copy number
than that of the ColE1 origin on the luminescent plasmids.
The fluorescent strains were assayed for plasmid stability using a protocol in-
volving daily passaging and fluorescence measurement using flow cytometry. The
data show that the fluorescence burden produces instability resulting in total re-
moval of the plasmid-bearing population after 10 days. All of the PSK mechanisms
were able to improve stability with axe/txe greatly outperforming the other systems.
The better performance of axe/txe than of hok/sok is somewhat of a surprise.
Firstly, hok/sok is native to E. coli and so one might expect it to be more capable
in an E. coli strain than the non-native axe/txe. Secondly, hok/sok is bactericidal
whereas axe/txe is merely bacteristatic. It is reasonable to assume that the plasmid-
free persister cells produced from loss of the axe/txe plasmid would at a later stage
begin to grow again.
The failure of the microcin-V system to achieve total plasmid stability is also
surprising. Changes to the functioning of the plasmid are clear when one consid-
ers the change in fluorescence in the selective controls. It is unclear from the data
available what led to the reduction in fluorescence. However, the variability in the
performance of the microcin-V system suggests that the bacteriocin is not being
produced reliably. The regulation of the native bacteriocin promoters is only par-
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tially understood but is certainly thought to be influenced by the environment in
which the bacteria are growing.
The luminescent strains show a lack of stability of luminescent expression
even in the strains grown under selective conditions. This suggests that the loss
in fluorescence cannot entirely be explained through plasmid loss. Interestingly,
the luminescence of all of the strains grown selectively, with the exception of two
outliers, trends towards the same level and plateau, though at different rates. If
a sub-population had accrued a loss-of-function mutation that gave it competitive
advantage by stopping luminescence production, one would expect the population
luminescence levels would trend to the level of the non-luminescent control. As
such, it is reasonable to assume that if mutations have arisen, it has been to reduce
luminescence rather than stop it. It can also be assumed that the entire population
would tend to this luminescence level as strains with higher luminescence would be
outcompeted and diluted through passaging. Sequencing of the 5’ UTR upstream of
the luxCDABE cassette could determine if the change in luminescence is due to mu-
tation within the plasmid. Most of the strains grown non-selectively lose lumines-
cence completely, which along with the assumption that complete loss-of-function
mutations aren’t occurring on the plasmid, suggests that the luminescent plasmids
are being lost more rapidly than the fluorescent ones were. The plasmid proves to be
so unstable that without a PSK system, luminescence is mostly lost after 24 hours.
Indeed the axe/txe system, which was infallible in the fluorescent plasmid, shows
total loss of luminescence in 4 of the 9 replicates. The bacteriocin system manages
to keep 2 replicates luminescing, beating the hok/sok system again.
Even though the luminescent plasmids show instability in liquid culture,
growth conditions in vivo are considerably different, with cells growing far more
slowly due to poor nutrient conditions within tumours [196]. The in vitro imag-
ing results demonstrate that all of the plasmid-bearing strains can colonise tumours
and produce luminescence. All of the plasmid-bearing strains perform similarly
in terms of luminescence levels, showing slow reduction in luminescence after a
peak 3-4 days after administration. The colony-count data, however, shows that the
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axe/txe system again performs best in terms of plasmid stability. The bacteriocin
shows no significant increase in stability over the non-PSK control. This may be
related to the iron-dependant repression of the putative bacteriocin promoters [181].
Environmental iron levels have been implicated in the proliferation of tumours, with
iron chelation inhibiting tumour cell proliferation [197]. High iron levels in the tu-
mour microenvironment may lead to the repression of the bacteriocin system. If
microcin-V were to be used in a tumour environment in the future, the replacement
of the native promoters should be considered.
Finally, it was shown that when challenged with plasmid-free cells at different
dilutions, the bacteriocin, as expected, was the only system that enabled the survival
of the plasmid-bearing population. This opens up the possibility for the bacteriocin
to be used for plasmid stabilisation in environments in which contamination is a
risk; though this would require changes to the bacteriocin promoter to make expres-
sion more reliable.
5.4 Conclusion
In conclusion, I have produced a new mathematical model of plasmid-loss, inte-
grating post-segregational killing from toxin-antitoxin and bacteriocin systems. I
have developed a novel hierarchical Bayesian methodology for fitting this model to
experimental data and demonstrated improvement over a standard Bayesian fitting
approach. I have experimentally compared three plasmid stabilisation mechanisms
in E. coli Nissle 1917. This is the first time that axe/txe and mccV have been demon-
strated as plasmid stabilisation mechanisms in commensal bacteria. This is also the
first demonstration that axe/txe performs better than the current standard mecha-
nism, hok/sok, in any bacterium. I have also shown, for the first time, that axe/txe
can stabilise burdensome plasmids in an in vivo mouse tumour model with better
efficacy than had previously been attained using hok/sok [13].
5.5 Future Work
The toxin-antitoxin and bacteriocin systems demonstrated in this Chapter improved
the stability of the plasmids on which they were borne. The model showed that of
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the three parameters that affect plasmid stability, only one of them is related to the
stability mechanism. However, separating the effects of plasmid loss rate from that
of the plasmid stability mechanisms proved difficult. An assumption had to be made
that the stability mechanisms had no effect on plasmid copy number, and therefore
no effect on plasmid loss rate. This allowed for a control plasmid to be used to
infer the loss rates of the stabilised plasmids. A more robust method for the deter-
mination of plasmid copy number would be desirable. Quantitative PCR (qPCR)
can be used to determine a population average measure of copy number [198, 199].
However, determination of the distribution of plasmid copy number within a pop-
ulation is important [29]. Flow-sorting of cells combine with droplet digital PCR
(ddPCR) allows for the determination of copy number within sub-populations that
can be chosen based on single cell fluorescence [200]. Along with statistical mod-
els, techniques such as these may be able to provide accurate measurements of the
distribution of plasmid copy number within a population. Until such methods have
been developed and verified, testing the stability mechanisms on plasmids with dif-
ferent origins of replication can provide a semi-quantitative verification of the effect
of copy number on plasmid maintenance. As such, the GFP fluorescent plasmid
used the plasmid stability assays is being modified with three additional origins of
replication: low copy pSC101, medium copy p15A, and the hybrid pRO1600/ColE1
used in the luminescent plasmid. These plasmids will be assayed for plasmid loss
using the same method as that used for the plasmids presented in this thesis.
The inconsistency of stabilisation for the bacteriocin system begs many ques-
tions. The native promoter was used in this work, but there is only a limited un-
derstanding as to its regulation. Experiments using better characterised promoters
could potentially improve the consistency of its stabilising effects. In addition, it
was noted that the fluorescence levels were reduced in the plasmid-bearing popula-
tion of the bacteriocin carrying strain. The copy number checks mentioned above
could be used to demonstrate whether the fluorescence reduction is due to the extra
burden of the bacteriocin causing a reduction in plasmid copy number. Additionally,
sequencing checks could be made to determine whether mutation of the regulatory
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region is causing the fluorescence reduction.
In addition to the two forms of stability mechanisms explored in this thesis,
TA systems and bacteriocins, active partitioning has also been used in previous syn-
thetic biological systems [13]. Naturally, these systems tend to occur on low copy
plasmids. Exploration of the efficacy of active partitioning in a range of plasmids
and a comparison against the systems presented here would be beneficial to their
further use in synthetic biology.
Even if perfect plasmid maintenance is possible, the evolutionary stability of
synthetic biological systems encoded on DNA remains a challenge. Particularly
for plasmids expressing high amounts of protein, loss-of-function mutants are often
heavily selected for. It is possible that TA systems or bacteriocins could provide
a solution to a subset of these mutations. Immunity to a toxin can be linked to
the continued production of a desired protein by placing the immunity gene in an
operon with that protein. Mutations which result in the loss of transcription from
the upstream promoter, will also result in loss of immunity, leading to the death
of any cells that stop transcribing the operon. Though this is not a full solution to
the problem of mutational instability, it is a step that may prove to be useful in the
construction of some simple recombinant protein production systems.
Chapter 6
General Conclusions
Synthetic biology has advanced rapidly over the last two decades by combining the
tools of molecular biology with the approach and principles of the engineering dis-
ciplines. These advances have enabled the further study of biological processes and
the development of complex, new-to-biology systems. However, there have only
been a few notable examples of synthetic biological systems leaving the laboratory
and being deployed in the real world.
In this thesis I have confronted two of the hurdles that currently stand in the
way of real world deployment of synthetic biological systems. For both industrial
and clinical applications of synthetic biology to advance further, removing the need
to use antibiotics and antibiotic resistance genes for circuit stability and contamina-
tion control is crucial. The toxin-antitoxin and bacteriocin systems presented here
enhance the segregational stability of burdensome plasmids and, therefore, offer an
alternative to the use of antibiotic resistance genes. The great challenge for the field
now is enhancing the mutational stability of synthetic biological systems. This can
perhaps be achieved through the prevention, correction or deletion of mutations.
However, a parallel approach that should be explored is the development of new
design paradigms that account for random but inevitable mutation events.
The second problem confronted here is that of population control. Division-
of-labour is being explored as a method to lessen the burden on individual cells
in order to reduce the evolutionary pressure on engineered strains. This requires
tools that enable the stable co-existence of multiple strains with differing growth
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rates. The SPoCK system, that I present here, for the control of multi-species bac-
terial populations has the potential to enable predictable, dynamic control over the
constituents of a population, while only necessitating the engineering of a single
controlling strain. The use of Bayesian modelling, and in particular methods such
as approximate Bayesian computation, allows us to explore vast numbers of pos-
sible system and experiment designs computationally. As the the systems that we
design and build become more complex and control is required at the community
level as well the cellular level, using approaches such as these to understand and
predict behaviour will become ever more critical.
Summary
In this thesis I have:
• Designed a system to stabilise multi-species bacterial communities using
competitive exclusion and dynamic bacteriocin production. This is the first
system to use bacteriocins to control community dynamics and the first sys-
tem to be able to control multi-species communities through the engineering
of a single strain.
• Mathematically demonstrated the ability of this system to produce stable or
oscillating communities, dependent on easily tunable inputs.
• Demonstrated a theoretical improvement to the robustness of this system
through the addition of a self-regulation feedback loop.
• Constructed the first inducible and repressible bacteriocin expression sys-
tems.
• Constructed and characterised the first density dependent bacteriocin expres-
sion system using a novel Bayesian methodology for parametrising Shea-
Ackers promoter dynamics models.
• Undertaken initial experiments with this system in chemostat, demonstrating
its ability to extend the presence of the two constituent populations.
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• Produced a new mathematical model of plasmid stability, incorporating post-
segregational killing from toxin-antitoxin and bacteriocin systems.
• Developed a hierarchical Bayesian methodology for fitting this model and
demonstrated its improvement over a standard Bayesian fitting approach.
• Carried out the first characterisation of the axe/txe toxin-antitoxin system and
microcin-V bacteriocin in E. coli Nissle 1917, in vitro and in an in vivo mouse
tumour model.
• Demonstrated that both of these systems perform better than the current stan-
dard system, hok/sok.
Appendix A
Steady State SPoCK Expressions
X =
D2K
−nβ
β (D(KX −KC)+KCµXmax−KXµCmax)
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nβ
β
)
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Appendix B
SPoCK Promoter Characterisation
Correlograms
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Figure B.1: Correlogram of SPoCK promoter characterisation posteriors. The posterior
distribution of each of the parameters in the Shea-Ackers promoter models are
shown on the diagonal. The bottom triangle shows the correlation between
each pair of parameters for every MCMC sample. The top triangle shows the
kernel densities of those correlations. Some parameters are highly correlated,
for example K1T and K2T.
Appendix C
SPoCK in Chemostat Results
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Figure C.1: Bioreactor results of SPoCK in competition. The circles show the points in
time at which samples were taken. Replicate 1 and 2 were at D = 0.1hr−1 and
replicates 3 and 4 were at D = 0.05hr−1.
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